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Prefaci 
L’increment exponencial de la pràctica d’activitat física i esport de la població dels 
països occidentals s’ha associat a la necessitat d’augmentar la comprensió dels 
processos de resposta muscular a l’exercici, i d’optimitzar-ne els processos de 
recuperació. Una de les respostes a l’exercici, especialment quan aquest comporta 
contraccions excèntriques de certa intensitat, és el dany muscular o, més 
concretament, el dany muscular induït per l’exercici (EIMD). Així, el dany muscular i 
l’EIMD, amb 26.796 i 1351 entrades a PubMed respectivament (febrer 2016), són 
fenòmens sobre els quals la fisiologia ha focalitzat l’atenció en els últims anys.  
Malgrat que certs processos inflamatoris puguin estar associats, el dany muscular no 
és el mateix que una lesió muscular. Les lesions musculars, generalment 
trencaments fibril·lars, s’observen, la majoria de vegades, a la unió miotendinosa i 
s’associen a una incapacitat muscular immediata i evident acompanyada d’una 
sensació de dolor aguda (80). Les lesions musculars produeixen la inhibició de la 
regeneració causada per la formació d’una cicatriu fibròtica, de manera que la funció 
mecànica del teixit es veu compromesa de manera notable. No obstant això, la 
majoria de vegades, l’execució d’exercicis que comporten la realització de 
contraccions excèntriques de certa intensitat desemboca en un dany a escala 
subcel·lular molt menys evident, amb la regeneració i adaptació funcional posteriors 
(36) a partir de la remodelació sarcomèrica (215). 
L’EIMD produeix un cert nivell de pèrdua de la funció muscular que, tot i que 
normalment no es perllonga més de set dies, pot afectar decisivament la 
programació de l’entrenament esportiu. A més, un dels símptomes de l’EIMD és el 
dolor muscular d’aparició tardana (DOMS). La cinemàtica dels exercicis en els quals 
se sol·licita la musculatura que pateix DOMS es pot veure alterada i incrementar 
potencialment el risc de patir lesions (50). De la mateixa manera, aquesta sensació 
de dolor o desconfort muscular podria tenir un impacte negatiu en l’adherència a 
programes d’activitat física (101). Així, una comprensió més àmplia del fenomen de 
l’EIMD i un diagnòstic acurat poden ajudar a optimitzar les càrregues d’entrenament, 
reduir les lesions i augmentar l’adherència a programes d’activitat física.  
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Abstract 
The aim of this thesis was to characterize lower limb exercise-induced muscle 
damage (EIMD) by analysing the time course and the magnitude of activity or 
concentration change of serum biochemical markers. For that purpose, lower limb 
EIMD was assessed by laboratory high intensity exercise (HIE) protocols (studies I, II 
and III) and field long duration exercise (LDE) protocols (studies IV and V). 
High intensity exercise 
In the first study (I), muscle damage induced by high intensity inertial half-squat 
exercise performed on a flywheel device was assessed through the serum evolution 
of muscle enzymes and fiber type-specific sarcomere proteins such as fast (type II) 
and slow (type I/ß) myosin (FM and SM respectively). Serum profiles were recorded 
at baseline and at different time points after exercise in ten healthy, physically active 
young men. The increase in serum muscle enzymes suggests increased membrane 
permeability of both fast (type II) and slow (type I) fibers, and the increase in FM 
reveals sarcomere disruption as well as increased membrane permeability of fast 
(type II) fibers. We concluded that an indirect molecular model of muscle damage 
could be constructed by measuring the time course of serum activity or concentration 
of muscle enzymes and proteins, according to their molecular weight, the fiber 
compartment in which they are located, and the fiber type (fast [type II] or slow [type 
I]) in which they are expressed. 
During the second study (II) we applied the indirect molecular model of EIMD to 
assess the muscle response. Specifically, in a trained pole vaulter (PV) and a 
physical education student (PE), we investigated the effect of a leg press exercise 
leading to failure (LPF) on changes in serum activity of muscle enzymes and serum 
concentration of FM and SM, while simultaneously examining mechanical output 
components as indicators of the performance and fatigue developed throughout the 
exercise. The PV’s exercise output revealed an explosive (power-oriented) profile 
leading to selective mild damage of fast fibers. In contrast, the PE exercise output 
showed a fatigue-resistant profile, which induced greater muscle enzyme activity and 
SM serum concentration, suggesting a higher extent of slow fiber damage. 
In the last HIE study (III), we investigated the degree of damage inflicted on the 
hamstring muscles by an intensive voluntary eccentric exercise. We analysed 
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differences in the extent of damage between-subjects and within-subjects (limb-to-
limb comparison). To do so, we assessed the relationship between serum 
biomarkers and other indirect markers of muscle damage. Thirteen males performed 
six sets of ten reps of eccentric unilateral leg curl with each leg. Results from this 
study challenge the notion that severe EIMD in humans is restricted to electrical 
stimulation protocols, since ten (‘high responders’) out of a total of thirteen subjects 
suffered severe muscle damage. Within-subject (limb-to-limb comparison) 
differences were also observed, revealing that experimental designs using 
contralateral limbs as a control should consider that different degrees of hamstring 
damage can be induced in the two legs. Sarcomeric mitochondrial creatine kinase 
(sMtCK) is a promising novel EIMD biomarker that allows identification of high 
responders. Finally, when muscle function is recovered, long-lasting increases in 
transverse relaxation time (T2) values suggest an adaptive process rather than 
damage. 
Long duration exercise  
The first LDE study (IV) applied the indirect molecular model of EIMD to assess the 
muscle response after mountain ultramarathon (MUM) in eight endurance-trained 
amateur athletes. From the results, we concluded that the increase in SM serum 
concentration after MUM may be indirect evidence of slow (type I) fiber-specific 
sarcomere disruptions. 
Finally, the last study (V) based on LDE protocols compared serum changes of 
biomarkers of EIMD after a 35-km mountain trail race (MTR) and a 55-km MUM. The 
sample was composed of one group of ten amateur trained male athletes who ran a 
35-km MTR and another group of six highly trained male athletes who ran a 55-km 
MUM. The results indicate that mountain running distance is related to deeper slow 
(type I) muscle fiber damage, even in highly trained individuals. 
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Resum 
L'objectiu d'aquesta tesi ha estat caracteritzar el dany muscular induït per diversos 
exercicis del tren inferior mitjançant l'anàlisi de l'evolució temporal i la magnitud de 
canvi de l'activitat o la concentració de marcadors bioquímics sèrics. Amb aquesta 
finalitat, el dany muscular induït per diversos exercicis del tren inferior s’ha avaluat 
mitjançant protocols de laboratori basats en exercicis d'alta intensitat (HIE) (estudis I, 
II i III) i protocols de camp consistents en exercicis de llarga durada (LDE) (estudis IV 
i V). 
Exercici d'alta intensitat 
En el primer estudi (I), el dany muscular induït per un exercici de mig esquat inercial 
d’alta intensitat es va avaluar mitjançant l'evolució en sèrum de l’activitat d'enzims 
musculars i la concentració de proteïnes del sarcòmer específiques del tipus de fibra 
(ràpida [tipus II] o lenta [tipus I]), com ara les isoformes ràpida (tipus II) i lenta (tipus I 
o ß) de la miosina (FM i SM, respectivament). Es van registrar els perfils sèrics de 
deu homes joves, sans i físicament actius a l'inici de l'estudi i en diversos punts 
temporals després de l'exercici. Mentre que l'augment sèric d’enzims musculars va 
suggerir un increment de la permeabilitat de la membrana tant de les fibres lentes 
(tipus I) com de les ràpides (tipus II), l’increment d’FM va suggerir la disrupció del 
sarcòmer, i també un increment de la permeabilitat de la membrana de fibres ràpides 
(tipus II). Per tant, vam concloure que un model molecular indirecte de dany 
muscular induït es pot construir mitjançant l’avaluació de l'evolució temporal de 
l'activitat o la concentració sèrica d'enzims i proteïnes musculars, d'acord amb el seu 
pes molecular, el compartiment de la fibra en la qual es troben i el tipus de fibra 
(ràpida [tipus II] o lenta [tipus I]) en les quals s'expressen. 
Durant el segon estudi (II) es va aplicar el model molecular indirecte d’EIMD per 
avaluar la resposta muscular. Concretament, es va avaluar, en un saltador de perxa 
entrenat (PV) i un estudiant d'educació física (PE), l'efecte d'un exercici de premsa 
de cames fins a l’extenuació (LPF). Els paràmetres mecànics de l’exercici es van 
utilitzar com a indicadors del rendiment i la fatiga induïda per LPF. El PV va revelar 
un perfil explosiu (orientat a la potència) que va induir a danys lleus i selectius de les 
fibres ràpides (tipus II). Per contra, el PE va mostrar un perfil resistent a la fatiga, i 
també una activitat enzimàtica superior i una elevada concentració sèrica d’SM, cosa 
que suggereix un grau més alt de dany de les fibres lentes (tipus I). 
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En l'últim estudi d’HIE (III), es va investigar el grau de dany induït per un exercici 
excèntric intensiu sobre la musculatura isquiotibial i es van analitzar les diferències 
en el grau de dany intersubjectes i intrasubjectes (comparació entre extremitats d’un 
mateix subjecte). Amb aquesta finalitat, es va avaluar la relació entre biomarcadors 
sèrics i altres marcadors indirectes de dany muscular. Tretze homes van realitzar sis 
sèries de deu repeticions de rull femoral unilateral i en van executar només la fase 
excèntrica amb cada cama. Atès que deu dels tretze participants en l’estudi van patir 
nivells elevats de dany muscular, els resultats desafien la noció segons la qual el 
dany muscular greu en humans es limita a protocols d'estimulació elèctrica. També 
es van observar diferències en la comparació entre extremitats, fet que va revelar 
que els dissenys experimentals que utilitzen l’extremitat contralateral com a control 
han de tenir en compte que es poden induir diversos graus de dany sobre la 
musculatura isquiotibial en ambdues cames d’un mateix subjecte. A més, la creatina 
quinasa mitocondrial del sarcòmer (sMtCK) sembla ser un nou i prometedor 
biomarcador d’EIMD que permet la identificació de high responders. Finalment, quan 
es recupera la funció muscular, increments persistents del temps de relaxació 
transversal (T2) suggereixen un procés d'adaptació/remodelació més que no pas 
dany muscular. 
Exercici de llarga durada 
El primer estudi d’LDE (IV) aplica el model molecular indirecte de dany muscular per 
avaluar la resposta del múscul després d’una ultramarató de muntanya (MUM) en 
vuit atletes (amateurs) entrenats en disciplines de resistència. Els resultats permeten 
concloure que l'augment de la concentració en sèrum d’SM després d’una MUM 
podria ser una evidència indirecta de disrupcions selectives del sarcòmer de fibres 
lentes (tipus I). 
Finalment, a l'últim estudi (V) basat en protocols d’LDE es van comparar els canvis 
induïts per una cursa de muntanya de 35 km (MTR) i una MUM de 55 km en els 
nivells sèrics de biomarcadors de dany muscular. La mostra de l’estudi es va 
compondre d’un grup de deu homes (amateurs) entrenats en disciplines de 
resistència, que van competir a l’MTR, i d’un altre grup de sis homes amb nivells 
elevats d’entrenament, que van competir a la MUM. Els resultats indiquen que la 
major distància recorreguda a la MUM podria estar relacionada amb nivells superiors 
de dany muscular de les fibres lentes (tipus I), fins i tot en individus altament 
entrenats. 
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1. INTRODUCTION 
1.1 EXERCISE-INDUCED MUSCLE DAMAGE 
Most people at some stage in their lives have probably experienced some kind of 
soreness or discomfort related to the performance of an unaccustomed activity, 
especially when involving high-force and/or high-velocity and/or high-strain eccentric 
contractions. The symptoms of muscle soreness and weakness experienced in the 
hours and days after novel eccentric exercise have been attributed to myofibrillar 
damage and are known in the scientific literature as ‘exercise-induced muscle 
damage’ (EIMD) (106). Although it has been one of the most important targets in 
sports science research, there is no established definition for EIMD. However, there 
is general agreement that it is a phenomenon characterized by a set of signs and 
symptoms (163) including ‘delayed onset muscle soreness’ (DOMS) (8), and an 
immediate and prolonged reduction in muscle function, most notably a reduction in 
force-generating capacity (FGC) (38). 
1.1.2 Direct evidence of exercise-induced muscle 
damage 
Direct evidence of EIMD, such as myofibrillar disruption and myofiber necrosis, 
requires histological analysis of muscle tissue (70). Fridén et al. (78, 79) provided the 
first evidence of morphological changes (i.e. Z-line disturbances) in the human 
contractile apparatus after an eccentric-biased exercise consisting in descending 
stairs repeatedly and eccentric cycling. Myofibrillar disruption is associated with 
structural changes to the t-tubule system and the sarcolemma (192). 
Immunohistochemical staining reveals degradation of cytoskeletal and myofibrillar 
proteins, which shows that part of the myofiber is necrotic (60, 123). Necrosis 
triggers an immune process characterized by an accumulation of inflammatory cells 
(monocytes/macrophages) observed 2-3 days post-EIMD within myofibers (118), 
which is a sign of degradation (163).  
Histological evidence of separations of the extracellular matrix from myofibers and 
increased blood constituents in the extracellular space has also been reported (190). 
Increased efflux of muscle enzymes (especially creatine kinase [CK]) indicates that 
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extracellular matrix damage might increase sarcolemmal membrane permeability 
(190, 206).  
The highest myofibrillar disruptions, observed histologically, have been found from 
one to four days following exercise. However they may also be observed immediately 
after exercise, as well as a week after exercise (79, 145, 174, 214). Myofibrillar 
disruptions that appear shortly after exercise signify damage, and the changes in 
myofibrillar structures observed some days into recovery may represent remodelling 
(214), especially if no significant changes in the FGC are found (81). 
1.1.3 Exercise-induced muscle damage: mechanical 
and metabolic hypotheses  
The events that occur as a consequence of eccentric exercise can follow two 
possible pathways: the mechanical stress and metabolic stress pathways (7, 10, 
102). Although the exact mechanisms that underlie the phases in EIMD are not fully 
understood, while the initial muscle damage events have been reported to be 
mechanically-induced, the metabolic pathway may more adequately explain the 
persistent signs and symptoms of damage for several days following exercise.  
Mechanical stress pathway 
Muscle damage can occur as a consequence of mechanical loading on myofibers 
(102). Eccentric lengthening of sarcomeres is non-uniform (194) and results in 
overstretched myofilaments, which may no longer overlap within the sarcomere. 
Therefore, due to sarcomere inhomogeneity/disruption, passive structures (desmin 
and titin) absorb the additional tension, and Z-line streaming occurs (139, 170). This 
may cause the failure of the contractile machinery, manifesting a reduction in muscle 
FGC (171)  (Figure 1).   
Metabolic stress pathway 
Metabolic stress induced by exercise is characterized by ischemia/hypoxia and an 
increase in heat, inorganic phosphates (and other metabolic waste accumulations), 
reactive oxygen species (ROS), and a decrease in pH. The disruption of calcium 
metabolism homeostasis due to an increase in the intracellular Ca2+ ions (135), 
stimulates proteolytic and phospholipolytic pathways leading to further myofibrillar 
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damage in the skeletal muscle (82). Eccentric exercise has been shown to lead to a 
loss of membrane integrity and an influx of Ca2+ into myofiber areas in rats (134). It 
has been recently proved in humans that there is a disruption in calcium homeostasis 
resulting from changes in the sarcoplasmic reticulum following a high intensity 
eccentric exercise consisting in 100 drop jumps (148). Elevated sarcoplasmic 
concentrations of Ca2+ activate several proteolytic and phospholipolytic pathways 
that degrade cytoskeleton, sarcolemma, mitochondria and contractile proteins (82) 
(Figure 1).  
 
Figure 1. Theoretical model of exercise-induced muscle damage indicating hypothetical 
mechanisms which may be involved in increasing membrane permeability and the 
subsequent rise in muscle enzyme and protein efflux. Adapted from (4, 111). 
1.1.4 Membrane permeability 
By either mechanical or metabolic pathways, or by both, muscle damage is 
associated with increased membrane permeability, which results in leakage of 
muscle enzyme and proteins into the blood. Increased membrane permeability 
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provides a route into and out of the sarcoplasm that is distinct from the conventional 
route of endocytosis and exocytosis (134). Several hypotheses have been 
formulated about the mechanisms that drive increased membrane permeability;, 
however, they are mostly based on investigations performed with animal models.  
McNeil and Khakee (134) first suggested that in rats performing eccentric exercise 
(running on a treadmill at an incline of 16º downhill), fiber membrane permeability 
was the result of membrane disruption due to mechanically induced stress. However, 
as it has been demonstrated that the resealing of artificially produced membrane 
disruptions occurs in less than a minute (14), alternative explanations for the 
membrane damage hypothesis have been proposed, which provide a more accurate 
explanation of the time course of muscle enzyme and proteins (peak at a minimum of 
1 day following eccentric exercise). Increased membrane permeability may be 
caused by the activation of ion (Ca2+) channels and a consequent increase in 
intracellular Ca2+, phospholipase activity and ROS that peroxide membrane lipids (4) 
(Figure 1).  
The membrane disruption mechanism could explain the increased membrane 
permeability and the subsequent muscle enzyme and protein leakage into the blood 
at early time points, and the activation of ion (Ca2+) channels hypothesis may provide 
a better explanation of the persistent increased membrane permeability that leads to 
muscle enzyme and protein leakage several hours or days after eccentric exercise 
(106). Therefore, if Ca2+ homeostasis is not restored within a few days of exercise, 
irreversible damage to the myofibrillar structure and the cytoskeleton occurs, leading 
to partial necrosis of the myofiber (77, 82, 171).  
1.1.5 Exercise-induced muscle damage assessment 
Direct assessment of muscle damage requires histological examination of muscle via 
biopsy. However, given the invasiveness and difficulty of gathering human muscle 
tissue samples, indirect markers of muscle damage including perceived muscle 
soreness (DOMS), T2 signal intensity via magnetic resonance imaging (MRI) 
techniques, muscle function (i.e., decrements in FGC), and muscle-specific enzyme 
and sarcomere protein efflux to blood have been widely used as surrogate measures 
in EIMD investigations (55). 
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Indirect markers of exercise-induced muscle damage 
The assessment of muscle damage requires reliable and valid indicators. This is 
definitely a major challenge because in human research there are no markers that 
are considered the ‘gold standard’ (163). It is necessary to assess the EIMD 
symptoms in a multifaceted way, and examine the relations within indirect markers 
with great caution. 
Muscle function 
Force-generating capacity 
Although other markers of muscle function (for instance, jump capacity) have been 
used, changes in muscle function, measured as FGC, seem to be the most valid 
indirect marker of muscle damage (163, 204). FGC seems to reflect myofibrillar 
disruptions, inflammation and necrosis better than any other markers of muscle 
damage (163). Raastad et al. (174) reported a high correlation (r = 0.89) between the 
magnitude of decrease in maximal voluntary contraction (MVC) and the proportion of 
muscle fibers with ultrastructural disruptions.  
FGC reductions that occur during or shortly after exercise may represent metabolic 
and/or central fatigue rather than damage, especially if concentric exercise protocols 
have been used (146). Because muscle fatigue is often recovered fairly quickly 
(within hours) (72) and muscle damage requires longer recovery periods before 
returning to baseline (depending on its degree > week) (163), persistent FGC 
decreases observed ≥ 24 h into recovery may be more representative of damage. 
Prolonged force loss in the days following eccentric exercise can usually last more 
than a week (146). Prolonged FGC recovery time results from the initial damage 
(mechanically-induced) during the exercise, and persistent damage several days 
following exercise results from the metabolic pathways involved in the regeneration 
process (55).  
Magnetic resonance imaging 
Changes in T2 signal intensity are thought to reflect increased extracellular water 
content. Thus, T2 increases after eccentric exercise are considered to indicate 
oedema in the muscle (55, 119). While short-lasting moderate increases in T2 found 
immediately after concentric or isometric exercise and returning to baseline values 
within 1 h post-exercise serve as an indicator of muscle recruitment (1, 73), 
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persistent increases in T2 from 24 h onwards following eccentric exercise are related 
to muscle damage (55, 182). Histological evidence of ultrastructural damage 
correlated significantly with increased MRI signal intensity 48 h following an eccentric 
biased exercise consisting in downhill running (157). Moreover, MRI is a safe non-
invasive method to localize muscles with increased membrane permeability from 
which enzymes and proteins leak into the blood (119). 
T2 values following eccentric exercise remain high when other indirect markers (i.e., 
FGC) of muscle damage have returned to baseline values (151). Specifically, 
increased T2 values have been found as long as 75 days (182) and 31 days (151) 
following (in both cases) an eccentric exercise of the elbow flexor muscles. Foley et 
al. (74) suggested that long-lasting T2 increases after swelling resolves and when 
other markers of EIMD have returned to baseline values cannot be attributed to 
extracellular water accumulation and may possibly reflect an adaptive process. 
Perceived muscle soreness 
DOMS, the most common symptom of EIMD, has been studied widely since the 
beginning of the 20th century (99). However, many unanswered questions relating to 
DOMS remain, and further research in this area is needed (50).  
A hypothesis that has gained support from experimental findings in human 
undergoing DOMS is that mechanoreceptors, including muscle spindles, and altered 
processing of activity in large diameter afferents and C-tactile fibers contribute to the 
soreness following eccentric exercise (15, 141, 205). Specifically, changes in 
processing at the level of the spinal cord allow mechanoreceptors through large 
diameter afferents to access the pain pathway (170). It has been suggested that 
these mechanisms may underlie the mechanical allodynia1 observed in DOMS. 
 
 
 
1Central pain sensitization that leads to the triggering of a pain response from stimuli which do 
not normally provoke pain (141).   
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Perceived muscle soreness usually peaks 24-72 hours after exercise and subsides 
within a week (186). As an indirect marker, DOMS is a poor indicator of eccentric 
EIMD, and changes in other indirect markers of muscle damage are not necessarily 
accompanied by DOMS (154). Moreover, DOMS does not reflect histological 
evidences of myofibrillar disruptions (163) and presents considerable variability 
between subjects (in time course and peak magnitude) in response to the same 
exercise stimulus (106). However, measured as perceived muscle soreness, DOMS, 
has been widely used as an indirect marker of EIMD in the scientific literature. 
 
Although in some of the studies in this thesis different indirect EIMD markers such as 
muscle function (measured as FGC), MRI and/or perceived muscle soreness 
(DOMS) have been used, the overall goal of the investigation was to assess the 
phenomenon of EIMD through the time course and magnitude of change of serum 
muscle biochemical markers (24). As a result, the next chapter in this introduction is 
dedicated to serum biomarkers of EIMD.  
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1.2 SERUM BIOMARKERS OF EXERCISE-
INDUCED MUSCLE DAMAGE 
Muscle enzymes and proteins leaked into blood following exercise may be used as 
EIMD biomarkers. A biomarker (biological/biochemical marker) is a measurable 
product or substance of an organism that is used as an indicator of a biological state 
to objectively measure physiological or pathogenic processes in the body that occur 
during health, disease or in response to pharmacological treatment (72). A surrogate 
endpoint has been defined as ‘a biomarker intended to substitute for a clinical 
endpoint’, the latter being ‘a characteristic or variable that reflects how a patient feels, 
functions, or survives’. A surrogate endpoint is expected to predict clinical benefit or 
harm (or lack of benefit or harm) based on epidemiologic, therapeutic, 
pathophysiologic, or other scientific evidence (24). Biomarkers are often easier and 
cheaper to measure than ‘true’ endpoints (12): for example, it is easier to measure a 
subject’s CK serum activity than use a muscle biopsy to measure the extent of 
muscle damage. 
The criteria established by Hill (92) to analyse association in determining causation 
can be used for deciding the characteristics a biomarker needs to be a reliable 
surrogate endpoint (11) (Table 1). 
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Guidelines Features of useful muscle damage biomarkers 
Strength A strong association between the effects of an exercise and the 
biomarker  
Consistency The association persists in different individuals, in different places, 
in different circumstances, and at different times 
Specificity The biomarker is associated with a specific muscle fiber type or 
compartment  
Temporality The time-course of changes in the biomarker and EIMD occur in 
parallel 
Biological gradient (exercise 
‘dose’ –responsiveness) 
Increasing exercise volume and intensity (with the same 
contraction pattern) produce an increase in the biomarker levels 
Plausibility Credible mechanisms connect the biomarker, the muscle damage, 
and the type of exercise performed 
Coherence The association is consistent with the type of exercise performed 
and the biomarker 
Experimental evidence An intervention produces results consistent with the association 
Analogy There is a similar result to which we can adduce a relationship 
Table 1. Austin Bradford Hill’s guidelines that increase the likelihood that an association is 
causative. Adapted from (11). 
Sorichter et al. (189) also described the features of an ideal biomarker of skeletal 
muscle fiber damage. One of these, which that group emphasized and is in 
accordance with Bradford Hill’s criteria, was that the marker should be absolutely 
muscle fiber-specific. Nowadays, most of the biomarkers of EIMD used in the 
scientific literature are not fiber-type-specific and do not meet all the required 
features of a useful muscle damage biomarker. However, although most of the 
skeletal muscle enzymes and proteins do not meet all the required features of an 
ideal biomarker, they offer information about the functional status of muscle tissue, 
and vary widely in exercise conditions, thus offering a fast, accurate method for 
evaluating EIMD (21). 
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1.2.1 Exercise-induced muscle damage biomarkers 
Enzymes 
Serum skeletal muscle enzymes are indirect markers of the functional status of 
muscle tissue, and vary widely in exercise conditions. The use of blood muscle 
enzymes as biomarkers offers a fast, accurate method for evaluating the muscle 
damage caused by exercise (21). Although many enzymes leak into the blood from 
damaged muscles, we focus on CK and transaminases, aspartate aminotransferase 
and alanine aminotransferase (AST and ALT, respectively), which have been widely 
used as biomarkers (indirect markers) of EIMD (30-32). 
Creatine kinase 
Characteristics 
CK is a dimeric globular enzyme of ∼82 kDa which is found in both the sarcoplasm 
and mitochondria of the muscle fiber (13). CK buffers cellular adenosine triphosphate 
(ATP) and adenosine diphosphate (ADP) concentrations by catalysing the double-
sided exchange of high-energy phosphate bonds between phosphocreatine and ADP 
produced during muscle contraction (32) (Figure 2). CK plays a key role in the 
energy homeostasis of cells with fluctuating energy requirements (201). 
Isoenzymes 
Structurally, CK has two polypeptide subunits: M, muscle type, and B, brain type. 
These subunits allow the formation of three tissue-specific isoenzymes in cytoplasm: 
CK-MB (cardiac and skeletal muscle), CK-MM (skeletal muscle) and CK-BB (brain). 
In the mitochondria there are two specific forms of mitochondrial CK (Mt-CK): 
ubiquitous Mt-CK (uMtCK) (expressed in various tissues such as brain and smooth 
muscle) and sarcomeric Mt-CK (sMtCK) (expressed in skeletal muscle) (180). While 
fast and slow fibers present almost equal CK activity (6), slow (type I) fibers have 
higher CK-MB and sMtCK (211).  
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Figure 2. The creatine kinase/phosphocreatine system and the compartment-specific 
isoenzymes of creatine kinase (CK) found in mitochondria and sarcoplasm. Adapted from 
(180). 
Location into the cell compartment 
Three isoenzymes (CK-MM, CK-MB, CK-BB) are located in the cytoplasm and two 
isoenzymes (uMtCK, sMtCK) in the mitochondria, providing specific information on 
injured tissue because of their tissue distribution (30) (Figure 2). Mitochondrial CK 
isoenzyme (Mt-CK) is an octameric enzyme localized in the intermembrane and 
cristae space of the mitochondria (66). Moreover, sMtCK is present only in striated 
muscle (164). 
Clinical reference values  
Baseline levels of serum CK in general population are in the range of 35 to 175 IU·L-1 
(13), and are higher in trained athletes (98). Specifically, reference intervals for CK in 
trained athletes from different sports were 82-1083 IU·L-1 in males and 47-513 IU·L-1 
in females (140).   
ATP!
ADP!
ATP!
CK!
ADP!
Mitochondria! Sarcoplasm!
Cr!
PCr!
CK!CK!
oxidative 
phosphorylation!
Mitochondrial creatine kinase!
CK!
ATP! ATP!
ADP! ADP!
sarcoplasm 
ATP/ADP ratio!
sarcoplasm !
ATP-consumption!
ATPase!
CK!
CK! Sarcoplasm creatine kinase (CK-MM, CK-BB, CK-MB)!
glycolysis!
 31 
Mechanisms of appearance and clearance from blood 
When exercise leads to muscle damage, CK appears in the blood via the pathway 
mentioned above (increased membrane permeability). The CK flux into serum is a 
physiological reaction to exercise but there is a breakpoint at 300-500 IU·L-1 (32). 
Leaked CK into the interstitial space is taken by the lymphatic system and released 
into blood circulation (22). Although not all the mechanisms implicated in CK 
clearance from the blood are known (13) it is commonly accepted that the 
reticuloendothelial system is responsible for this function and that the clearance time 
depends on subject’s training status and the intensity and duration of exercise (59).  
Peak magnitude and temporal response following eccentric exercise 
Time course to CK serum peak following eccentric exercise shows a wide variability 
between studies. Peak magnitude is determined by many factors related to exercise 
(such as intensity and duration), as well as by genetics, the subject’s training status 
and/or previous exposure to exercise and the muscles involved (13, 30, 32, 106). 
Focusing on lower limb exercise protocols, regular athletic resistance exercises 
performed bilaterally and downhill running, evoke the smallest magnitude and fastest 
peak CK response (~ 1000 IU·L-1, 1 day after exercise), followed by isolated 
(unilateral) high intensity eccentric contractions of the knee extensors (range: 200 to 
25.000 IU·L-1, at 1-4 days after exercise), and, finally, ultra-marathon running over 
extreme distances (> 40.000 IU·L-1, immediately after the exercise) and 
neuromuscular electrostimulation of the knee extensors (range: 1350-85.000 IU·L-1, 
at 4 days after exercise) (Table 2). Thus, the contrasting findings on CK time course 
and peak magnitude challenge the appropriateness of comparing fiber responses 
from studies using quite different eccentric exercise protocols. 
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Authors Exercise (mode) Sets and 
repetitions  
Intensity Peak magnitude 
(time to peak) 
Davies et 
al. (62, 63)  
Barbell half-squat 
(bilateral) 
10 x 10 (-) 70% of subject’s 
body mass 
 ~ 800 IU·L-1  
(1 day) 
 
Malm et al. 
(130)  
Treadmill downhill 
running at 4º or 8º  
1 x 45 min 
(each condition 
of 4º and 8º) 
4º: 50% of VO2max 
8º: maximum 
tolerated speed 
~ 1000 IU·L -1  
(1 day) 
Nurenberg 
et al. (157) 
Treadmill downhill 
running at 8º 
1 x 30 min 8 km·h-1 200-1200 IU·L -1 
(range: 12-36 
hours) 
Trappe et 
al. (196) 
Isolated knee extension 
(unilateral)  
10-14 x 10 (1 
min) 
120% of concentric  
1-RM 
~ 5000 IU·L-1  
(5 days) 
Stupka et 
al. (191) 
Leg press and isolated 
eccentric leg extension 
(unilateral). ROM: 15-
90º  
Leg press:  
3 x 12 
Leg extension: 
10 x 10 (3 min) 
Leg extension: 
120% of concentric 
1-RM 
:  200-1400 IU·L-1 
: 300-2100 IU·L-1 
(range: 4 days) 
Bourgeois 
et al. (29) 
Leg press and isolated 
eccentric leg extension 
(unilateral) 
6 x 10 (-)  Leg extension: 80-
85% of concentric  
1-RM 
~ 750 IU·L-1  
(1 day) 
Beaton et 
al. (17)  
Eccentric isokinetic leg 
extension (unilateral). 
ROM: 60-120º 
30 x 10 (1 min) 30º·s-1 ~ 300 IU·L -1  
(2 days) 
Paulsen et 
al. (162) 
Eccentric isokinetic leg 
extension (unilateral). 
ROM: 35-105º 
30 x 10 (30 
sec) 
30º·s-1 ~ 200-25.000 IU·L-1  
(range: 4 days) 
Child et al. 
(51) 
Eccentric isokinetic leg 
extension (unilateral). 
ROM: from prone 
position, almost full 
extension and flexion 
1 x 70 (10 sec 
between each 
rep) 
1.75 rad·s-1 ~ 16.000 IU·L-1  
(4 days) 
Fouré et al. 
(76) 
Neuromuscular 
electrostimulation. Hip 
and knee angles joints 
secured at 90º and 
100º, respectively 
1 x 40 
contractions 
(each leg) 
Maximal level of 
evoked force 
according to the 
pain threshold 
1350-85.000 IU·L-1  
(range: 4 days) 
Skenderi et 
al. (185) 
246-km continuous 
running race 
  ~ 43.000 IU·L-1 
(after the race) 
Table 2. Characteristics from the studies in which creatine kinase (CK) were used for the 
assessment of muscle response to lower limb eccentric exercise. ROM, range of movement. 
1-RM, one repetition maximum. 
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Transaminases 
Characteristics 
AST and ALT are both enzymes of 90 kDa (175). AST catalyses the interconversion 
of aspartate and α-ketoglutarate to oxaloacetate and glutamate, and ALT catalyses 
the reversible transfer of α-amino group of alanine to the α-keto group of 
ketoregularic acid to generate glutamate and pyruvate. These reactions occur 
between the mitochondria and the cytosol, and provide energy to cells (30). It has 
been reported that slow (type I) fibers have higher AST activity (177).  
Location in the cell compartment  
ALT is found in the cytoplasm and AST is found both in the cytoplasm and the 
mitochondria. These enzymes are mainly in the skeletal and myocardial muscle, liver 
and erythrocytes (30, 210).  
Clinical relevance and reference values  
Although AST and ALT increases may be due to muscle and/or liver damage, when 
more specific hepatic injury markers such as alkaline phosphatase (ALP) and 
gamma glutamyltransferase (γGT) remain unaltered, EIMD can be distinguished from 
liver damage (20). The transaminases AST and ALT are released at a constant rate, 
and their usual healthy levels represent the equilibrium between the normal turnover 
of hepatocytes and clearance of enzymes from blood (28). According to Nathwani et 
al. (142), normal serum values for AST range between 10-40 IU·L-1, and ALT 
between 20-65 IU·L-1.     
Mechanisms of appearance and clearance from blood 
When exercise leads to muscle damage, transaminases, especially AST, appear in 
blood via the pathway mentioned previously (increased membrane permeability). 
Although in animal models it has been suggested that muscle-released 
transaminases, specifically AST, could reach the circulating blood directly from the 
intracellular compartment, leaked muscle enzymes are mainly transported via the 
lymph into the blood stream because of the extremely low capillary permeability of 
muscle tissue (127). 
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Peak magnitude and temporal response following eccentric exercise 
Although the etiologic bases for transaminase increases are not well understood, and 
the reliability of AST (and especially ALT) as EIMD biomarkers still remains unclear, 
numerous studies following cycling or running ultra-endurance events have reported 
serum increases in transaminases, using AST and ALT as muscle damage 
biomarkers (20, 68). Studies using serum transaminases as EIMD biomarkers are 
displayed in Table 3, where it can be observed that most studies analysing long 
distance events found AST and ALT serum peaks immediately after exercise. 
Petersson et al. (168) reported serum increases of AST and ALT between 2 and 5 
days after a whole body weightlifting program in men who were not experienced with 
strength exercises and who had no evidence of liver disease. Large increases of 
transaminases are also described in patients hospitalized under ‘extreme exercise’ 
conditions (i.e., vigorous squatting session or long distance run) (142) Table 3. Time 
course to serum peak seems to differ between ultra-endurance exercise 
(immediately after exercise) and resistance exercise (range 2-4 days after exercise) 
Table 3. 
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Authors Exercise (mode) Sets and 
repetitions  
Intensity Peak magnitude 
(time to peak) 
Skenderi et al. 
(185) 
246-km 
continuous 
running race 
  AST: ~ 1200 IU·L-1 
(post) 
ALT: ~ 250 IU·L-1 
(post) 
Klapcińska et al. 
(113) 
48-hours flat 
Ultra-Marathon 
  AST: ~ 800 IU·L-1 
(post) 
ALT: ~ 220 IU·L-1 
(post)  
Nathwani et al. 
(142) 
‘Extreme 
exercise’ 
(vigorous 
squatting or long 
distance run) 
NR NR AST: 2466 (range: 
421-3967) IU·L-1 
ALT: 497 (range: 115-
712) IU·L-1 (at 
hospitalization) 
Nosaka et al. 
(152) 
Eccentric biceps 
curl (unilateral). 
ROM: 50-170º 
1 x 24 (15 sec 
between each 
rep) 
Maximal  AST: 105 IU·L-1  
(4 days) 
Clarkson et al. 
(56) 
Eccentric biceps 
‘preacher’ curl 
(bilateral) 
2 x 25 (5 min, 
12 sec 
between each 
rep) 
Maximal AST: 113 IU·L-1  
(4 days) 
ALT: 45 IU·L-1  
(4 days) 
Oakley et al. (158) Eccentric 
isokinetic knee 
flexion (unilateral) 
5 x 10 (1 min) NR AST: 144 IU·L-1  
(3 days) 
ALT: 45 IU·L-1  
(3 days) 
Fonda et al. (75)  Drop jumps 
(bilateral), Leg 
curl (bilateral) 
5 x 10 (1 min) 
each exercise 
Drop jumps: 0.6 m 
height, Leg curl: 
70% and 130% of 
concentric 1-RM 
AST: 47 IU·L-1  
(4 days) 
Table 3. Characteristics from the studies in which aspartate aminotransferase (AST) and/or 
alanine aminotransferase (ALT) were used for the assessment of muscle response to 
exercise. NR, none reported. ROM, range of movement. 1-RM, one repetition maximum. 
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Sarcomere proteins 
Although other skeletal muscle sarcomere proteins such as α-actin (131), troponin I 
(187), and troponin isoforms, including fast troponin (fsTnI) and slow troponin I 
(ssTnI) (46), have been used as biomarkers of EIMD, the next section focuses on 
myosin and the studies which have used β/slow myosin heavy chain (MHC) 
fragments as an EIMD biomarker. 
Myosin 
Characteristics 
With a molecular mass of ∼493 kDa (95), sarcomeric myosin is a contractile protein 
that slides along actin, hydrolyses adenosine triphosphate (ATP) and produces 
movement (167). It is composed by three functional subdomains: (1) the motor 
domain which interacts with actin and binds ATP, (2) the neck domain which binds 
light chains and calmodulin, and the tail domain which serves to anchor and position 
the motor domain so that it can interact with actin (181). Myosin molecules can be 
dissociated into six polypeptide chains: two heavy chains (MHC), coiled around each 
other forming a double helical structure with a molecular weight of ∼200 kDa each, 
and two pairs of light chains (LC) or calmodulin with a molecular weight of ∼15-
26kDa (85), called essential or alkali LC and regulatory or phosphorylatable LC 
respectively (178). 
Isoforms and fiber type 
Human skeletal muscle fibers can be differentiated histochemically into slow (type I) 
and fast (type II), which can be further subdivided into types IIa and IIx (23, 207) 
depending on its myosin heavy chain (MHC) isoforms (167). The existence of 
numerous MHC isoforms (MHC1 or ß/slow, MHC2A and MHC2X or fast) differentially 
distributed in different fibers makes MHC the best available marker for fiber typing 
(178). MHC2 isoforms are characteristic of fast (type II) fibers from skeletal muscle 
only, and the MHC1 isoform is found in slow (type I) fibers from both cardiac and 
skeletal muscle. MHC isoforms revealed the existence of ‘pure’ (only one MHC 
isoform) and ‘hybrid’ (two or more MHC isoforms) muscle fibers (166) (for a review 
see Schiaffino and Reggiani (178)).  
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Location in the fiber compartment 
Myosin is located in the sarcomere, conforming the thick filament in a bipolar 
disposition throughout the A-band, and cross-linked at the center by the M-band (2). 
Appearance in blood following eccentric exercise 
Mair et al. (129) first described β/slow MHC fragments as EIMD biomarkers of slow 
(type I) fibers and established the upper reference limit of β/slow MHC fragments in 
plasma at 300 µU·L-1. According to its time course, there seems to be a delay in the 
release of β/slow MHC fragments in serum once the exercise is completed (129, 172, 
187, 188). The first significant increases in serum levels of β/slow MHC fragments 
appear 24 h after exercise (172, 188) but the serum peak shows a wide variability 
ranging from 48 h (172) to 6 or 9 days after exercise (129) (Table 4). However, while 
eccentric exercise laboratory studies involved recreationally active subjects (physical 
education students), Prou et al. (172) analysed muscle response in highly trained 
triathletes (14.8 hours per week of training). The magnitude of increase in β/slow 
MHC fragments has been reported to indicate degradation of myofibrils as well as 
increased membrane permeability (129).  
Authors Exercise (mode) Sets and 
repetitions  
Intensity Peak magnitude and/or 
time course 
Mair et al. 
(129) 
Eccentric leg extension 
(unilateral) in an 
exercise rack 
7 x 10 (3 min) 110% of 
MVC 
 Started to rise from the 
2nd day and peaked the 
6th-9th day after exercise 
(no values available) 
Prou et al. 
(172) 
Nice Triathlon  Swimming: 4 km 
Cycling: 120 km 
Running: 32 km 
 Baseline: 142 ± 69 µU·L-1 
Post: 156 ± 116 µU·L-1 
48 h: 2603 ± 1405 µU·L-1 
4 days: 1002 ± 523 µU·L-1 
Sorichter et al. 
(187) 
Eccentric leg extension 
(unilateral) in an 
exercise rack  
7 x 10 (3 min) 150% of 
MVC 
Peak values between 1 
and 4 days (median: 330, 
range: 168-454 µU·L-1) 
Sorichter et al. 
(187) 
Treadmill downhill 
running at 16% incline  
1 x 20 min 70% 
VO2max 
Peak values at 48 h 
(median: 1021, range: 
457-1540 µU·L-1) 
Sorichter et al. 
(188) 
Eccentric leg extension 
(unilateral) in an 
exercise rack. 
7 x 10 (3 min) 150% of 
MVC 
Before: 93 µU·L-1 
1 day after: 416 µU·L-1 
4 days after: 458 µU·L-1 
Table 4. Characteristics from the studies in which β/slow myosin heavy chain (MHC) 
fragments were used for the assessment of muscle response to lower limb eccentric exercise. 
MVC, maximal voluntary contraction. 
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New tendencies in exercise-induced muscle damage serum 
biomarkers 
In view of the features that an ideal serum biomarker should have (189), a number of 
studies have recently focused on biomarkers of skeletal muscle fast (type II) fibers. 
Chapman et al. (46) and Dahlqvist et al. (61) proposed serum increases of fsTnI as 
indirect markers of fast (type II) fibers. In relation to degrees of muscle injury 
established by magnetic resonance images, Guerrero et al. (2008) suggested 
increases in the blood stream of muscle myosin isoforms, fast (type II) and slow (type 
I / ß) (FM and SM respectively) as valid and reliable biomarkers of muscle injury 
because of their fiber specificity.  
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1.3. THE EXTENT OF EXERCISE-INDUCED 
MUSCLE DAMAGE  
Based on an extensive review, Paulsen et al. (163) were the first authors to propose 
categorizing the degree of EIMD as mild, moderate and severe, according to FGC 
reduction and CK serum activity:  
o Mild EIMD is characterized by small reductions in FGC (< 20%), CK activity 
lower than 1000 IU·L-1, and full recovery is normally complete within 48 hours.  
o Moderate EIMD corresponds with sensible FGC declines (20-50%), CK activity 
higher than 1000 IU·L-1, and/or recovery is complete between 2 and 7 days 
following exercise.  
o Severe EIMD is characterized by a large reduction in FGC (> 50%), CK activity 
higher than 10.000 IU·L-1, and long-lasting recovery (> week). 
1.3.1 Variables influencing the extent of exercise-
induced muscle damage  
Exercise intensity 
As stated above, eccentric exercise, especially when involving high intensity 
contractions (i.e., high-force and/or high-velocity and/or high-strain) can cause 
muscle damage. The relationship between the different intensity factors with the 
extent of EIMD is examined next. 
Eccentric contraction force 
In electrically stimulated extensor digitorum longus muscles in mice, it was observed 
that the extent of damage was related to the peak force developed during eccentric 
contractions (132). In humans, the role of eccentric exercise force magnitude on the 
muscle damage extent has been widely studied on the upper extremities (i.e., elbow 
flexors; biceps brachii). Specifically, Nosaka and Newton (153), and Peake et al. 
(165) indicated that exercise intensity played an important role in the extent of 
muscle damage by comparing a single bout of maximal and submaximal (50% and 
10% of maximum isometric strength respectively) eccentric contractions of the elbow 
flexors. However, the influence of eccentric peak torque on the extent of muscle 
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damage is controversial. Chapman et al. (45) found no relationship between the 
eccentric peak torque, measured during an exercise consisting in eccentric 
contractions of the elbow flexors, and the level of muscle damage. In contrast, high 
specific torque eccentric contractions (via electrical stimulation) of the knee 
extensors were found to induce greater changes in markers of muscle damage (26). 
Eccentric contraction velocity 
The commonly held belief amongst athletes and coaches that high velocity exercise 
results in superior levels of muscle damage is supported by most human 
experiments comparing fast versus slow eccentric contractions (42-44, 183). Only 
one study has found a greater magnitude of muscle damage after a slow velocity 
protocol (161), and one other reported no differences between velocities analysed for 
muscle damage markers (16). However, it should be taken into account that all the 
experiments comparing the effect of fast versus slow eccentric contractions over the 
extent of muscle damage involved the elbow flexors, so extrapolating those 
observations to other muscle groups may be misleading. Moreover, although 
different studies using animal models have also found a relationship between the 
eccentric contraction velocity and the extent of muscle damage (132, 203), Brooks 
and Faulkner (35) stated that eccentric velocity was only relevant for the degree of 
muscle damage during lengthening contractions with a large strain.  
Eccentric contraction strain 
One of the most critical factors for EIMD is high strain (i.e., muscle lengthening 
beyond the optimum length for force-generation) (139, 171). In animals, it has been 
proved that the extent of muscle damage is highly dependent on the eccentric strain 
magnitude (123, 124, 193, 208) and that muscle length before stretch may influence 
muscle damage by significantly increasing the fiber strain magnitude (37). Those 
observations were confirmed in human experiments at different muscle lengths 
(range of motion) involving the elbow flexors (109, 144, 155) and the knee extensors 
(52); these studies reported similar results in so far as more force was lost after 
subjects exercised with muscle initially set at a longer length. For example, in an 
exercise consisting of eccentric contractions of the knee extensors at short muscle 
length (160º to 80º) and long muscle lengths (120º to 40º), Child et al. (52) reported a 
greater FGC decline after exercise at the longer muscle length. 
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The large variances observed in studies analysing the influence of exercise intensity 
over the extent of muscle damage may be due to the disparity in methods (exercise 
protocol, muscle function variables measured, subjects’ training background, if any, 
and muscle group/s involved). The large variation in muscle damage indices within 
and between studies makes it difficult to reach a definitive conclusion on the 
contribution of eccentric exercise intensity factors. Therefore, although the extent of 
muscle damage is related to exercise intensity factors such as high-force and/or 
high-velocity and/or high-strain, many other variables such as the mode of muscle 
activation, genetic variability, age, gender, the muscle group involved and/or the 
novelty of eccentric exercise may also substantially influence the extent of EIMD 
(106, 163).  
Mode of muscle activation  
The notion that muscle damage necessarily occurs following voluntary eccentric 
exercise in humans has been strongly challenged. Recently it was shown that the 
extent of muscle damage in humans was greater following electrically stimulated 
contractions (severe disturbances of Z-lines, myofibers and extracellular matrix 
followed by a large loss of FGC and myofiber necrosis) (60) than following voluntary 
eccentric contractions (minor myofibrillar disruptions and minor reductions in FGC) 
(81, 136). Moreover, extremely large CK serum increases (range: 1350 to 85.000 
IU·L-1) have been found following isometric electrical stimulation-induced muscle 
damage of the knee extensors (76) (Table 2). According to Paulsen et al. (163), 
exercise involving electrically stimulated contractions can induce severe EIMD and, 
although large variations in the responses of healthy individuals are expected, 
regular athletic training involving voluntary eccentric contractions (i.e., resistance 
exercise) typically causes mild EIMD. Intensity factors related to the eccentric 
component of the resistance exercise such as high-force and/or high-velocity and/or 
high-strain, may increase the degree of muscle damage from mild to moderate.  
Muscle group involved 
It has been stated that knee extensors are less predisposed to muscle damage 
following high intensity eccentric contractions, since their exposure to eccentric 
contractions in daily activity is one of the main factors determining susceptibility (48). 
Moreover, because of the differences in the architecture of the arm and leg muscles, 
it is possible that mechanical stress per muscle unit differs between these two 
muscle groups when doing eccentric exercises of the same intensity (121).  Changes 
 42 
in muscle length during eccentric contractions appear to be another contributing 
factor (48). Experiments involving maximal isokinetic voluntary contractions of the 
elbow flexors have reported high levels of EIMD, reflected by large, long-lasting 
decreases in FGC (≥ 50%, 1 day after exercise) (46, 120) and sharp CK serum 
increases (9698 ± 4270 IU·L-1, 4 days after exercise) (120). Moreover, Chapman et al. 
(46) found significant increases in sfTnI from baseline (5.5 ± 5.2 ng·mL-1) to 14.6 ± 
12.8 ng·mL-1, and 89.5 ± 71.4 ng·mL-1, at 1 to 4 days following eccentric exercise, 
indicating selective fast (type II) fiber damage.  
Fiber susceptibility  
In animal models, it has been proved that fast (type II) fibers are more susceptible to 
EIMD (125, 199) due to their morphological and biomechanical characteristics such 
as their less elastic titin isoform (97), lower desmin content (53), narrower Z-discs 
(128), shorter fiber length (122) and lower optimum length for tension (34) than slow 
fibers. In human studies, histological (79, 108) and serum biochemical (46) evidence 
of selective fast (type II) fibers damage following intense eccentric exercise has also 
been found.  
Hydhal and Hubal (106) propose that muscle response to eccentric contractions 
functions on a continuum along which exercise intensity (i.e., high-force and high-
velocity and/or high-strain) has a direct influence over the extent of muscle damage, 
but that other modifying factors (genetic variations, muscle group involved and/or 
novelty of exercise) are also crucial and must be carefully analysed (Figure 3). 
Further human studies are necessary to clarify how eccentric exercise intensity 
affects the extent of muscle damage. 
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Figure 3. Individual response to a bout of eccentric exercise is dependent on several factors, 
including exercise intensity, the mode of muscle activation, genetic variability, the muscle 
group involved and the novelty of the exercise. Lines with bidirectional arrows indicate that 
response under each condition can occur anywhere along the continuum, e.g., high exercise 
intensity results in a greater extent of muscle damage than low exercise intensity but may 
also result in a less damaging stimulus under circumstances of voluntary contractions, low 
genetic responding, low novelty, etc. Adapted from (106, 163). 
Genetic variability: high versus low responders 
Large inter-individual variation in response to eccentric exercise is commonly 
reported (45, 47, 58, 105, 152, 162). Based on the extent of muscle damage 
individuals, can be characterized as ‘low’, ‘moderate’ or ‘high’ responders (163). The 
‘repeated bout effect’ (RBE), defined as the adaptation whereby a single bout of 
eccentric exercise protects against muscle damage from subsequent eccentric bouts 
(133), and may last some months following the first bout (156), have been proposed 
as one of the mechanisms responsible for the variations between individuals. Aside 
from age or gender, other contributing factors that could explain those large 
variations include genetic variability across individuals (54, 104, 212, 213) and 
training status (32, 162, 200). 
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1.4 MUSCLE DAMAGE INDUCED BY LONG 
DURATION EXERCISE 
Exercise volume (i.e., duration) may also substantially influence the extent of muscle 
damage. It is well known that prolonged exercise can lead to muscle damage, 
especially if there is a component of eccentric work, as in running (9). For this reason, 
long distance running under laboratory or field conditions has been widely used as 
an EIMD model. 
1.4.1 Level running distance and muscle damage 
Functionally, in order to support the weight of the body against gravity, most lower 
limb muscles work eccentrically for some part of the normal gait cycle during flat 
running. When this eccentric work of the ‘anti-gravity’ muscles (knee extensors, 
muscles of the anterior and posterior tibial compartments and hip extensors) is 
performed over a long distance, muscle damage is likely to occur. Histological 
evidence of myofibrillar disruption (202) and necrosis (91) has been found in 
endurance runners after the completion of a long-distance running competitive event 
such as the athletic marathon (42,195 km).  
Regarding running distance, Noakes (149) indicates that increases in serum muscle 
enzymes following a running event are related more to duration than to intensity. 
During level running it has been well established that the total running distance 
covered or the time spent running is related to the amount of Ca2+ accumulation and 
the extent of muscle damage (159). Furthermore, the degree of muscle enzyme 
leakage was found to be dependent on running distance (159). During a 48-h flat 
running ultra-marathon, increased serum levels of CK, LDH, AST and ALT indicate 
that active muscle suffers a significant degree of sarcolemmal damage with 
increased running distance (113). Moreover, in ultra-endurance events (100-km) a 
significant degree of sarcolemmal damage is caused during the run (160) and can 
lead to extraordinarily high serum enzyme levels, as demonstrated during a 246-km 
ultra-endurance event in which participants’ mean values of CK increased from 178 ± 
18 at the baseline to 43.763 ± 6764 IU·L-1 immediately after the race (185). Therefore, 
the longer the distance run, the greater the stress and damage on muscle tissue. 
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1.4.2 Mountain trail running 
There is no consensus about the definition of mountain running competitions, which 
is a semantic debate beyond the scope of the present thesis. The term ‘mountain trail 
race’ (MTR) has been generically used to refer to competitive long-distance off-road 
runs from 15 to > 90 km, which are performed in a mountain context and involve a 
great cumulative elevation gain (uphill and downhill) (64). The term ‘mountain ultra-
marathon’ (MUM) has been specifically associated to MTR over a longer distance 
than the marathon (> 42,195 km) (137). While distance and the total elevation gain 
(climb distance-1 ratio) are the main extrinsic indicators of effort in MTR, the pace 
running is the most important performance parameter. 
These kinds of competition present an exclusive physiological stress profile induced 
through combined fatigue and muscle damage: They have experienced a great rise 
in popularity during the last decade (94) and offer a unique opportunity for field-
specific assessments of EIMD in humans. 
1.4.3 Mountain trail running as an exercise-induced 
muscle damage model in exercise physiology 
In spite of the popularity of these strenuous events, very little is known about the 
structural damage inflicted on the muscle fibers of the athletes who participate. It is 
generally agreed that mountain running competition causes muscle damage due to 
neuromuscular fatigue (138) and the numerous eccentric contractions completed 
during the downhill phases (67, 130). When running downhill, the eccentric 
component increases because the peak flexion angles become significantly greater, 
and this is a much stronger stimulus for damage than level or uphill running (67).  
As previously indicated, the change in muscle function, measured as reduced FGC, 
has been proposed to be a reliable and valid indirect marker of muscle damage, 
reflecting myofibrillar disruption, inflammation and necrosis (174). Protocols 
analysing downhill running, as encountered in trail races, normally induce mild to 
moderate muscle damage (33, 71, 130). Field studies analysing the neuromuscular 
fatigue and damage induced by long distance mountain running have reported 
significant decreases in FGC both immediately and several days after a MUM. 
Specifically, (138) reported a 35% reduction in baseline MVC torque shortly after a 
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166-km MUM and this reduction was still significant ( 9% below baseline levels) five 
days after the competition, which is consistent with a moderate EIMD process.  
 
1.4.4 Serum biomarkers of muscle damage and 
mountain trail running 
Biochemical assessment of muscle damage has also been used in mountain trail 
competitions, but the relationship between distance and muscle enzyme efflux is 
unclear when comparing CK values obtained by different studies analysing the 
physiological consequences of MUM (Table 5).  
Authors Sample Mountain ultra-marathon distance 
and negative elevation gain 
CK (IU·L-1)  
Hoffman et 
al. (93) 
40 women and 
176 men  
161-km 
7000 m 
After: range: 1500 to 
264.300, median: 20.850, 
mean: 32.956 
Millet et al. 
(138) 
22 experienced 
ultra-marathon 
runners 
166-km 
9500 m  
Baseline: 144 ± 94 
After: 13.633 ± 12.626 
Saugy et 
al. (176)  
15 experienced 
ultra-marathon 
runners 
330-km 
24.000 m 
Baseline: 112 ± 33 
After: 3719 ± 3045 
Table 5. Creatine kinase (CK) values obtained in different studies analysing Mountain ultra-
marathon physiological consequences. 
The inconsistency between CK activity and the MUM distance displayed in Table 5 
may be due to the high complexity of mountain trail competitions (total elevation 
gain), environmental factors (weather and surface conditions), and the pacing 
strategy used by runners, especially during downhill running when the eccentric 
component is exacerbated (67). Moreover, when competing over very long distances, 
athletes tend to experience high levels of fatigue and use a more conservative 
pacing strategy in order to finish the race. For example, Saugy et al. (176) reported 
that most of the participants in a 330-km MUM (Tor des Géants) walked the last part 
of the competition due to nociceptive feedback and sleep deprivation-induced fatigue. 
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Sarcomere proteins have also been used as biomarkers of muscle damage induced 
by mountain running. Koller et al. (116) used β/slow (type I) MHC fragments as a 
muscle fiber type-specific damage biomarker. That group found β/slow MHC 
fragment increases in plasma in trained individuals following a MUM (67-km 
distance; 30-km downhill running) and although slow (type I) MHC fragments are 
common to skeletal and cardiac muscle, the damage was mainly related to slow 
(type I) fibers of skeletal muscle. 
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2. RESEARCH AIMS and HYPOTHESES 
2.1 AIMS 
2.1.1 General aims 
The aim of this thesis was (I) to characterize the muscle damage induced by different 
lower limb exercises by analysing the time course and the magnitude of activity or 
concentration change of serum leaking enzymes and investigate into new biomarkers, 
as well as (II) to examine its relationship with other indirect markers of muscle 
damage. 
2.1.2 Specific aims 
The specific aims of this thesis were: 
Preliminary aim 
1. To construct an indirect molecular model of EIMD by measuring the time 
course of serum activity or concentration of muscle enzymes and proteins, 
according to their molecular weight, the fiber compartment in which they are 
located, and the fiber type (fast [type II] or slow [type I]) in which they are 
expressed (study I).   
Functional aims 
2. To analyse the extent of lower limb muscle damage induced by high intensity 
exercise under laboratory conditions by measuring serum levels of 
biomarkers (studies I, II and III). 
3. To analyse the extent of lower limb muscle damage induced by long duration 
exercise under competitive conditions (i.e., mountain trail running) by 
measuring serum levels of biomarkers (studies IV and V).   
4. To examine the influence of mountain trail distance and runners’ training 
status on the serum levels of muscle damage biomarkers (study V) 
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2.2 HYPOTHESES 
Study I 
1. Myosin isoforms are a valid and highly sensitive biomarker of exercise-
induced sarcomere damage. 
2. A model of mild EIMD can be constructed by measuring the time course of 
the serum activity or concentration of muscle enzymes and proteins following 
high intensity concentric-eccentric (C-E) inertial exercise, according to their 
molecular weight and the fiber compartment in which the enzyme or protein is 
located. 
3. By measuring fiber type-specific sarcomere proteins such as FM and SM, the 
type of fibers damaged by exercise can be assessed. 
4. Fast (type II) and slow (type I) fibers are damaged in a similar manner during 
high intensity C-E inertial exercise. 
Study II 
1. A C-E leg press exercise leading to failure (LPF), a high intensity and volume 
exercise, induces both fast (type II) and slow (type I) fibers damage. 
2. A national level pole vault athlete, as a power athlete, is expected to have 
higher proportions of fast (type II) fibers in the knee extensors; therefore, high 
power outputs during C-E leg press exercise leading to failure (LPF) are 
expected.  
3. In contrast, a physical education student is likely to have similar proportions 
of fast (type II) and slow (type I) fibers in the knee extensors; therefore, high 
fatigue-resistant outputs during LPF can be expected. 
4. The LPF output is related to the type of fibers damaged. 
Study III 
1. Severe hamstring muscle damage can be induced in humans following an 
intensive unilateral (performed separately with both legs) eccentric leg curl 
exercise (ELC).  
2. Different degrees of muscle damage can be expected between-subjects 
following an intensive unilateral ELC (performed separately with both legs).  
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3. Similar degrees of muscle damage can be expected within-subjects (limb-to-
limb comparison) following the same intensive unilateral ELC (performed 
separately with both legs).  
4. sMtCK is a valid and highly sensitive biomarker of exercise-induced skeletal 
muscle damage.  
Studies IV and V 
1. Since there is evidence of muscle damage after prolonged mountain running, 
and since endurance-trained athletes have higher proportions of slow (type I) 
fibers, competing in a mountain trail race (MTR) or a mountain ultra-marathon 
(MUM) (> 42.195 km) induces slow (type I) fiber-specific sarcomere 
disruptions.  
2. Mountain trail distance (exercise duration) is related to the extent of slow 
(type I) fiber muscle damage.  
3. Training status is related to a muscle protective effect reflected by a lower 
release of muscle enzymes and type-specific sarcomere proteins to blood 
stream and/or an enhanced clearance. 
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3. METHODS 
This thesis presents data from five consecutive studies. Lower limb EIMD was 
assessed by laboratory high intensity exercise (HIE) protocols (studies I, II and III) 
and by field long duration exercise (LDE) protocols (studies IV and V). Here we 
summarize the methods used in laboratory HIE and field LDE studies. For further 
details, the reader is referred to the corresponding article. 
3.1 Subjects 
Forty-nine healthy male (48) and female (1) subjects gave written, informed consent 
to participate in the experiments. The main characteristics of the subjects are 
displayed in Table 6.  
Study Subjects n Age (years) Mass (kg) Height (cm) 
HIE 
I Physical education students 10 28.6 ± 6.1 73.3 ± 6.9 175 ± 6.5 
II Pole vault athlete 
Physical education student 
1 
1 
2 
22.8 
22.5 
73.8 
69.9 
1.72 
1.71 
III Physically active young men 13 22.9 ± 2.1 74.0 ± 5.8 177 ± 6.2 
LDE 
IV Trained mountain runners 
Men 
Woman 
 
7 
1 
8 
 
39.8 ± 3.3 
39.1 
 
76.9 ± 7.9 
67 
 
 
179 ± 5.2 
173 
V Mountain runners 
Moderately trained  
Highly trained  
  
10 
6 
16 
 
37.7 ± 7.4 
34.0 ± 5.2 
 
73.9 ± 9.4 
71.3 ± 8.8 
 
178 ± 3.4 
176 ± 7.3 
Table 6. Main characteristics of the subjects from the five studies composing the thesis 
(mean ± standard deviation). HIE, high intensity exercise (laboratory protocols). LDE, long 
duration exercise (field protocols). 
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3.1.1 High intensity exercise 
Subjects from laboratory HIE studies (I, II and III) were asked not to perform any 
exercise either during the week before or during the experimental period. No subjects 
had suffered myotendinous injuries in the past year and, with the sole exception of 
the pole vault athlete, the subjects were recreationally active but had not been 
involved in any regular resistance-training program for at least six months prior to the 
experiments.  
3.1.2 Long duration exercise 
Subjects from field LDE studies (IV and V) were healthy, trained mountain running 
competitors who had not suffered muscle injuries in the six months before 
participating in the studies. In order to avoid bias, no instructions were given 
regarding the type of training performed the week before the competitions in which 
the field LDE studies were performed, but competitors were asked about this matter 
in order to better interpret baseline data. Physical activity until 48 hours after the race 
was limited and massages were prohibited.  
3.1.3 Ethical approval of research 
The studies complied with the standards of the World Medical Association 
(Declaration of Helsinki) and approval was given by the Ethics Committee of the 
Catalan Sports Council (Government of Catalonia) (0099S/690/2013).   
3.2 Study design 
Both laboratory HIE and field LDE studies were carried out with baseline tests, the 
exercise protocol or competition, and repeated post-tests; i.e., observational pre-post 
design from a single group or two groups of subjects (Table 7, Table 8, Table 9, and 
Table 10). 
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3.2.1 High intensity exercise 
Baseline  Post-exercise 
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 
Hours -0.5 0 24 48 72 96 120 144 
Tests  EXERCISE       
Blood sample  X  X X    X 
Perceived muscle soreness  X  X X X X X X 
Jump (SJ and CMJ) X  X X    X 
Max. Power (concentric and eccentric) X       X 
Table 7. Schematic overview of experimental procedures of laboratory high intensity exercise 
study I.  
Baseline  Post-exercise 
 Day 0 Day 1 Day 2 
Hours -0.5 0 24 48 
Tests  EXERCISE   
Blood sample  X  X X 
Power (concentric and eccentric)  X   
Table 8. Schematic overview of experimental procedures of laboratory high intensity exercise 
study II.  
Baseline  Post-exercise  
 Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Hours -0.5 0 24 48 72 96 120 144 168 
Tests  EXERCISE        
Blood sample  X  X X X    X 
Perceived muscle soreness  X  X X X X X X X 
Magnetic resonance imaging X  X      X 
Maximal voluntary contraction X  X X X    X 
Table 9. Schematic overview of experimental procedures of laboratory high intensity study III.  
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3.2.2 Long duration exercise 
Baseline  Post-exercise 
 Day -1 Day 0 Day 1 Day 2 
Hours -24 0 1 24 48 
Tests  EXERCISE    
Blood sample  X  X X X 
Table 10. Schematic overview of experimental procedures of field long duration exercise 
studies (IV and V).  
3.3 Choice of muscle groups 
In laboratory studies, lower limb muscles (specifically knee extensors (quadriceps 
femoris) and/or flexors (hamstring muscles)), were chosen because they are crucial 
for human locomotion and sport performance, and also because these muscle 
groups are widely used in exercise physiology research. In field studies involving 
mountain running competitive events, these muscle groups also have a fundamental 
role.  
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3.4 Exercise protocols 
In order to replicate what happens in the sports context, during the laboratory HIE 
studies EIMD protocols consisting in regular resistance training exercises were 
applied. The leg curl and (especially) the squat are frequently used exercises in the 
field of strength and conditioning. The main characteristics of the laboratory HIE 
studies are displayed in Table 11. In field LDE studies, strenuous mountain running 
competitive events were used as EIMD models.  
 Exercise characteristics 
Study I II III 
Exercise Vertical half-squat Horizontal half-squat Prone leg curl 
Machine (device) Inertial Pneumatic Weight stack 
Main muscle group Knee extensors Knee extensors Hamstring (isolation) 
Secondary muscle 
groups 
Hip and ankle 
extensors 
Hip and ankle 
extensors 
None 
Contraction type Con-Ecc Con-Ecc Ecc 
Mode Bilateral Bilateral Unilateral 
Rep velocity Maximum (power 
oriented) 
Maximum (power-
endurance oriented) 
3 seconds 
Sets and reps 7 x 10 9 x failure 6 x 10 (each leg) 
Rest (min) 3 3 3 
Load Highest resistance level 
(minimum cone radius) 
75% 1-RM 120% 1-RM 
Intensity (eccentric) éé éé ééé 
Table 11. Lower limb exercises characteristics from laboratory high intensity exercise studies. 
Con, concentric. Ecc, eccentric. 1-RM, one repetition maximum.  
3.5 Blood sampling and processing 
A 5- or 8-mL blood sample was drawn from an antecubital vein and allowed to clot 
for 30 minutes in a tube (SST II Advance, Becton Dickinson Vacutainer Systems, 
UK). Blood was centrifuged at 3000 g for 10 minutes at 4ºC. Three 200 µl aliquots of 
serum were immediately pipetted into Eppendorf tubes and stored at -80ºC until 
analysed.   
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Biochemical analyses of CK, AST and ALT were performed in an Advia 2400 
automatic device (Siemens Medical Solutions Diagnostics, Tarrytown, NY, USA), 
following the method of the International Federation of Clinical Chemistry 
Committee’s primary reference procedures for the measurement of catalytic activity 
concentrations of enzymes (184). 
CK-MB analysis was performed using a Dimension Clinical Chemistry System 
(Siemens Healthcare Diagnostics, Tarrytown, NY, USA) with a sensitivity limit of 0.5 
ng·mL-1, following the method described by Vaidya and Beatty (197). An Enzyme 
Amplified Sensitivity Immunoassay (EASIA) from Diasource (Biosource, Louvain-la-
Neuve, Belgium) was used to measure IL-6 serum concentrations with a sensitivity 
limit of < 2 pg/mL. Serum cTnI determinations were done in a Dimension Clinical 
Chemistry System automatic device (Siemens Healthcare Diagnostics, Tarrytown, 
NY, USA) with an analytical measurement range of 0.017 to 40 ng·mL-1. Serum 
concentration of sMtCK was measured by using a commercial enzyme linked 
immunosorbent assay (ELISA) kit SEC386Hu (Cloud Clone Corp., Houston, TX, 
USA) according to the manufacturer’s protocol.  
To measure FM and SM serum concentrations an ELISA-sandwich using monoclonal 
antibodies (all Sigma Aldrich, Poole, UK) developed by the Department of 
Physiological Science I from the University of Barcelona was used. Briefly, two plates 
(Corning 96-well EIA/RIA, Sigma Aldrich, Poole, UK) were coated overnight at 4ºC, 
one plate with monoclonal anti-myosin (skeletal, fast) clone My-32 and another plate 
with monoclonal anti-myosin (skeletal, slow) clone NOQ7.5.4D. Monoclonal anti-
myosin (skeletal, fast) clone My-32 localizes an epitope on the MHC 2 and 
monoclonal anti-myosin (skeletal, slow) clone NOQ7.5.4D recognizes an epitope 
located on the heavy meromyosin portion of ß/slow MHC. The plates were blocked 
with block buffer (Super Blocking Buffer, Thermo Fisher Scientific Inc., Rockford, IL, 
USA). A calibration curve of a 6-point serial dilution from 0 to 250 ng was obtained 
with commercial pure myosin of porcine muscle M0273. Each sample (10 µL) was 
then loaded by triplicate into the wells of the plate. Washes were done with 
phosphate buffered saline (PBS), pH 7.4, 10mM. The ELISA for both fast (type II) 
and slow (type I/ß) myosin (FM and SM respectively) plates was then completed by 
adding anti-myosin polyclonal antibody M7523, and afterwards, by adding mouse 
anti-IGG linked to peroxidase A6154. Incubation steps (60 min at 37ºC) were 
performed immediately after adding the antibodies and/or samples. Finally, 
tetramethylbenzidine (TMB) (Sigma Aldrich, Poole, UK) liquid substrate system for 
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ELISA was added and allowed to react at room temperature. The reaction was then 
stopped with H2SO4, and the quantity of FM and SM was measured 
spectrophotometrically (Synergy 2 Multi-Mode Microplate reader, Biotek Instruments, 
Winooski, VT, USA) at 450nm. Sample myosin concentrations were determined by 
interpolation from the calibration curve (r2 > 0.9). Samples were analysed in triplicate 
with an intra-assay coefficient of variation (CV) below or equal to 10% for FM and SM 
respectively. 
All these analyses were conducted at the Hospital Clínic (Barcelona, Spain) and at 
the Department of Physiological Science I at the University of Barcelona (Barcelona, 
Spain). 
3.6 Magnetic resonance imaging 
MRIs (3 T scanner; Siemens, Erlangen, Germany) were performed ~30 min prior to 
exercise and 24 hours and 7 days following exercise. Subjects were supine on the 
MR-gurney with head outside the MR-bore and thighs covered with one 32- and two 
flexible 4-channel coils respectively in the proximal and distal segments. A custom-
made foot-restrain device was used to standardize and fix limb position, and to avoid 
any compression of thigh muscles. Twelve cross-sectional images of the thigh of 
both legs were obtained, starting at the very distal margin of the ischial tuberosity, 
and using the following scan sequences: (a) axial fat-suppressed proton density, TR 
3000 ms, TE 30-33, eco train 4, slice thickness 3.5 mm, gap 28 mm, FOV 400x290 
mm, matrix 320x180 and ipat 2; (b) axial T2 mapping, TR 1000 ms, TE (18, 36, 54, 
72, 90, 108), eco train 6, FOV 400x400 mm, matrix 256x256, slice thickness 3.5 mm 
and gap 28 mm. A parametric image was generated from the T2 mapping sequence 
using the Leonardo workstation (Siemens, Erlangen, Germany). Scout images and 
anatomical landmarks were obtained to ensure identical positioning in pre- and post-
scans. 	
T2 of hamstring muscles (semitendinosus [ST]), and biceps femoris long head 
[BFlh]) and short head [BFsh]) from both legs were measured using eFilm Lite v.3.1 
software (Merge Healthcare, Chicago, IL). Using the fat-suppressed images to detect 
any confounding artefact (i.e., vessels, fat), a circular region of interest (ROI) was 
selected for individual hamstring muscles in each of the T2 mapping images where 
muscles were visible. Following pre-exercise scan analysis, the same-size circular 
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ROIs were placed in the T2 images of the post-exercise scan, to ensure the same 
positioning as in the pre-exercise analysis. In the evaluations, the images containing 
areas at 30% (proximal), 50% (middle) and 70% (distal) of thigh length from upper 
border of ischial tuberosity (0%) to the lower border of the tibial plateau (100%) were 
used (117). The same researcher performed the MR imaging scan and the T2 
calculation. High interrater reliability has been previously reported with intraclass 
correlation coefficients ranging from 0.87 to 0.94 (39). 
3.7 Muscle soreness 
A 10-point visual rating scale (VRS) was used to quantify muscle soreness in lower 
limb muscles. Each number on the scale was accompanied by descriptive words for 
soreness, from 0 to 10 (intolerably intense). Participants were asked to fill in the VRS 
before and after the exercise, at the same time of day. In experiments involving the 
knee extensors, subjects were asked to fill in the VRS during a body weight squat to 
a knee joint angle of 90º, and in experiments involving the knee flexors, subjects 
stretched and contracted (isolated unloaded knee flexion from a stand up position) to 
assess general soreness throughout the hamstring muscles. 
3.8 Muscle function 
Muscle function of knee extensors and knee flexors (hamstring muscles) was 
assessed by different FGC tests in studies I and III. 
3.8.1 Force-generating capacity 
Maximum power test 
A maximum inertial concentric-eccentric (C-E) power test (Pmax) was developed as an 
indicator of the specific dynamic FGC of the knee extensors. During the Pmax test, 
dynamic muscle work was characterized using the evolution of force, displacement, 
and velocity data, sampled at a frequency of 100 Hz by MuscleLab 4020e from the 
force sensor and linear encoder (Ergotest Technology, Langesund, Norway). The 
test consisted in a half-squat exercise that participants started from a 90º knee angle 
static position using an adjustable pulley on the flywheel inertial resistance device. 
Three submaximal repetitions were performed to initiate rotation of the flywheel, 
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which were immediately followed by five maximal voluntary C-E repetitions, with no 
pause. The three highest power repetitions were selected, and their average 
concentric and eccentric power was calculated and established as maximum C-E 
power. 
Jump test 
Jump tests were used to evaluate lower body dynamic explosive strength. A 
MuscleLab 4020e electronic contact mat (Ergotest Technology) was used to 
determine the squat jump (SJ) and countermovement jump (CMJ) flight time. For the 
SJ, the participants were positioned on the contact mat with a knee angle of 90° and 
were not allowed to jump until 4 s passed; for the CMJ, they performed a fast flexion 
movement of the knee joint, followed by a maximum-effort vertical jump. For both 
tests, the participants retained the hands-on-hips position until the final phase of the 
jumps. The best of three trials was recorded for further analysis. 
Maximal voluntary contraction test 
In study III, FGC was measured as MVC; i.e., average force in a 1-s window when a 
force plateau had been established (195). MVCs of the knee flexor muscles were 
measured for each leg with a force gauge connected to an A/D converter system, 
MuscleLab 4020e (Ergotest AS, Langesund, Norway). Subjects were prone with the 
hip joint at 40º of flexion and with the knee joint at 30º of flexion and received verbal 
encouragement during the test to ensure maximal effort. Subjects performed two 
isometric MVCs of 3 to 5 seconds with a 1-min rest between contractions, and if any 
countermovement was evident, an additional MVC was measured. 
3.9 Statistics 
Data were tested for approximation to a normal distribution using the Shapiro-Wilk 
test. Asymmetrically distributed data were log- or sqrt-transformed before analysis.  
One-way (studies I, II, and IV) and two-way (study III) repeated measure analysis of 
variance (ANOVA) followed by a paired t-test with a Bonferroni correction was 
performed to identify statistically significant changes from baseline. Repeated 
measure analysis of covariance (ANCOVA) (group x time [covariate: training hours 
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per week]) (study V) followed by a paired t-test with a Bonferroni correction was 
performed to identify statistically significant changes from baseline.  
Transformed data that still did not show a normal distribution were analysed using 
Friedman’s test followed by the Wilcoxon signed rank test with a Bonferroni 
correction to identify significant changes from baseline. 
Associations between variables of interest were assessed using Pearson’s 
correlation coefficient test or Spearman’s rank order correlation coefficient (choice 
dependent on Shapiro-Wilk test for Gaussian distribution). 
The unpaired t-test and the Mann-Whitney test (choice dependent on Shapiro-Wilk 
test for Gaussian distribution) were used to analyse differences between groups.  
Data are presented as mean ± standard error of the mean (SEM), unless otherwise 
stated. The level of significance was set at P < 0.05 (studies I, II, III and V) or P < 
0.01 (study IV). 
The statistical analysis was conducted using SPSS version 20.0 (SPSS Statistics, 
IBM corp., Armonk, NY, USA) statistical analysis software. 
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4. STUDIES 
The studies were based on the aims and hypothesis proposed and will be presented 
as five studies, as follows. 
HIE, laboratory studies: I, II, III. 
LDE, field studies: IV, V. 
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4.1 Study I 
Muscle enzyme and fibre type-specific sarcomere protein 
increases in serum after inertial concentric-eccentric exercise  
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Muscle damage induced by inertial exercise performed on
a flywheel device was assessed through the serum evolu-
tion of muscle enzymes, interleukin 6, and fiber type-
specific sarcomere proteins such as fast myosin (FM) and
slow myosin (SM).We hypothesized that a model of muscle
damage could be constructed by measuring the evolution
of serum concentration of muscle proteins following iner-
tial exercise, according to their molecular weight and the
fiber compartment in which they are located. Moreover, by
measuring FM and SM, the type of fibers that are affected
could be assessed. Serum profiles were registered before
and 24, 48, and 144 h after exercise in 10 healthy and
recreationally active young men. Creatine kinase (CK)
and CK-myocardial band isoenzyme increased in serum
early (24 h) and returned to baseline values after 48 h. FM
increased in serum late (48 h) and remained elevated 144 h
post-exercise. The increase in serum muscle enzymes sug-
gests increased membrane permeability of both fast and
slow fibers, and the increase in FM reveals sarcomere
disruption as well as increased membrane permeability of
fast fibers. Consequently, FM could be adopted as a fiber
type-specific biomarker of muscle damage.
Although there is reasonable evidence that unaccus-
tomed or vigorous muscle activity, especially that
involving eccentric contractions, can cause exercise-
induced muscle damage (EIMD), the notion that muscle
damage necessarily occurs following voluntary eccentric
exercise in humans has been much challenged (Paulsen
et al., 2012). Recently, it was proven that the extent of
muscle damage in humans was greater following elec-
trically stimulated contractions (severe disturbances of
Z-lines, myofibers, and extracellular matrix followed by
a loss of force-generating capacity and myofiber necro-
sis; Crameri et al., 2007) than following voluntary
eccentric contractions (minor myofibrillar disruptions
and minor changes in force-generating capacity; Gibala
et al., 2000; Crameri et al., 2007; Mikkelsen et al.,
2009). Although large variations in the responses of
healthy individuals are expected, exercise involving
regular athletic training with voluntary eccentric con-
tractions (e.g., resistance exercise) typically causes mild
EIMD [i.e., a small reduction in force-generating capac-
ity (< 20%) and creatine kinase (CK) activity lower than
1000 U/L] and full recovery is normally complete within
a few days (Paulsen et al., 2012).
Direct evidence of EIMD requires histological analy-
sis of muscle tissue (Faulkner et al., 1993). However, in
the context of sports activity, such an invasive technique
is rarely used. Although they do not always accurately
reflect the extent of EIMD, indirect markers are widely
used, including delayed onset muscle soreness, decre-
ments in force-generating capacity, and muscle-specific
enzyme and protein efflux to blood (Clarkson & Hubal,
2002). The mechanisms involved in the appearance of
different muscle enzymes and proteins in blood follow-
ing eccentric exercise still remain unclear but depend on
features such as their structure, molecular weight, and
charge or membrane charge; the cellular compartment in
which the enzyme or protein is located; the pathway the
enzyme or protein follows into the blood; and the clear-
ance rate of the enzyme or protein (Lindena &
Trautschold, 1983; Mair et al., 1992; Sorichter et al.,
1999; Dahlqvist et al., 2013).
Increased membrane permeability provides a route
into and out of the sarcoplasm that is distinct from the
conventional route of endocytosis and exocytosis.
McNeil and Khakee (1992) suggested that in rats, it
could be caused by the loss of sarcolemmal integrity as
a result of eccentric exercise (running on a treadmill at
an incline of 16° downhill). Also in rats, following elec-
trical stimulation, increased membrane permeability can
be related to the excitation-induced Ca+2 uptake
(Mikkelsen et al., 2004) and several days after eccentric
exercise, as shown in mouse models of Duchenne mus-
cular dystrophy, membrane permeability can remain
high because of the activation of ion channels (Allen
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et al., 2005). Enzymes leaked from muscle are then
mainly transported via the lymph into the blood stream
because of the extremely low capillary permeability of
muscle tissue (Lindena & Trautschold, 1983). One of the
enzymes that are released from the sarcoplasm through
permeabilized membranes is CK, which has been widely
used as a serum muscle damage biomarker. However,
there is no evidence that CK levels reliably reflect the
degree of muscle damage (Fridén & Lieber, 2001) and it
is not fiber type specific (Chapman et al., 2013). So, a
muscle fiber-specific biomarker is required to evaluate
the damage induced by exercise according to muscle
fiber type. Recently, Chapman et al. (2013) proposed
skeletal muscle fast and slow troponin I as fiber type-
specific biomarkers and indicated that type II (fast
twitch) fibers are more susceptible to eccentric EIMD, in
agreement with other findings (Lieber & Friden, 1988).
However, skeletal muscle troponin I has a soluble pre-
cursor pool in the sarcoplasm (3–4% of total skeletal
muscle troponin I), which seems to be responsible for its
rapid release from the muscle to the blood stream
(Sorichter et al., 1997), and could lead to misleading
results because its early appearance in serum cannot be
exclusively related to sarcomere disruptions.
In relation to degrees of muscle injury established by
magnetic resonance images, Guerrero et al. (2008) pro-
posed increases in the blood stream of muscle myosin
isoforms, fast (FM) and slow (SM), as ideal biomarkers
of muscle injury because of their fiber specificity.
Myosin is a sarcomere protein, with a molecular mass of
493 kDa (Holtzer & Lowey, 1959) that slides along
actin, hydrolyses ATP and produces movement. Myosin
has different heavy and light isoforms depending on the
fiber type (Pette & Staron, 2000). While FM is charac-
teristic of skeletal muscle only, SM is found in both
cardiac and skeletal muscle. A moderate serum rise in
FM or SM, below the injury levels described in Guerrero
et al. (2008), could indicate sarcomere disruption of a
specific fiber type because of to its molecular mass, its
structural localization, and the absence of a soluble cel-
lular myosin pool (Sorichter et al., 1997).
It has been reported that most human limb skeletal
muscles are composed of a mixture of slow (type I) and
fast (type II) fibers (Lexell et al., 1983). Autopsy studies
of knee extensor muscles show that the percentage of
type II fibers account for a 54.5% of vastus lateralis,
45.7% of vastus intermedius, 49.4% of vastus medialis,
and 57.7% of rectus femoris (Garrett et al., 1984). In
vastus lateralis biopsies performed on young men
(n = 95; 21.2 ± 2.2 years), 59.8% of muscle fibers were
type II (Staron et al., 2000). Because of this mixed fast
and slow muscle fiber composition, we must expect
different degrees of serum increase of FM and SM,
depending on the intensity, volume, and type of muscle
contraction during exercise.
Sports and exercise movements are a combination of
concentric and eccentric (C-E) muscle contractions.
Moreover, the magnitude of the eccentric muscle con-
traction in most sports actions (e.g., sprinting or
jumping) is related to the previous concentric phase.
Since the presentation of the flywheel principle (Berg &
Tesch, 1998), many sports trainers and physicians use
devices based on the inertia of rotating flywheels. These
allow highly specific sports exercises to be performed in
which the eccentric contraction is directly dependent on
the preceding concentric contraction or, if desired, brief
episodes of eccentric overload can be induced (Tesch
et al., 2004). Flywheel inertial resistance devices have
proved effective in promoting early skeletal muscle
hypertrophy and strength gain because of the high
torques required to stop the rotation (Tesch et al., 2004).
In the present study, we used an exercise design that
achieves high-intensity biphasic C-E intervention of the
knee extensor muscles, to replicate what occurs in
several sports actions. For the first time, the physiologi-
cal response to this exercise performed on a flywheel
inertial resistance device was assessed through the time
course evaluation of serum muscle enzymes, muscle
myosin isoforms, serum muscle inflammation biomarker
(interleukin 6; IL-6), perceived muscle soreness, and
dynamic force-generating capacity. We hypothesized
that a model of mild EIMD can be constructed by mea-
suring the time course of the serum concentration of
muscle proteins following inertial exercise, according to
their molecular weight and the fiber compartment in
which the enzyme or protein is located. Moreover, by
measuring fiber type-specific sarcomere proteins such
as FM and SM, the type of fibers affected could be
assessed.
Methods
Participants
Ten healthy men [mean ± standard deviation (SD): age 28.6 ± 6.1
years; height 175 ± 6.5 cm; bodyweight 73.3 ± 6.9 kg], who had
not suffered any myotendinous injuries for 1 year before the
experiments, volunteered to participate in the study. All were
recreationally active but had not been involved in any training
program for at least 6 months prior to the experiments. They were
asked not to perform any exercise during the week before and
throughout the experimental period.
The experiment was conducted in accordance with the code of
ethics of the World Medical Association (Declaration of Helsinki)
and approval was given by the Ethics Committee of the Catalan
Sports Council (Generalitat de Catalunya) (0099S/690/2013).
All the participants were informed about the purpose of the
study, known risks, and possible hazards associated with the
experimental protocol before recruitment and each gave written
consent.
Inertial exercise design
In order to evaluate muscle response to high-intensity voluntary
C-E exercise, the participants were required to perform seven sets
of 10 maximum-intensity repetitions of the half-squat exercise in a
flywheel inertial resistance device (Portable VersaPulley™, Heart
Rate Inc., Costa Mesa, California, USA). The device is comprised
of a cone attached above a flywheel, and as the flywheel and cone
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spin, a tether winds and unwinds around the cone. The concentric
action unwinds the tether and the eccentric action occurs during
rewinding. The flywheel inertial resistance device was configured
with the tether threaded through a pulley attached to a platform.
The end of the tether was attached to a shoulder and waist harness,
so the subjects could pull vertically on the tether. For the flywheel
inertial resistance, the arm pulley was set at the highest resistance
level, which corresponds to the minimum cone radius.
The participants started from a 90° knee angle static position
and made three submaximal repetitions immediately before 10
high-intensity voluntary C-E repetitions, with no pause. Three
minutes rest was given between sets. In order to achieve high-
intensity voluntary C-E repetitions, the individual maximum
execution rhythm (MER) was set as the proper lifting cadence and
the participants were verbally encouraged to follow it during each
repetition and set. Moreover, and despite volitional aspects, during
inertial exercise, resistance is at the momentary maximum ensur-
ing a maximal C-E effort at any given point in the range of motion
(Tesch et al., 2004).
Inertial exercise kinetics assessment
During inertial C-E exercise, dynamic muscle work was charac-
terized using the evolution of force, displacement, and velocity
data, sampled at a frequency of 100 Hz by MuscleLab 4020e from
the force sensor and linear encoder (Ergotest Technology,
Langesund, Norway; Tesch et al., 2004). Moreover, an electronic
metronome (Qwik Time QT-3 Quartz, 1 X S006p, Qwik TUNE®;
Moras et al., 2009), which emits a regular beep at a pace calibrated
in beats per minute (bpm), was used to control the exact repetition
rate, set as MER.
Dynamic force-generating capacity and perceived
muscle soreness
Before the inertial exercise, the participants completed a jump test
and an inertial half-squat maximum power (Pmax) test as indicators
of the specific dynamic force-generating capacity of the knee
extensors. The jump test was repeated 48 h and 144 h post-
exercise, while the Pmax test was performed only before and 144 h
after completion of the exercise, as it could affect the results of
blood muscle damage biomarkers. Moreover, the subjects were
instructed to assess their muscle soreness on a visual rating scale
(VRS) both before exercise and 24, 48, 72, 96, 120, and 144 h
post-exercise (Fig. 1).
Jump test
Jump tests have been used as lower body dynamic explosive
strength evaluation tools. A MuscleLab 4020e electronic contact
matt (Ergotest Technology) was used to determine the squat jump
(SJ) and countermovement jump (CMJ) flight time. For the SJ, the
participants were positioned on the contact mat with a 90° knee
angle and were not allowed to jump until 4 s had passed, while for
the CMJ, they performed a fast flexion movement of the knee joint,
followed by a maximum-effort vertical jump. For both tests, the
participants retained the hands-on-hips position until the final
phase of the jumps. The best of three trials was recorded for further
analysis.
Pmax test
To assess inertial Pmax, the participants started the half-squat test
from a 90° knee angle static position using an adjustable pulley on
the flywheel inertial resistance device. Three submaximal repeti-
tions were performed to initiate rotation of the flywheel, which
were immediately followed by five maximal voluntary C-E rep-
etitions, with no pause. The three highest power repetitions were
selected, and their average time duration was calculated and con-
verted to a MER in bpm (Moras et al., 2009) for each participant.
Muscle soreness
A 10-point VRS was used to quantify muscle soreness in the knee
extensor muscles during a body weight squat to a 90° knee joint
angle. Each number on the scale was accompanied by descriptive
words for soreness, from 0 (none) to 10 (intolerably intense).
Participants were asked to fill in the VRS 24, 48, 72, 96, 120, and
144 h after the exercise, at the same time of day.
Pre 0 h 24 h 48 h 72 h 96 h 120 h 144 h 
Blood 
sample 
Jump test Jump test 
INERTIAL EXERCISE 
(7 x 10 reps)  
Baseline 
values Post-exercise values  
Blood 
sample 
Blood 
sample 
Blood 
sample 
VRS VRS VRS VRS VRS VRS VRS 
Pmax test  
(5 reps)  
Pmax test  
(5 reps)  
Biomarkers 
Muscle 
soreness 
Dynamic 
force-
generating 
capacity 
Jump test 
Fig. 1. Schematic overview of experimental procedures. VRS, visual rating scale (perceived muscle soreness). Pmax test, inertial
half-squat maximum power test (five repetitions). Exercise (7 × 10), inertial half-squat exercise (7 sets of 10 repetitions).
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Blood sampling and processing
To study how inertial exercise affects fiber structure and which
types of muscle fibers are involved the most in maintaining per-
formance during exercise, FM and SM were measured in serum.
EIMD has previously been related to an increased serum concen-
tration of muscle enzymes, so we measured CK, creatine kinase-
myocardial band isoenzyme (CK-MB), aspartate aminotransferase
(AST), and alanine aminotransferase (ALT). Furthermore, the
inflammatory response was assessed as IL-6 serum levels.
Five milliliters of blood was obtained from the volunteers
before the inertial exercise, and 24, 48, and 144 h after the exercise
(Fig. 1). The samples were centrifuged at 2000 g for 10 min at
4 °C. Serum aliquots were stored at −80 °C until analysis. Serum
was used to measure enzymatic activities and FM and SM levels.
Biochemical analyses of CK, AST, and ALT were performed in an
Advia 2400 automatic device (Siemens Medical Solutions Diag-
nostics, Tarrytown, New York, USA), following the method of the
International Federation of Clinical Chemistry’s Committee
primary reference procedures for the measurement of catalytic
activity concentrations of enzymes (Siekmann et al., 2002).
CK-MB analysis was performed using a Dimension Clinical
Chemistry System (Siemens Healthcare Diagnostics), following
the method described by Vaidya and Beatty (1992). An enzyme
amplified sensitivity immunoassay from Diasource (Biosource,
Louvain-la-Neuve, Belgium) was used to measure IL-6 serum
concentrations with a sensitivity limit of < 2 pg/mL.
To measure FM and SM serum concentrations, we developed an
enzyme-linked immunosorbent assay (ELISA sandwich) using
monoclonal antibodies (all Sigma Aldrich, Poole, UK).
Two plates (Corning 96-well EIA/RIA, Sigma Aldrich, Poole,
UK) were coated overnight at 4 °C, one plate with monoclonal
anti-myosin (skeletal, fast) clone My-32 and another plate with
monoclonal anti-myosin (skeletal, slow) clone NOQ7.5.4D. The
plates where blocked with block buffer (Super Blocking Buffer,
Thermo Fisher Scientific Inc., Rockford, Illinois, USA). A calibra-
tion curve of serial dilution from 0 to 250 ng was obtained with
commercial pure myosin of porcine muscle M0273. Washes were
done with phosphate buffered saline, pH 7.4, 10 mM. The ELISA
for both FM and SM plates was then completed by adding anti-
myosin polyclonal antibody M7523, and afterwards, by adding
mouse anti-IGG linked to peroxidase A6154. Incubation steps
(60 min at 37 °C) were done immediately after adding the anti-
bodies and/or samples. Finally, tetramethylbenzidine (Sigma
Aldrich) liquid substrate system for ELISA was added and allowed
to react at room temperature. The reaction was then stopped with
H2SO4, and the quantity of FM and SM was measured spectropho-
tometrically (Synergy 2 Multi-Mode Microplate reader, Biotek
Instruments, Winooski, Vermont, USA) at 450 nm. Sample
myosin concentrations were determined by interpolation from the
calibration curve (r2 > 0.9). Samples (10 μL) were analyzed in
triplicates with an intra-assay coefficient of variation (CV) below
9% for FM and below 6% for SM. Linearity of FM assay was 80%
and 90% for the SM assay.
Statistical analysis
Distributions were considered for each of the variables, with the
normality of continuous variables assessed using the Shapiro–
Wilk test. As the CK and CK-MB activity data were asymmetri-
cally distributed, these values were log-transformed before
analysis. One-way repeated-measures analysis of variance was
used to identify the effect of time on muscle enzyme activities, FM
and SM levels, perceived muscle soreness, and muscle dynamic
force-generating capacity. If significant effects were found, a post-
hoc Bonferroni-corrected Student’s t-test was applied. The
Wilcoxon signed rank test was used on log-transformed data that
still did not show a normal distribution (CK-MB). Correlations
between variables of interest were calculated using Pearson’s cor-
relation coefficient. Intra-participant variability was expressed as
the coefficient of variation: CV (%) = 100 × SD/mean value. Data
are presented as mean ± standard error of the mean (n = 10),
unless otherwise stated. The level of significance was set at
P < 0.05. All the statistical analysis was conducted using the SPSS
version 20.0 (SPSS Statistics, IBM Corp., Armonk, New York,
USA) statistical analysis software.
Results
Inertial exercise kinetics
Exercise kinetics was assessed to evaluate the magnitude
of the eccentric phase of the inertial exercise and how
concentric contractions influence eccentric ones. The
kinetics (displacement, velocity, and force) of the inertial
exercise carried out on the flywheel inertial resistance
device provided us the average and peak power (Fig. 2).
The results showed that both average and peak
power were strongly correlated between concentric and
eccentric muscle contractions (r = 0.940; P > 0.001 and
r = 0.912; P = 0.001). Concentric average power
(530 ± 130 watts) was 40% greater than eccentric
average power (320 ± 80 watts; P > 0.001), and concen-
tric peak power (1100 ± 260 watts) was 39% greater than
eccentric peak power (670 ± 160 watts; P = 0.001;
Fig. 3). The average intra-participant variability in dis-
placement (produced by knee flexion–extension) during
the exercise was 4% in both the concentric and the
eccentric phase.
Dynamic force-generating capacity and perceived
muscle soreness
Pmax test
With regard to dynamic force-generating capacity, the
average displacement during the half-squat inertial Pmax
test was similar before inertial exercise (concentric:
39.17 ± 4.24 cm, and eccentric: 36.99 ± 4.99 cm) and at
144 h after inertial exercise (concentric: 38.94 ±
3.33 cm, and eccentric: 37.92 ± 3.47 cm). MER was also
similar between the pre-inertial exercise Pmax test
(43 ± 4 bpm) and the 144 h post-inertial exercise Pmax
test (44 ± 2 bpm). In contrast, while significant differ-
ences were observed between average and peak eccentric
power exerted in the pre-inertial exercise (0 h), Pmax test
(P = 0.03) and in the 144 h post-inertial exercise Pmax test
(P = 0.004), no significant differences were observed
between the average and peak concentric power in the
pre-inertial exercise (0 h) Pmax test and 144 h post-inertial
exercise Pmax test (Fig. 4).
Jump test
The results showed that lower body dynamic explosive
strength evaluated by the jump tests was not significantly
modified by inertial exercise. At 48 and 144 h, the SJ and
CMJ values were slightly lower than the pre-exercise
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jump test values. SJ values were 31.84 ± 4.71 cm pre-
exercise, 31.17 ± 3.99 cm at 48 h post-exercise, and
30.69 ± 4.32 cm at 144 h post-exercise (a decrease of 2.1
and 3.6%, respectively). CMJ were 36.73 ± 5.12 cm pre-
exercise, 35.19 ± 5.04 cm at 48 h post-exercise, and
35.25 ± 5.91 cm at 144 h post-exercise (a decrease of
4.2% and 4.0%, respectively).
Muscle soreness
The average values for perceived muscle soreness during
a body weight squat to a 90° knee joint angle were higher
24 h after the inertial exercise, remained at the higher
values at 48 h, and declined to control values at 96 h
(Fig. 5).
Serum muscle enzymes, FM and SM, and IL-6
To analyze the muscle response and which types of fibers
were most involved in inertial C-E exercise, we evalu-
ated changes in FM and SM and enzymes in serum over
time. After the exercise, there was a progressive increase
in average FM serum levels, which reached its highest
value at 48 h, and remained significantly elevated at
144 h. In contrast, SM showed similar blood concentra-
tions at all the times analyzed after the exercise com-
pared to the values obtained before the inertial exercise
(Table 1). Individual analysis of relative FM and SM
serum concentrations was also performed. After the
exercise, there were nonuniform increases in FM serum
levels in nine of the participants (range 35% to 259%
from baseline values). Only one participant showed no
FM changes (< 6% from baseline values). The pattern of
increase to the relative FM peak was also different
between the participants. While five of them reached the
serum peak 144 h post-exercise, three reached it at 48 h
and only one at 24 h. With regard to SM, only three
participants showed slight increases until the relative
peak at 24 and 48 h (range 23% to 60% from baseline
values) following inertial exercise (Fig. 6). The FM/SM
ratio was significantly increased by 51% ± 21%
(P = 0.02) at 48 h and by 96% ± 36% (P = 0.007) 144 h
post-exercise (Table 1).
All enzyme activities prior to inertial exercise were
within the normal range (Table 1). After exercise, the
Fig. 2. Inertial exercise kinetics and kinematics in one participant’s C-E repetition. Displacement applied to the flywheel during the
knee flexion–extension (a). Velocity applied to the flywheel during displacement (b). Force applied to the flywheel during displacement
(c). Power applied to the flywheel as a product of force and velocity (d). Vertical dashed–dotted line denotes the C-E deflection.
Fig. 3. Power (watts) applied by a participant during one set of
inertial exercise. Note that concentric power is greater than
eccentric power. Horizontal dashed–dotted line denotes the C–E
deflection. Vertical dashed line delimits repetitions. CON,
concentric; ECC, eccentric.
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time course of serum activity of CK, CK-MB, and
AST were similar, while ALT showed no variations.
Serum CK levels were 2.9-fold higher at 24 h (P = 0.01)
and returned to baseline values 144 h after exercise.
CK-MB showed a significant increase at 24 h (P =
0.005) and returned to baseline values 48 h post-
exercise. The behavior of both AST and ALT was differ-
ent from that of CK, CK-MB: despite a slight
nonsignificant increase at 24 h in serum AST concentra-
tion, activity remained constant throughout the rest
period after the exercise (Table 1). However, total pooled
data from CK and AST activities were highly correlated
(r = 0.769; P > 0.001; Fig. 7). The IL-6 serum levels of
two participants prior to the inertial exercise were higher
than the normal range (≤ 5 pg/mL). No changes were
seen in the average values of IL-6 following the exercise.
However, it is interesting to note that five participants
showed nonuniform increases in IL-6 serum levels
(range 31% to 1150% from baseline values), while the
other five participants showed no changes from baseline
values (Fig. 8).
Discussion
We examined the influence of inertial high-intensity vol-
untary C-E exercise on knee extensor muscles and how it
affects the different types of muscle fibers. To this end,
we chose a half-squat exercise on a flywheel inertial
resistance device, and FM and SM as fiber type-specific
sarcomere proteins that are potential biomarkers of
muscle damage.
Our results show for the first time in a well-
characterized inertial exercise that fast and slow fibers
respond differently following a high-intensity voluntary
C-E exercise based on a movement similar to many
sports actions (e.g. jumping, sprinting). We found an
increase in the FM isoform in blood, indicating a sarco-
mere disruption of fast fibers; while the absence of
change in the serum SM isoform and the serum increase
in both AST (albeit nonsignificantly) and CK-MB sug-
gested that slow fibers were mainly affected at the sar-
colemmal level. Moreover, because CK is not fiber type
specific, the changes in total CK activity cannot be
related exclusively to increased membrane permeability
of fast fibers.
The inertial C-E exercise that we studied induces sig-
nificant perceived muscle soreness, and increases in
serum CK concentrations. Neither effect is large, sug-
gesting that mild EIMD was inflicted (Paulsen et al.,
2012). The CK increases are very similar to those
reported in prior studies, which induced mild EIMD
using voluntary eccentric exercise protocols involving
the knee extensors (Bourgeois et al., 1999; Davies et al.,
2011). Interestingly, although only mild EIMD was pro-
duced, sarcomere disruptions of fast fibers were sug-
gested by FM serum increases. Other studies using
greater muscle work volumes (200 eccentric contrac-
tions) found higher CK activity following exercise
without histological evidence of myofiber damage
(Mikkelsen et al., 2009). This is probably because CK
presents large inter- and intra-individual variability
and only provides evidence of muscle damage in a
dichotomous fashion: damaged or not damaged (Fridén
& Lieber, 2001) and minor sarcomere disruptions
can indeed occur without significant changes in the
Fig. 4. Concentric and eccentric average (a) and peak (b) power increases between pre (0 h) and 144 h post-exercise in Pmax test (n = 9).
* and **, Significantly different from the pre-exercise value at P < 0.05 and P < 0.01, respectively.
Fig. 5. Changes in muscle soreness. ** and ***, Significantly
different from the pre-exercise value at P < 0.01 and P < 0.001,
respectively.
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force-generating capacity (Gibala et al., 2000). More-
over, eccentric contractions of the leg muscles can lead
to serum increases in IL-6 for several days following
exercise (Paulsen et al., 2012). However, in the present
study, no clear inflammatory response was seen follow-
ing the inertial exercise, as the serum concentration of
IL-6 showed large inter- and intra-individual variability
in the magnitude of and the time to the serum peak in five
of the participants. Furthermore, no correlation was
found between IL-6 and enzyme or protein serum
concentrations.
With regard to the inertial exercise kinetics, our results
showed that values for concentric average and peak
Table 1. Changes in serum concentration of the muscle enzyme and fibre-type-specific proteins before (0 h) and 24, 48 and 144 h after inertial exercise
Pre (0 h) 24 h 48 h 144 h
FM (μg/L) 1082.8 ± 203.9 1391.0 ± 254.8 1562.4 ± 241.9* 1485.6 ± 157.7**
SM (μg/L) 1887.9 ± 247.7 1893.0 ± 245.9 2067.9 ± 241.4 1738.9 ± 259.8
FM/SM ratio 0.58 ± 0.09 0.73 ± 0.11 0.77 ± 0.10* 0.98 ± 0.12**
CK (U/L) 221.4 ± 42.7 652.7 ± 198.3** 416.2 ± 126.9 196.1 ± 50.2
CK-MB (ng/mL) 1.32 ± 0.27 1.83 ± 0.26** 1.18 ± 0.25 1.31 ± 0.41
AST (U/L) 25.10 ± 2.77 32.90 ± 3.57 29.50 ± 3.06 23.00 ± 2.62
ALT (U/L) 21.30 ± 2.81 22.50 ± 2.79 21.40 ± 2.41 22.80 ± 2.99
Data are presented as mean ± SEM. FM, fast myosin. SM, slow myosin. CK, creatine kinase. CK-MB, creatine kinase-myocardial band isoenzyme. AST,
aspartate aminotransferase. ALT, alanine aminotransferase. * and **, Significantly different from the pre-exercise value at P < 0.05 and P ≤ 0.01,
respectively.
Fig. 6. Individual changes in serum concentration of FM (fast
myosin) (a) and SM (slow myosin) (b), until serum peak at 24,
48, or 144 h following inertial exercise. Data are normalized to
baseline values (100%). * and **, Significantly different from
the pre-exercise value at P < 0.05 and P < 0.01, respectively.
Fig. 7. Association between serum creatine kinase (CK) and
aspartate aminotransferase (AST) in the total pool of data (pre,
24, 48, and 144 h post-exercise; P > 0.001).
Fig. 8. Individual data of changes in serum concentration of IL
6 (interleukin-6), until serum peak at 24, 48, or 144 h following
inertial exercise. Data are normalized to baseline values (100%).
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power during maximal inertial exercise are greater than
eccentric values. However, the eccentric average and
peak power is highly dependent on the preceding con-
centric phase because of the kinetic energy of the rotat-
ing flywheel (Tesch et al., 2004). In addition, as previous
studies have established causality between eccentric
exercise and changes in indirect markers of muscle
damage (Clarkson & Hubal, 2002), it seems reasonable
to relate the increases in perceived muscle soreness and
CK mostly to the eccentric phase of the inertial exercise.
Most evidence indicates that fast fibers cannot be selec-
tively recruited for eccentric contractions over a wide
range of effort and speed (Chalmers, 2008), and during
inertial exercise resistance is at its momentary
maximum, thereby ensuring a maximal C-E effort at
every point in the range of motion (Tesch et al., 2004).
Therefore, fast and slow fibers should be recruited and
damaged in a similar manner during maximal C-E
inertial exercise.
Consequently, we can expect that serum concentra-
tions of FM and SM should increase in a similar manner.
Nevertheless, our results showed that only FM serum
concentration was significantly raised after the inertial
exercise: no differences were observed in SM serum
levels. The increases in the FM serum concentration
indicate sarcomere disruption of fast fibers. This is in
agreement with Chapman et al. (2013) and Dahlqvist
et al. (2013), who proposed troponin I as a fiber type-
specific biomarker of sarcomere damage, despite the fact
that only Chapman et al. (2013) found increases in fast
skeletal troponin I in healthy participants. Moreover,
increases in serum FM support the claim that fast fibers
are more susceptible to eccentric EIMD (Lieber &
Friden, 1988) because of their morphological and bio-
mechanical characteristics; less elastic titin isoform, less
desmin content, narrower Z-discs, and shorter optimum
length for tension than slow fibers (for a review see
Schiaffino & Reggiani, 2011).
FM and SM levels in serum have been used before as
muscle injury biomarkers (Guerrero et al., 2008). An
increase in FM serum levels and the FM/SM ratio were
related to grade I muscle injury, diagnosed by magnetic
resonance. Although our results show higher baseline
serum levels of both FM and SM than we have
described previously as reference values, the FM/SM
ratio before exercise (0.58), which is considered a
control value, was similar to that found before
(Guerrero et al., 2008). The increase in the FM/SM
ratio confirmed that mainly fast fiber sarcomeres were
disrupted after the inertial exercise. Furthermore,
although FM was significantly increased in serum 48
and 144 h after the inertial exercise, the FM/SM ratio
was below the levels described by Guerrero et al.
(2008) (2.20), which indicated an absence of grade I
muscle injury. It must be pointed out that in Guerrero
et al. (2008), serum myosin concentration was deter-
mined by Western blot technique and, in the present
study, was determined by ELISA, which allowed for
faster but also reliable assessments of myosin isoforms
serum levels.
Although the SM serum concentration remained
almost unaltered in all the individuals, indicating that the
sarcomere integrity of slow fibers was not compromised,
sarcolemmal damage to the skeletal muscle slow fibers
cannot be ruled out because of the increased serum activ-
ity of CK-MB.
CK is a poor indicator of sarcomere damage (Fridén
& Lieber, 2001) and is not fiber type specific
(Chapman et al., 2013), but the significant increase in
serum total CK and CK-MB activity at 24 h could be
evidence of increased membrane permeability because
of their sarcoplasmic (cytosolic) location (Dahlqvist
et al., 2013).
The present study also reported no changes in ALT
serum concentration and only nonsignificant serum
increases in AST 24 h after the inertial exercise; but a
strong association between CK and AST. AST could
play a role similar to that of CK and CK-MB as a
biomarker of increased membrane permeability, as it is
also found in the sarcoplasm (cytosol). Moreover, while
fast and slow fibers present almost equal CK activity
(Apple & Tesch, 1989), slow fibers have higher
CK-MB (Yamashita & Yoshioka, 1991) and AST
(Schantz & Henriksson, 1987) activity. As a conse-
quence, a 24 h rise in CK-MB and AST could be more
precisely associated with increased membrane perme-
ability of slow fibers, which suggests that this kind of
fiber is also recruited and damaged at the sarcolemmal
level by inertial exercise.
The fact that the serum peak in AST and, especially
CK and CK-MB coincided at 24 h could be associated
with their similar molecular weight (82 kDa, 87 kDa,
and 92 kDa, respectively). Their mainly sarcoplasmic
location could also explain their similar serum profiles,
as they reach the interstitium because of an increase in
the membrane permeability of both fast and slow fibers.
It is known that membrane permeability increases during
eccentric exercise by mechanical stress-induced mem-
brane disruptions (McNeil & Khakee, 1992). However,
as it has been demonstrated that the resealing of artifi-
cially produced membrane disruptions occurs in less
than a minute (Bansal et al., 2003), increased membrane
permeability caused by the activation of ion (Ca+2) chan-
nels and a consequent increase in reactive oxygen
species that affect membrane lipids (Allen et al., 2005)
may more adequately explain muscle enzyme and
protein leakage several hours or days after eccentric
exercise.
The time course of FM was different. The average
serum FM concentrations were significantly elevated at
48 h, as previously found (Guerrero et al., 2008), and
levels were still high at 144 h after inertial exercise.
Moreover, the analysis of individual cases showed non-
uniform changes in the magnitude and the time of the
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serum peak, as reported by Mair et al. (1992) and
Sorichter et al. (1997) with beta (slow) myosin heavy-
chain fragments. It has been suggested that the first event
after exercise is a degradation process in which protease
calpain initiates the turnover of fiber proteins by releas-
ing them from their filamentous sarcomere structure
(Goll et al., 2003). Degradation is then completed by the
ubiquitin–proteasome system (Eble et al., 1999). One
reason for the late increase in serum FM is that sarco-
mere protein turnover is slower than that of sarcoplasmic
proteins (Neti et al., 2009) and total maximum calpain
activity is augmented 48 h after eccentric exercise,
reaching a level three times higher after 144 h (Kanzaki
et al., 2010). Another reason for the late increase in
serum FM and its delayed peak values could be the
absence of a soluble myosin heavy-chain precursor
pool (Sorichter et al., 1997). The cascade of reactions
that results in activated skeletal muscle protein metabo-
lism is a complex process that could explain the differ-
ences between the time course of FM and muscle
enzymes.
Finally, eccentric power output (average and peak
power) was enhanced 144 h post-exercise, when FM
serum concentration was still significantly above base-
line values. Following the proposal of Paulsen et al.
(2012), in the present study, only mild EIMD was
inflicted, as force-generating capacity, expressed as
jumping ability, only suffered a slight decrease and
eccentric power output was significantly improved
144 h post-exercise. Furthermore, enzyme serum activ-
ity and perception of muscle soreness rose only mod-
erately. Minor sarcomere disruptions can indeed occur
without significant changes in the force-generating
capacity (Gibala et al., 2000), probably because force
can be transmitted near a few disrupted sarcomeres, as
it can be transmitted laterally through neighboring
myofibrils, across the sarcolemma, and through the
extracellular matrix (Grounds et al., 2005). So, if the
structural components involved in lateral force trans-
mission remain undamaged, only slight changes in
muscle function are expected (Raastad et al., 2010). Yu
et al. (2004) propose that the sarcomere alterations
observed 7 days after eccentric exercise could indicate
muscle adaptation and regeneration, rather than
damage. Accordingly, 144 h post-exercise, FM serum
levels could be related to a sarcomere remodelling
process rather than damage. Finally, in inexperienced
participants, as in the present study, there is an
improvement in the ability to apply force after a single
strength training session that is related to motor learn-
ing factors (Selvanayagam et al., 2011). The magnitude
of the mild EIMD, the lateral force transmission, the
relationship between time-persistent high FM serum
levels and both sarcomere turnover and adaptation, and
the early strength gains caused by neural factors
explain the 144 h post-exercise eccentric power output
enhancement.
In short, the present study shows for the first time
that high-intensity C-E inertial exercise of the knee
extensors, involving a highly specific movement similar
to several sports actions, induces a different level of
damage in fast and slow fibers. Interestingly, while an
increase in muscle damage biomarkers such as CK-MB
could indicate increased membrane permeability of
slow fibers, FM serum increases revealed sarcomere
disruption as well as increased membrane permeability
of fast fibers. Moreover, FM is sensitive even when the
EIMD is mild, which demonstrates that skeletal muscle
myosin isoforms could be adopted as fiber type-specific
biomarkers of muscle damage. Our results support a
model of muscle damage based on the serum evolution
of muscle enzymes and muscle FM and SM according
to their molecular weight and the fiber compartment in
which they are located.
Perspectives
Although direct evidence of muscle damage is histologi-
cal, in a sports context, the analysis of EIMD is essen-
tially based on indirect evidence such as the
measurement of serum biomarkers, especially CK,
which is not an ideal biomarker. Recently, myosin
isoforms were shown to be reliable biomarkers of muscle
injury in patients who were previously diagnosed by
magnetic resonance and ultrasonography (Guerrero
et al., 2008). For the first time, the present study reports
a close relationship between inertial exercise and serum
increases in FM, which indicate sarcomere disruptions
as well as increased membrane permeability of the fast
fibers in physically active and healthy individuals. This
original finding could be useful for researchers who
study EIMD and need a fiber type-specific biochemical
marker of skeletal muscle obtained through a minimally
invasive technique. Additionally, myosin isoforms have
favorable release times and stability in blood. Thus, they
provide a highly sensitive biomarker of sarcomere
damage, which is easy to use in diagnoses that are not
performed immediately after exercise.
Key words: Inertial exercise, exercise-induced muscle
damage, knee extensor, fast myosin, creatine kinase,
dynamic force-generating capacity.
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4.2 Study II 
Fast fibre damage after leg press exercise leading to failure: 
the case of a pole vaulter 
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serum rises of several muscle enzymes and SM until 48 h after exercise. 47	
Conclusions. The PV’s exercise output revealed an explosive (power-oriented) profile 48	
leading to selective mild damage of fast fibres. In contrast, the PE exercise output 49	
showed a fatigue-resistant profile, which induced greater muscle enzyme activity and 50	
SM serum concentration, suggesting a higher extent of slow fibre damage. 51	
 52	
Keywords: leg press, muscle failure, creatine kinase, myosin isoforms, power output. 53	
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Introduction 67	
Although the physiological responses to exhausting leg press exercise leading to 68	
failure (LPF) have been well-documented recently in recreational endurance-trained 69	
athletes with a high mean percentage of slow (type I) fibres (65±12%),1 care should 70	
be taken when generalizing the results to power athletes, who are expected to have 71	
higher proportions of fast (type II) fibres. Fast fibres generate high peak power and 72	
contract with high shortening speed, mainly determined by the myosin isoform,2 and 73	
their energy failure implies a great decrease in muscle power output, especially at fast 74	
movement rates.3 In this sense, LPF is primarily used for muscle strength and 75	
hypertrophy, inducing selective fatigue of fast fibres and then progressive recruitment 76	
of slow (type I) fibres, which decreases mechanical efficiency in the final part of the 77	
exercise.1 Since resistance training, when it is exhaustive and has a demanding 78	
eccentric component, typically causes mild muscle damage,4 indirect evidence of few 79	
myofibrillar disruptions from both fast and slow fibres can be expected following LPF.  80	
The purpose of this study was therefore to investigate, in a trained pole vaulter (PV), 81	
the effect of LPF on changes in serum activity of muscle enzymes and serum 82	
concentration of myosin isoforms, as indirect biomarkers of sarcomere disruptions of 83	
fast and slow fibres,5 while simultaneously examining the mechanical output 84	
components as indicators of performance and fatigue developed throughout exercise. 85	
Besides, the PV case study was compared against a control subject who had similar 86	
characteristics to those described in previous studies using exhausting leg press 87	
exercise models.1 88	
 89	
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Methods 104	
Participants 105	
Two participants were recruited for the study: a national level, under-23, pole PV (age 106	
22.8 years, weight 73.8 kg, height 1.72 m) who trained 12 hours per week, had six 107	
years of athletic training experience, and a personal best of 4.85 m; and a physical 108	
education student (PE) (age 22.5 years, weight 69.9 kg, height 1.71 m) who 109	
performed 6-7 hours per week of physical activity consisting of endurance running 110	
and recreational football training. The study conformed to the World Medical 111	
Association’s code of ethics (declaration of Helsinki) and approval was given by the 112	
Ethics Committee of the Catalan Sports Council (Generalitat de Catalunya) 113	
(0099S/690/2013).  114	
Design 115	
Single control-case study  116	
Blood analyses 117	
Blood samples of 5 mL were collected before exercise (baseline) and 24 and 48 h 118	
after exercise. Serum was obtained and analyzed for fast and slow myosin (FM and 119	
SM respectively), creatine kinase (CK), aspartate aminotransferase (AST) and alanine 120	
aminotransferase (ALT), and creatine kinase MB isoform (CK-MB).5 121	
One repetition maximum assessment 122	
After three warm-up sets, a resistance was chosen that was thought to be slightly 123	
below the concentric one repetition maximum (1-RM), and participants were 124	
instructed to perform one repetition in a pneumatic leg press (Air300, Keiser 125	
Corporation, Fresno, CA, USA). Participants started the test from a knee 90º-angle 126	
static position using the adjustable seat of the pneumatic machine, and performed a 127	
concentric extension to reach the full extension of 180º against the resistance. 128	
Following increases in resistance between trails were adjusted to minimize the total 129	
number of attempts (3-4) required before the 1-RM was obtained.  130	
Exercise 131	
Participants performed 9 sets of concentric-eccentric repetitions until failure at a 132	
workload equivalent to 75% of concentric 1-RM in the pneumatic leg press, which 133	
allows for constant resistance throughout the whole range of motion independently of 134	
the velocity of exercise. A 3-min rest between sets was given. The participants were 135	
encouraged to complete the whole range of motion of every repetition as rapidly as 136	
possible. The concentric and eccentric work, velocity and power of each repetition 137	
were recorded using a linear encoder integrated to MuscleLab 4020e (Ergotest 138	
Technology AS, Langesund, Norway) system. Fatigue index (%) (FI) was calculated 139	
as follows:  140	
([Max Power – Min Power] / Max Power) x 100 141	
The participants were provided with visual feedback (MuscleLab software) and verbal 142	
encouragement in order to maximize power output and achieve muscle failure. 143	
Statistical analysis 144	
	 5	
The normality of each variable was tested using the Shapiro-Wilk test. The unpaired 145	
t-test or Mann-Whitney test (the choice was dependent on a normality test for 146	
Gaussian distribution) were used to test differences between subjects’ mechanical 147	
output variables. Friedman’s test with post-hoc Wilcoxon signed-rank tests with a 148	
Bonferroni correction was used to test differences between the PV’s average power 149	
output in the first set and the rest of the sets. 150	
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Results 176	
The 1-RM was 320 kg for the PV and 250 kg for the PE. The PV performed higher 177	
total work during exercise, but no average work differences were found between 178	
participants (Fig. 1[a]). The fatigue index was greater in the PV in every set, and 179	
significant differences were found between the participants’ average fatigue index (P 180	
= 0.004) (Fig. 1[b]). The PV applied higher concentric average velocity during the 181	
first sets of the LPF (Fig. 1[c]). Compared to the concentric average power exerted by 182	
the PV during the first set of the LPF, significant (P < 0.01) reductions (range: -12% 183	
to -19%) were found during the exercise, with the exception of sets 2 and 6, in which 184	
no significant differences were observed. Moreover, during the first six sets the 185	
concentric average power exerted by the PV was significantly (P < 0.01) higher 186	
(range: 14% to 35%) than that of the PE (Fig. 1[d]).  187	
A clearly different response in biochemical markers was observed between 188	
participants. While, the PV showed slight serum increases in CK (from 183 to 405 189	
IU·L-1) and CK-MB (from 0.5 to 1.6 ng·mL-1) at 24 h, and a clearly decreasing trend 190	
to enzyme baseline activity values at 48 h after exercise, the PE presented sharp 191	
serum rises, over the clinical normality range, of CK-MB (from 0.5 to 4.4 ng·mL-1) at 192	
24 h, and of CK (from 142 to 1000 IU·L-1) and AST (from 24 to 41 IU·L-1) at 48 h 193	
after exercise (Fig. 2). The PV only showed mild increases in serum FM (from 1557 194	
to 1998 µg·L-1) at 24 h and remained high (1928 µg·L-1) 48 h after exercise. In 195	
contrast, the PE presented moderate serum rises of SM until a peak (from 1303 to 196	
1892 µg·L-1) 48 h after exercise (Fig. 3).  197	
 198	
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Discussion and conclusions 213	
This case study presents unique data from a highly trained PV. The results indicate 214	
that selective, mild, fast-fibre damage was induced following LPF.  215	
Pole vault competitors have similar characteristics to sprint athletes, since a high 216	
approach speed is necessary in this track and field event,6 so a high percentage of fast 217	
fibres is expected in these athletes. Unfortunately, there are no histochemical studies 218	
involving trained pole vault athletes, but Korhonen et al.7 stated that young sprint 219	
trained competitors (18-33 years) present a high relative fast-fibre percentage in the 220	
vastus lateralis area (59±6%). 221	
During the first two sets of LPF, the PV developed a high average power and velocity, 222	
which are related to the fast-fibre capacity to generate great power output and contract 223	
with elevated shortening speed.3 LPF required a maximal effort from the PV, as 224	
reflected by a clear decrease in power output, observed from the third set onwards, 225	
which indicates energy failure and selective fatigue of fast fibres.1 Evident reductions 226	
in total work output per set also suggested progressive recruitment of slow (type I) 227	
fibres, with a decrease in mechanical efficiency.1 In contrast, the PE showed a 228	
significantly lower power output, but an extraordinary capacity for maintaining its 229	
average power throughout exercise, which could be related to slow fibres’ 230	
specialization for fatigue-resistant response during continuous activity.2 Although 231	
fatigue was not as evident as in the PV, a marked reduction in mechanical work 232	
probably reflected greater recruitment and progressive decrease in slow fibres’ 233	
efficiency.  234	
Interestingly, the exercise output profile was in accordance with the serum 235	
biochemical response of both participants. In the PV, selective recruitment and fatigue 236	
of fast fibres led to damage of those fibres, which was suggested by FM increases 237	
observed 24 h after LPF. Slight FM increases in serum have been previously related 238	
to mild exercise-induced muscle damage (few myofibrillar disruptions).5 In contrast, 239	
the PE moderate serum SM increases after exercise, which suggested slow-fibre 240	
damage,8 probably related to higher recruitment and fatigue of these types of fibres 241	
during exercise. Both FM and SM serum levels were high 48 h after LPF because of 242	
myosin complex degradation metabolism.9 The PV’s slight FM increases in serum 243	
were accompanied by marginal CK activity rises at 24 h, returning to almost baseline 244	
values at 48 h after LPF, which is indirect evidence of a metabolic recovery status,10 245	
probably related to strength training adaptations. In contrast, the PE showed clinically 246	
relevant increases in CK, CK-MB and AST until 48 h after exercise, which suggests a 247	
greater extent of muscle damage. Moreover, sharp serum increases in CK-MB and 248	
AST activities reinforced the notion that slow fibres were damaged, since these 249	
enzyme activities are higher in slow fibres.11	12       250	
In conclusion, biochemical response seems to be closely related to exercise output. 251	
We can say that the PV’s exercise output revealed an explosive (power-oriented) 252	
profile, leading to selective, mild damage of fast fibres. In contrast, the PE exercise 253	
output showed a fatigue-resistant profile, which induced greater muscle enzyme 254	
activity and SM serum concentration, and suggests a greater extent of slow fibre 255	
damage.  256	
 257	
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Figure captions 351	
 352	
Fig. 1. Leg press leading to failure output variables comparison between a pole 353	
vaulter (PV) and a physical education student (PE) at baseline and 24 and 48 h after 354	
exercise. Total work output (sum per set) and average work ± standard deviation per 355	
set (a), fatigue index per set and average fatigue index ± standard deviation of the 356	
whole exercise (b), average concentric (positive values) and eccentric (negative 357	
values) velocities ± standard deviation per set (c), and average concentric power ± 358	
standard deviation per set (d). #Significant difference between participants at P < 0.01. 359	
*Significantly lower than the first set of values at P < 0.01. 360	
 361	
Fig. 2. Muscle enzyme serum activity comparison between a pole vaulter (PV) and a 362	
physical education student (PE) at baseline and 24 and 48 h after exercise. Creatine 363	
kinase (CK) (a), creatine kinase MB isoform (CK-MB), (b), aspartate 364	
aminotransferase (c), and alanine aminotransferase (d). A dashed line indicates the 365	
upper limit of clinical normality values.  366	
 367	
Fig. 3. Fibre-type-specific sarcomere proteins’ serum concentration comparison 368	
between the pole vaulter (PV) and physical education student (PE) at baseline and 24 369	
and 48 h after exercise. Fast myosin (FM), and slow myosin (SM). Data are 370	
normalized to baseline values. 371	
 372	
 373	
 374	
 375	
 376	
 377	
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Functional assessment of differences between and within 
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ABSTRACT 1 
Purpose: The aims of this study were to investigate the degree of damage inflicted 2 
on the hamstring muscles by intensive voluntary eccentric exercise and to analyse 3 
differences in the extent of between-subject and within-subject damage (limb-to-limb 4 
comparison). 5 
Methods: Thirteen males performed six sets of ten reps of eccentric unilateral leg 6 
curl with each leg. Before and at regular intervals for 7 d after exercise, force-7 
generating capacity (FGC) was measured with maximal isometric voluntary 8 
contraction (MVC). Serum enzyme levels, magnetic resonance imaging (MRI) 9 
transverse relaxation time (T2) and perceived muscle soreness were also assessed 10 
and compared against FGC.  11 
Results: Two groups of subjects were identified according to the extent of exercise-12 
induced muscle damage (EIMD) reflected by sharp, long-lasting FGC declines: high 13 
responders (n = 10) and moderate responders (n = 3). Significant differences were 14 
also found in FGC within-subjects (limb-to-limb comparison) from the high responder 15 
group. Changes in serum enzyme levels after exercise were correlated with MVC 16 
losses. Sarcomeric mitochondrial creatine kinase (sMtCK) increases were only 17 
observed in high responders. The MRI T2 analysis revealed that the semitendinosus 18 
(ST) was the hamstring muscle most damaged by exercise. ST T2 values obtained 7 19 
d after exercise from the leg whose hamstring muscles showed larger FGC decline 20 
were correlated to MVC reductions, but no correlations were found between T2 21 
values and MVC reductions in the leg whose hamstring muscles showed the smaller 22 
FGC decline.  23 
Conclusion: The results challenge the notion that severe EIMD in humans is 24 
restricted to electrical stimulation protocols. Within-subject (limb-to-limb comparison) 25 
 3 
differences reveal that experimental designs using contralateral limbs as a control 1 
should take into account that different degrees of hamstring damage can be induced 2 
in each leg. sMtCK is a promising novel EIMD biomarker that allows identification of 3 
high responders. When muscle function is recovered (i.e., when MVC returns to 4 
baseline values) the long-lasting increases in T2 values suggest an adaptive process 5 
rather than damage.  6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 4 
INTRODUCTION 1 
Repeated eccentric contractions (i.e., lengthening muscle actions) can lead to 2 
muscle damage, and it may take days or weeks for the muscles to recover (8) (13, 3 
29, 48). This type of damage has been named ‘exercise-induced muscle damage’ 4 
(EIMD) (47). Muscle damage induced by extreme regimes of eccentric exercise 5 
present signs such as myofibrillar disruptions (22, 23) and myofiber necrosis (25, 33). 6 
Those signs are commonly assessed by histological examination of muscle tissue via 7 
biopsy; however, this invasive technique is rarely used when hamstring muscles are 8 
involved. In those cases, the combined evaluation of EIMD symptoms such as 9 
prolonged loss of force-generating capacity (FGC) (8, 49), delayed onset muscle 10 
soreness (14, 39), enzyme leakage from damaged fibers (42, 45), and increase in 11 
muscle proton transverse relaxation time (T2) (21, 32) can be a valid alternative. 12 
Specifically, FGC seems to reflect myofibrillar disruptions, inflammation, and necrosis 13 
better than any other markers of muscle damage (47). In this regard, a high 14 
correlation (r = 0.89) was reported between the magnitude of decrease in maximal 15 
isometric voluntary contraction (MVC) and the proportion of muscle fibers with 16 
ultrastructural disruptions (49). Based on the association found in several studies 17 
between loss of FGC and myofibrillar disruptions, Paulsen et al. (47) suggested 18 
using the term ‘severe’ EIMD when a large loss of FGC (≥ 50% reduction) and/or 19 
long-lasting recovery (> 1-week) were found following muscle damaging protocols. 20 
However, although FGC provides reliable and valid information about the extent of 21 
muscle damage, it does not offer any evidence of the location of the damage process, 22 
either in the muscle or in the fiber structure. Therefore, when hamstring muscle 23 
response to intensive eccentric exercise is evaluated, and when ‘severe-EIMD’ is 24 
likely, proxy markers of muscle damage such as magnetic resonance imaging (MRI) 25 
and serum biochemical markers are needed to obtain a more accurate picture of the 26 
phenomenon.  27 
 5 
The hamstring muscles comprise the biceps femoris long head (BFlh), the biceps 1 
femoris short head (BFsh), the semimembranosus (SM), and the semitendinosus 2 
(ST). These muscles present anatomical, architectural, and functional differences 3 
from each other (53). MRI can identify changes in each muscle and, in particular, T2 4 
provides a quantitative index of muscle activation (30) and damage (20, 32). 5 
Because the degree of response to intensive eccentric exercise in different muscles 6 
is likely to vary (35), MRI can be a powerful tool for identifying differences among 7 
hamstring muscle damage. Unilateral intensive eccentric leg curl has been shown to 8 
be effective in isolating the ST muscle (30, 37), and it seems reasonable to assume 9 
that when most of the eccentric work relies on a single isolated muscle, the extent of 10 
muscle damage is exacerbated.  11 
Serum muscle enzyme activities following eccentric exercise have been widely used 12 
as indirect biochemical markers of muscle damage (7). Muscle enzyme leakage to 13 
the bloodstream has been associated with increased membrane permeability (29, 14 
45). The combination of different proxy markers such as serum biomarkers and T2 15 
can be applied to identify muscles from which enzymes are being released into the 16 
circulation (32).  17 
Mitochondria have recently been recognized as key players in cellular regulatory 18 
systems such as Ca2+ management and apoptosis (40), and magnetic resonance 19 
spectroscopy has indicated that impaired mitochondrial function may be a 20 
consequence of EIMD. Because mitochondrial creatine kinase (MtCK) activity is 21 
believed to be active as an energy sensor by coupling cellular energy state to cell 22 
apoptosis (50), we measured serum levels of sarcomeric mitochondrial creatine 23 
kinase (sMtCK) as a potential biomarker of mitochondrial damage from the 24 
sarcomere. 25 
 6 
The present study is part of a multidisciplinary research project dedicated to 1 
analysing hamstring muscle response to eccentric exercise. The purpose of this 2 
study was to investigate the degree of damage inflicted on the hamstring muscles by 3 
an intensive voluntary eccentric exercise and to analyse differences in the extent of 4 
hamstring muscle damage between subjects and within subjects (limb-to-limb 5 
comparison). In this study, analyses of the FGC of the hamstring muscles have been 6 
combined with evaluations of  muscle enzyme leakage and MRI.    7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 7 
MATERIALS AND METHODS 1 
Subjects. Thirteen healthy male students (mean ± SD, age = 22.9 ± 2 yr, height = 2 
1.77 ± 0.6 m, weight = 74 ± 6 kg) with no history of hamstring injuries gave written 3 
informed consent to participate in the study. Subjects’ dominant leg was determined 4 
by asking them their preferred leg when kicking a ball. The fitness level of the 5 
subjects varied according to their daily physical activity; two subjects were sedentary 6 
and the other eleven were “moderately active” to “physically active” (exercising 2 – 5 7 
exercising d·wk-1) (Table 1). Subjects were involved in systematic heavy resistance 8 
strength training for at least six months prior to the experiments. Moreover, they were 9 
asked not to perform any exercise during the week before or at any time during the 10 
experimental period. The study complied with the code of ethics of the World Medical 11 
Association (Declaration of Helsinki) and was approved by the Ethics Committee of 12 
the Catalan Sports Council (Generalitat de Catalunya) (099S/690/2013). 13 
Experimental design. Changes in muscle function were examined for 1 wk following 14 
a bout of unilateral eccentric hamstring curls performed with each leg. The recovery 15 
of the muscle FGC was assessed by repeated tests of isometric MVC during a knee 16 
flexion from a prone position. The first MVC test was performed before the eccentric 17 
exercise to establish the baseline values, and the rest of the tests were repeated 24, 18 
48 and 72 h and 7 d after exercise. 19 
In order to obtain a detailed biochemical monitoring of the muscle enzyme leakage, 20 
blood samples were scheduled immediately before assessment of FGC. To conduct 21 
a non-invasive analysis of the physiological changes that occur in the muscles 22 
recruited during exercise, MRI were also obtained just before assessment of FGC at 23 
baseline and at 24 h and 7 d after exercise. Finally, perceived muscle soreness in 24 
 8 
the hamstring muscles was also assessed by using a visual rating scale (VRS) 1 
before and 24, 48, 72 h and 4, 5, 6 and 7 d after exercise (Fig. 1).  2 
Eccentric exercise. Subjects performed six sets of 10 eccentric unilateral hamstring 3 
leg curls (Prone Leg Curl TechnogymTM, Italy) at 120% of their 1-repetition maximum 4 
(1-RM) with each leg, with a 3-min rest between sets. The 1-RM assessment and the 5 
exercise protocol are described elsewhere (30, 37).  6 
Force-generating capacity. FGC was measured as MVC; i.e., average force in a 1-7 
s window when a force plateau had been established (Tesch, 2004 #165). MVC of 8 
the hamstring muscles were measured for each leg with a force gauge connected to 9 
an A/D converter system, MuscleLab 4020e (Ergotest AS, Langesund, Norway). 10 
Subjects were prone with the hip joint at 40º of flexion and with the knee joint at 30º 11 
of flexion, and were verbally encouraged during the test to ensure maximal effort. 12 
Subjects performed two isometric MVCs of 3 to 5 seconds with a 1-min rest between 13 
contractions, and if any countermovement was evident, an additional MVC was 14 
measured. According to the percentage of reduction of FGC and its time course, the 15 
muscle damage experienced by the subjects was classified into severe EIMD (i.e., 16 
large reduction in MVC of > 50% of baseline values, and/or recovery was not 17 
completed in 1 week) or moderate EIMD (i.e., notable MVC declines of 20-50% of 18 
baseline values, and recovery was completed between 48 h and 7 d) (Paulsen, 2012 19 
#489) during the repeated MVC tests following eccentric exercise. The leg that 20 
showed the larger loss of MVC was considered to have the greater hamstring muscle 21 
damage.  22 
Muscle soreness. A 10-point VRS was used to quantify muscle soreness in the 23 
hamstring muscles. Each number on the scale was accompanied by descriptive 24 
words for soreness, from 0 (none) to 10 (intolerably intense). Subjects stretched and 25 
 9 
contracted (isolated unloaded knee flexion from a stand up position) to assess 1 
general soreness in the whole hamstring muscles. 2 
Blood analysis. An 8-mL blood sample was drawn from an antecubital vein. The 3 
blood was allowed to clot for 30 min at room temperature (21ºC) and was then 4 
centrifuged at 3000g for 10 min at 4ºC. After separation, serum aliquots were stored 5 
at -80ºC until analysis. Measurements of creatine kinase (CK), aspartate 6 
aminotransferase (AST) and alanine aminotransferase (ALT) were performed on an 7 
Advia 2400 automatic device (SiemensTM Medical Solutions Diagnostics, Tarrytown, 8 
NY, USA). Creatine kinase MB isoform (CK-MB) analysis was performed following 9 
the method described by (Vaidya, 1992 #647) using a Dimension Clinical Chemistry 10 
System (SiemensTM Healthcare Diagnostics, Tarrytown, NY, USA) with a sensitivity 11 
limit of 0.5 ng/mL. Serum concentration of sMtCK was measured by using a 12 
commercial ELISA kit SEC386Hu (Cloud Clone Corp., Houston, TX, USA) according 13 
to the manufacturer’s protocol.  14 
Magnetic resonance imaging. MRIs (3 T scanner; Siemens, Erlangen, Germany) 15 
were performed ~30 min prior to exercise and 24 hours and 7 days following exercise. 16 
Subjects were supine on the MR-gurney with the head outside the MR-bore and 17 
thighs covered with one 32- and two flexible 4-channel coils respectively in the 18 
proximal and distal segments. A custom-made foot-restraint device was used to 19 
standardize and fix limb position, and to avoid any compression of thigh muscles. 20 
Twelve cross-sectional images of the thigh of both legs were obtained, starting at the 21 
very distal margin of the ischial tuberosity, and using the following scan sequences: 22 
(a) axial fat-suppressed proton density, TR 3000 ms, TE 30-33, eco train 4, slice 23 
thickness 3.5 mm, gap 28 mm, FOV 400x290 mm, matrix 320x180 and ipat 2; (b) 24 
axial T2 mapping, TR 1000 ms, TE (18, 36, 54, 72, 90, 108), eco train 6, FOV 25 
400x400 mm, matrix 256x256, slice thickness 3.5 mm and gap 28 mm. A parametric 26 
 10 
image was generated from the T2 mapping sequence using the Leonardo 1 
workstation (Siemens, Erlangen, Germany). Scout images and anatomical landmarks 2 
were obtained to ensure identical positioning in baseline and post-scans.  3 
T2 of hamstring muscles (semitendinosus [ST]), and biceps femoris long head 4 
[BFlh]) and short head [BFsh]) from both legs were measured using eFilm Lite v.3.1 5 
software (Merge Healthcare, Chicago, IL). Using the fat-suppressed images to detect 6 
any confounding artefact (i.e., vessels, fat), a circular region of interest (ROI) was 7 
selected for individual hamstring muscles in each of the T2 mapping images where 8 
muscles were visible. Following pre-exercise scan analysis, the same-size circular 9 
ROIs were placed in the T2 images of the post-exercise scan, to ensure the same 10 
positioning as in the pre-exercise analysis. In the evaluations, the images containing 11 
areas at 30% (proximal), 50% (middle) and 70% (distal) of thigh length from upper 12 
border of ischial tuberosity (0%) to the lower border of the tibial plateau (100%) were 13 
used (30). The same researcher performed the MR imaging scan and the T2 14 
calculation. High intertester reliability, with intraclass correlation coefficients ranging 15 
from 0.87 to 0.94, has previously been reported (9). 16 
Statistics. For variables that were normally distributed (Shapiro-Wilk test), a one-17 
way repeated-measures ANOVA followed by a paired t-test with a Bonferroni 18 
correction was performed to identify statistically significant changes from baseline. 19 
The exception was CK-MB, for which Friedman’s test, followed by Wilcoxon signed 20 
rank test with a Bonferroni correction, was used. A two way repeated-measures 21 
ANOVA (leg dominance x time) was performed to identify the main effects of leg 22 
dominance over MVC. A two-way repeated-measures ANOVA (muscle region x time) 23 
followed by a paired t-test with a Bonferroni correction was performed to identify 24 
statistically significant differences between T2 values of hamstring muscles after 25 
exercise. Differences between FGC reductions and T2 values from each leg were 26 
 11 
assessed using the unpaired T-Test. Differences between subgroups of subjects 1 
were assessed using the Mann-Whitney test. Associations between variables of 2 
interest were assessed using Pearson’s correlation coefficient test or Spearman’s 3 
rank order correlation coefficient (the choice depending on the Shapiro-Wilk test for 4 
Gaussian distribution). Data are presented as means ± standard error of the mean 5 
(SEM) unless otherwise stated. The level of significance was set at P < 0.05. The 6 
statistics were performed with SPSS version 20.0 (SPSS Statistics, IBM Corp., 7 
Armonk, NY, USA).  8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 12 
RESULTS 1 
Force-generating capacity. According to the MVC data, the muscle damage 2 
experienced by the subjects was classified into severe or moderate, following the 3 
criteria presented above (see methods). Subjects were then grouped into ‘high’ (n = 4 
10) or ‘moderate’ (n = 3) responders according to the degree of muscle damage 5 
experienced (severe or moderate respectively). With the sole exception of subjects 5, 6 
6 and 8, the leg whose hamstring muscles showed the larger decrease in FGC was 7 
the non-dominant one, but no significant effect of leg dominance (dominant or non-8 
dominant) was found. Time-related changes in MVC from high and moderate 9 
responders are shown in Fig. 2. High responders’ legs whose hamstring muscles 10 
showed the greater FGC reduction suffered significant MVC decreases of 34 ± 7%, 11 
52 ± 7%, 39 ± 8%, and 38 ± 7% at 24, 48, 72 h and 7 d after exercise respectively. 12 
Unexpectedly, in high responders, the leg whose hamstring muscles showed the 13 
smaller reduction in MVC only presented statistically significant decreases of 18 ± 14 
6% and 34 ± 9% at 24 and 48 h respectively, and the percentage of MVC reduction 15 
differed significantly between legs at 48 h and 7 d after exercise (Fig. 2). The three 16 
subjects (subjects 1, 7, and 9) classified as moderate responders showed a 17 
surprisingly low loss of FGC in both legs, and significant differences were found in 18 
MVC declines between groups at 48 h and 7 d after exercise (Fig. 2) (Fig. 6).  19 
Muscle soreness. High responders’ perceived muscle soreness during stretching 20 
and contracting (isolated unloaded knee flexion from a stand up position) was 21 
significantly elevated over baseline values at every time-point analysed. Muscle 22 
soreness increased after exercise and peaked at 72 h, with a value of 7.8 ± 0.3 23 
arbitrary units (a.u.). Significant differences were found between high and moderate 24 
responders and between the  hamstring muscles of the legs that showed the larger 25 
and the smaller loss of FGC at 72, 96 and 120 h after exercise (Fig. 3). Significant 26 
 13 
correlations were found between high responders’ legs whose hamstring muscles 1 
showed the larger FGC reduction, MVC declines, and muscle soreness at 48 h (r = -2 
0.726; P = 0.008) and 72 h (r = -0.637; P = 0.026) after exercise.  3 
Creatine kinase. Serum CK levels of high responders followed a sharp increasing 4 
pattern until 72 h after exercise, when peak activity was observed (45,455 ± 9922 5 
U·L-1 [range: 530 – 95,920 U·L-1]), and then a decreasing trend was shown 7 d after 6 
exercise (13,990 ± 3622 U·L-1 [range: 4198 – 42,972 U·L-1]). Serum CK values of the 7 
moderate responders followed a biphasic pattern, increasing at 24 h after exercise, 8 
declining slightly at 48 h, and then increasing again until its peak at 7 d after exercise 9 
(701 ± 163 U·L-1 [range: 447 – 1005 U·L-1]). Significant differences were seen in 10 
serum CK activity between the two groups at 48, 72 h and 7 d after exercise (Fig. 4) 11 
(Fig. 6). Significant correlations were found between reductions of MVC and CK at 48 12 
h (r = -0.720; P = 0.006) and 7 d (r = -0.566; P = 0.044) after exercise. 13 
Creatine kinase-MB isoenzyme. Serum CK-MB levels of high responders showed 14 
only a significant increase at 72 h after exercise (5.81 ± 3.3 ng·mL-1 [range: 0.6 – 15 
35.1 ng·mL -1]) and no differences were found between groups (Fig. 4).   16 
Sarcomeric mitochondrial creatine kinase. Serum sMtCK concentrations of high 17 
responders increased until a significant peak at 72 h (547 ± 115 ng·mL-1 [range: 0 – 18 
918 ng·mL -1]) and remained significantly elevated 7 d after exercise (237 ± 53 19 
ng·mL-1 [range: 76 – 616 ng·mL -1]). Significant differences were found between 20 
groups at 72 h and 7 d after exercise (Fig. 4). Significant correlations were found 21 
between peak reductions of MVC and sMtCK at 48 h (r = -0.691; P = 0.009) and 7 d 22 
(r = -0.572; P = 0.041) after exercise. 23 
Aspartate aminotransferase. High responders’ AST activity showed a sustained 24 
increase above the clinically normal range (5 – 40 IU·L-1) until a peak at 72 h after 25 
 14 
exercise (691 ± 191 IU·L-1 [range: 21 – 1813 IU·L-1]), and 7 d after the exercise it was 1 
still significantly higher than baseline values (422 ± 96 IU·L-1 [range: 132 – 1097 IU·L-2 
1]). Significant differences were found between groups at 48, 72 h and 7 d after 3 
exercise (Fig. 4). A significant correlation was found between peak reductions of 4 
MVC and AST at 48 h (r = -0.753; P = 0.003). 5 
Alanine aminotransferase. Serum ALT activity in high responders (n=10) showed a 6 
sharp increase above the clinically normal range (5 – 40 IU·L-1) at 72 h, but was only 7 
statistically significantly elevated 7 d after exercise (183 ± 191 IU·L-1 [range: 23 – 365 8 
IU·L-1]). Significant differences were found between groups at 48, 72 h and 7 d after 9 
exercise (Fig. 4). Significant correlations were found between peak reductions of 10 
MVC and ALT at 48 h (r = -0.698; P = 0.008) and 7 d (r = -0.578; P = 0.039) after 11 
exercise. 12 
Magnetic resonance imaging. Significant T2 increases of 146%, 172% and 186% 13 
were found in all sections of ST (proximal [30%], middle [50%], and distal [70%] 14 
respectively) from high responders 7 d after exercise (Fig. 6). Moderate T2 increases 15 
of 67% revealed that BFsh from high responders was also damaged 7 d after 16 
exercise. No T2 differences in BFlh with regard to baseline were found. Significant 17 
differences between groups were found in T2 values hamstring ST from both legs 7 d 18 
after exercise. Surprisingly, no T2 differences were found between the leg’s 19 
hamstring muscles that showed the larger and the lower loss of FGC following 20 
exercise (Table 1). Analyses of variance revealed no T2 differences between ST 21 
muscle regions. Finally, the T2 values obtained 7 d after exercise from all ST 22 
sections (proximal [30%], middle [50%], and distal [70%], respectively) for the leg 23 
whose hamstring muscles showed the greater FGC decline were correlated to MVC 24 
reductions but, in contrast, no correlations were found between T2 values and MVC 25 
 15 
reductions in the leg whose hamstring muscles showed the smaller FGC decrease 1 
(Fig. 5). 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 16 
DISCUSSION 1 
Sharp, long-lasting decreases of FGC (observed until 7 d after exercise) 2 
accompanied by long-lasting severe increases of circulating enzymes (i.e., > 10,000 3 
IU·L-1), T2 values and perceived muscle soreness in ten of the subjects from the 4 
sample (n = 13) were consistent with a severe EIMD process. These results 5 
challenge the notion that severe muscle damage in humans is restricted to electrical 6 
stimulation protocols (15, 21). 7 
Force-generating capacity  8 
Between-subjects. We first classified the 13 subjects into groups on the basis of the 9 
leg that suffered the larger loss in MVC following intensive hamstring eccentric 10 
exercise. This is a reliable measure that is considered the best indirect marker of the 11 
extent of EIMD (28, 47, 55). Two groups of subjects were identified according to the 12 
extent of EIMD reflected by peak FGC declines: high responders (n = 10, average 13 
peak MVC loss = 52%, severe EIMD) and moderate responders (n = 3, average 14 
peak MVC loss = 21%, moderate EIMD), assuming that the number of fibers with 15 
ultrastructural and myofibrillar disruptions is reflected by the reduction in FGC (33, 34, 16 
47, 49).  17 
In a sample of young sedentary subjects, the intensive eccentric leg curl exercise 18 
protocol was shown to induce elevated levels of EIMD (FGC was not fully recovered 19 
1 w after exercise) (30). However, in the present study, in which most of the subjects 20 
were active, the same exercise protocol (plus one more set) did not induce severe 21 
EIMD in all subjects: in three, EIMD was ‘only’ moderate (47). Even when subjects 22 
are exposed to a standardized exercise protocols, a large inter-subject variability 23 
exists in the severity of FGC loss (1, 24, 46). In this study, groups did not differ from 24 
each other according to any demographic or baseline measure, although there 25 
 17 
seemed to be differences in the levels of sport activity and training. Although the 1 
contributing factors to the large between-subject variations in individual responses 2 
remain unclear, one of the most widely supported theories is that low and/or 3 
moderate responders show a smaller decrease of muscle function because they 4 
have executed high-force eccentric work using the same muscle group over a period 5 
of some months (43). This phenomenon is commonly referred to as the ‘repeated-6 
bout effect’ (RBE) (36). In the present study, the RBE was probable since the sport 7 
activities carried out by moderate responders were athletics (participants 1 and 9) 8 
and football (participant 7). Both athletics practitioners were used to performing long-9 
distance sprints, and it is well known that hamstring muscle activity rises with 10 
increasing running speed (2, 31), and that posterior tight muscles act eccentrically 11 
during both the late swing and the terminal stance phases of the running cycle (53, 12 
57). Participant 7 was involved in a regular football-training program in which long-13 
distance sprints also occur and his participation in an on-field hamstring-injury 14 
prevention program cannot be ruled out. Moreover, moderate responders were active 15 
(participant 7) or moderately active (participants 1 and 9), and since activity (training) 16 
status seems to be a contributing factor to variations in individual responses to 17 
eccentric exercise (17, 23, 46), it seems reasonable to assume that their activity 18 
levels have a protective effect against EIMD. Although other contributing factors such 19 
as certain genetic factors (27) cannot be ruled out, the RBE conferred by the type of 20 
sport and the activity level (training status) seem to be the factors that explain the 21 
smaller decline of hamstring muscle function in moderate responders. 22 
Within-subjects (high responders limb-to-limb comparison). Experimental designs 23 
based on a single group observational comparison of response by using contralateral 24 
limbs have been used (11). However, this kind of model is based on the assumption 25 
that changes in markers of muscle damage between limbs are similar, but our study 26 
also found significant differences in muscle function within subjects (limb-to-limb 27 
 18 
comparison). To the best of our knowledge, this is the first study comparing 1 
hamstring muscle damage within subjects (limb-to-limb comparison) after the same 2 
unilateral leg curl exercise performed with each leg. In this regard, high responders 3 
showed significant differences in MVC reductions between legs after exercise. As 4 
found in previous studies, these differences in the magnitude of EIMD were not 5 
influenced by lower limb dominance (26). It might be speculated that hamstring 6 
muscles are not equally resilient to EIMD following eccentric exercise; however 7 
further investigation is needed to confirm or dismiss this suggestion. 8 
Serum enzymes  9 
Between-subjects. Differences between subjects (high and moderate responders) 10 
suggested by FGC losses were confirmed by the differences in the increases in  CK 11 
and other serum enzyme activities or concentrations after exercise. It has been 12 
stated that CK, to some extent, reflects the amount of myofibrillar damage, especially 13 
when damage becomes severe (33). Moreover, large increases in CK activity 14 
observed 4-5 days after exercise may reflect a segmental myofiber  necrosis (33). 15 
The correlation between CK serum levels and MVC (FGC losses) found 7 d after 16 
exercise supports the notion that long-lasting CK increases are related to 17 
fibermyofiber necrosis. Moreover, the large CK activity increases found in high 18 
responders can be explained by certain genetic factors. For example, it has been 19 
stated that the subjects with homozygous myosin light chain kinase (MLCK) 49T and 20 
heterozygotes for the MLCK C37885A rare allele had large amounts of CK after 21 
eccentric exercise (12). Hubal et al. (27) reported that variations in single nucleotide 22 
polymorphisms in chemokine ligand 2 (CCL2) and its chemokine receptor 2 (CCR2) 23 
were related to large CK increases.  24 
 19 
Of particular interest were the serum increases in sMtCK, because, in contrast to the 1 
other biochemical markers, the increases were only significant in high responders. 2 
The mitochondria have recently been recognized as key players in cellular regulatory 3 
systems like Ca2+ management and apoptosis (40). Specifically, MtCK have been 4 
reported to play the role of an energy sensor, coupling cellular energy state to cell 5 
apoptosis (50). The significant serum increases in sMtCK found in high responders 6 
are likely to be indicative of mitochondrial swelling and of disruption and decline in 7 
muscle respiratory capacity (10) and, given the correlations observed between 8 
sMtCK and MVC (FGC reductions) at 48 h and especially 7 d after exercise, it seems 9 
reasonable to assume that FGC reductions reflect a number of myofibrils that have 10 
died due to an apoptotic process triggered by large sMtCK increases. Moreover, it 11 
has been demonstrated in rats that prolonged exercise induces mitochondrial 12 
damage but that training status has a protective effect on the mitochondria against 13 
exercise (10) via a specific reduction of the mitochondrial Ca2+ uptake (5) and an 14 
increase in antioxidant capacity (54). Although it has only been proved in animal 15 
models (Sprague-Dawley rats) (10), it seems reasonable to assume that moderate 16 
responders’ training status might confer a protective effect on the mitochondria 17 
against eccentric EIMD. Consequently sMtCK could be adopted as a novel and 18 
promising EIMD biomarker, sensitive to training status and suitable for the 19 
recognition of high responders. 20 
Long-lasting increases in AST and ALT were only found in high responders. Although 21 
AST and (especially) ALT are often considered specific markers of liver injury, they 22 
are ubiquitously present in most tissues, including skeletal muscle (6, 16). Moreover, 23 
hypertransaminasemia is commonly present in patients with high CK levels resulting 24 
from extreme exercise (38). However, hepatic damage cannot be ruled out because 25 
more specific hepatic injury markers such as alkaline phosphatase (ALP) and 26 
gamma glutamyltransferase (γGT) (3) have not been measured. 27 
 20 
Magnetic resonance imaging 1 
Within-hamstring (muscle comparison). Muscle damage was localized in three 2 
hamstring muscles (BFlh, BFsh, and ST) by using MRI T2 relaxation time. In both 3 
groups of subjects (high and moderate responders), and in accordance with Kubota 4 
et al. (30) and Mendiguchia et al. (37), the T2 results suggested that the individual 5 
responses of the hamstring muscles following the eccentric leg curl exercise differed 6 
between hamstring muscles; the ST was the most damaged, probably because of its 7 
architectural characteristics. Specifically, ST is a fusiform muscle with long fascicle 8 
lengths and a small physiological cross-sectional area (56), which explains its major 9 
contribution to eccentric knee-flexion exercise (37) and its higher sensitiveness to 10 
eccentric exercise (30).  11 
Within-Semitendinosus (muscle region comparison). Uniform changes were found 12 
across all the ST regions measured (proximal [30%], middle [50%], and distal [70%]). 13 
Although Kubota et al. (30) found non-uniform changes among ST regions following 14 
intensive eccentric exercise, these differences were only found at 48 and 72 h 15 
following exercise. As in our study, those authors found uniform changes across the 16 
measured ST regions at 24 h and 7 d after eccentric leg curl exercise.  17 
Between-subjects. In contrast to moderate responders, ST and to a lesser extent 18 
BFs in high responders showed long-lasting T2 increases 7 d after exercise in the leg 19 
whose hamstring muscles showed the greater FGC decline. T2 increases have been 20 
correlated to ultrastructural abnormalities observed by histology in humans after 21 
downhill running (44) and illustrate an oedematous process (13, 18, 35, 52) which is 22 
consistent with the higher extent of muscle damage reflected by persistent FGC 23 
reductions 7 d after exercise.  24 
 21 
Within-subjects (high responders limb-to-limb comparison). Interestingly, all the ST 1 
regions measured from the leg whose hamstring muscles showed the greater FGC 2 
decline were correlated with MVC reductions but, in icontrast, no correlations were 3 
found between T2 values and MVC reductions in the leg whose hamstring muscles 4 
showed the smaller FGC decline. It has been shown that following eccentric exercise 5 
T2 values remain elevated, even when other markers of muscle damage have 6 
returned to baseline values (13). Specifically, elevated T2 values have been found as 7 
long as 75 days (51) and 31 days (41) following (in both cases) eccentric exercise of 8 
the elbow flexor muscles. Foley et al. (19) suggested that long-lasting T2 increases 9 
after other markers of EIMD have returned to baseline values might reflect an 10 
adaptive process rather than damage. Accordingly, since the muscle function in the 11 
leg whose hamstring muscles showed the smaller FGC decline was recovered 7 d 12 
after exercise (i.e., MVC returned to baseline values), it seems reasonable to relate 13 
its long-lasting increases in T2 values to an adaptive process. Although T2 has been 14 
identified as a relevant biomarker of muscle damage (4, 20, 32), the results of the 15 
present study reinforce the notion that MRI must be accompanied by muscle function 16 
assessments when muscle damage is analysed.       17 
In summary, the results of indirect markers of EIMD obtained in ten of the subjects 18 
from the sample (n = 13) challenge the notion that severe muscle damage in humans 19 
is restricted to electrical stimulation protocols (15, 21). However, the results showed 20 
a wide range of FGC loss (from 7% to 84%), reflecting a different degree of EIMD 21 
between subjects (high and moderate responders) which may be related to the 22 
subjects’ level of sport activity and training status. The results also challenge the 23 
assumption that changes in markers of muscle damage are similar between limbs, 24 
since within-subject (limb-to-limb comparison) differences were also found in the high 25 
responder group. Experimental designs using contralateral limbs as a control should 26 
take into account that different degree of hamstring damage can be induced between 27 
 22 
legs, at least in high responders. Changes in the serum enzyme activities or 1 
concentrations after exercise were in accordance with the between-subject 2 
differences (high and moderate responders) in the extent of EIMD reflected by FGC 3 
reductions. Furthermore, and although further investigation is needed, it seems that 4 
sMtCK is a promising novel EIMD biomarker that allows identification of high 5 
responders. The MRI analysis revealed that ST was the hamstring muscle most 6 
damaged by the eccentric leg curl exercise, and uniform T2 changes were observed 7 
across sections of this muscle. Finally, since the muscle function in the leg whose 8 
hamstring muscles showed the smaller FGC decline was recovered 7 d after 9 
exercise (i.e., the MVC returned to baseline values), it seems reasonable to relate its 10 
long-lasting increases in T2 values to an adaptive/remodeling process rather than to 11 
damage.  12 
 13 
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FIGURE CAPTIONS 1 
Figure 1. Schematic overview of experimental design.  2 
Figure 2. Mean (± SEM) values of percentage of maximal voluntary contraction 3 
(MVC) from the hamstring muscles of the leg that showed the larger (a) and the 4 
smaller (b) loss of force-generating capacity following exercise. *, ** and *** : 5 
significantly different from baseline value at P < 0.05, P < 0.01 and P < 0.001, 6 
respectively. # Significant difference between groups at P < 0.05. ϕ and ϕϕϕ.  7 
Significant difference between high responders’ legs at P < 0.05 and P < 0.001 8 
respectively.   9 
Figure 3. Mean (± SEM) values (a.u., arbitrary units) of perceived muscle soreness 10 
from the hamstring muscles of the leg that showed the larger (a) and the smaller (b) 11 
loss of force-generating capacity following exercise. * Significantly different from 12 
baseline value at P < 0.05. # Significant difference between groups at P < 0.05. ϕ 13 
Significant difference between high responders’ leg at P < 0.05.  14 
Figure 4. Mean (± SEM) values of (a) CK, creatine kinase (note the logarithmic scale 15 
on the y-axis); (b) CK-MB, creatine kinase MBmass isoenzyme; (c) AST, aspartate 16 
aminotransferase; (d) ALT, alanine aminotransferase; (e) sMtCK, sarcomeric 17 
mitochondrial creatine kinase; (f) CRP, C-Reactive protein. *, ** and ***: Significantly 18 
different from baseline value at P < 0.05, P < 0.01 and P < 0.001 respectively. #, ## 19 
Significant difference between groups at P < 0.05 and P < 0.01 respectively.  20 
 21 
 22 
 24 
Figure 5. Correlation between percentage of change of maximal voluntary 1 
contraction (MVC) and semitendinosus (ST) T2 muscle section (30%, proximal; 50%, 2 
middle; 70%, distal) values from the hamstring muscles of the leg that showed the 3 
larger (a) and the smaller (b) loss of force-generating capacity 7 days after exercise 4 
(n = 13). rs  : Spearman correlation coefficient.  5 
Figure 6. Representative T2-weighted magnetic resonance images of the middle 6 
section (50% of thigh length) from a moderate responder (subject 7) (left) and a high 7 
responder (subject 3) (right) before and 24 h and 7 d after eccentric exercise (Biceps 8 
femoris long head, BFlh, Biceps femoris short head, BFsh, and Semitendinosus, ST). 9 
Values of percentage of maximal voluntary contraction (MVC) from the hamstring 10 
muscles of the leg that showed the larger and the smaller loss of force-generating 11 
capacity (LL FGC and SL FGC, respectively) and values of CK (creatine kinase) at 12 
baseline and at regular intervals for 7 d after exercise. Note that both subjects play 13 
the same sport (football) but present different activity levels (high versus medium) 14 
(Table 1). 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 25 
TABLES 1 
Table 1. Characteristics of the subjects’ physical activity levels. 2 
Subject Activity level Sport activity 
1 Medium Athletics, recreational 
2 Low Indoor football, recreational 
3 Medium Football, recreational 
4 Medium Indoor football, recreational 
5 Low No exercise 
6 Low Basketball, recreational 
7 High Football, active 
8 Low No exercise 
9 Medium Cycling and athletics, recreational 
10 Medium Water polo, active 
11 Medium Running, recreational 
12 High Roller hockey, active 
13 Medium Football, recreational 
 3 
Activity levels: low, two exercise bouts per week; medium, two to four exercise bouts 4 
per week, high, more than four exercise bouts per week. 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 26 
Table 2. Mean values (± SEM) of T2 (ms) from hamstring muscles before and after 1 
unilateral eccentric curls.  2 
   T2 (ms) 
   
Leg 
Muscle (Section) Time  Group LL FGC SL FGC 
BFsh  Baseline High responders (n=10) 43.4 ± 2.2 45.7 ± 1.5  
(70%, distal) 24 h  49.8 ± 2.6 60.2 ± 4.2*** 
 7 d  72.6 ± 9.6* 73.7 ± 11.6* 
 Baseline Moderate responders (n=3) 47.2 ± 9.3 47.9 ± 7.7 
 24 h  50.8 ± 9.7 49.9 ± 8.1 
 7 d  48.0 ± 8.5 46.7 ± 7.4 
ST  Baseline High responders (n=10) 48.0 ± 1.7 51.8 ± 1.9 
(30%, proximal) 24 h  110.7 ± 42.3 117.3 ± 25.6 
 7 d  117.9 ± 14.6*** 154.0 ± 19.8*** 
 Baseline Moderate responders (n=3) 44.8 ± 9.1 52.6 ± 8.1 
 24 h  54.8 ± 12.8 68.4 ± 10.6 
 7 d  49.6 ± 18.9# 59.7 ± 9.1# 
ST  Baseline High responders (n=10) 44.4 ± 1.9 43.2 ± 2.3 
(50%, middle) 24 h  113.4 ± 48.3 89.4 ± 17.9 
 7 d  119.8 ± 20.0*** 122.9 ± 15.0*** 
 Baseline Moderate responders (n=3) 43.2 ± 8.2 46.9 ± 7.5 
 24 h  49.5 ± 9.3 53.5 ± 8.5 
 7 d  43.7 ± 14.9## 45.3 ± 6.8# 
ST  Baseline High responders (n=10) 43.5 ± 0.8  46.3 ± 1.9 
(70%, distal) 24 h  62.4 ± 8.7 72.8 ± 8.7 
 7 d  124.6 ± 21.2*** 143.2 ± 17.7*** 
 Baseline Moderate responders (n=3) 43.7 ± 8.6 48.2 ± 7.5 
 24 h  47.1 ± 9.1 49.1 ± 7.5 
 7 d  44.0 ± 17.9## 45.3 ± 6.0# 
 3 
Only T2 (ms) values from hamstring muscle sections that showed significant time-4 
related changes from baseline are shown (Biceps femoris short head, BFsh, and 5 
Semitendinosus, ST). T2 values from the hamstring muscles of the leg that showed 6 
the larger and the smaller loss of force-generating capacity following exercise, LL 7 
FGC and SL FGC respectively. *, ** and *** Significantly different from baseline value 8 
at P < 0.05, P < 0.01 and P < 0.001 respectively. #, ## Significant difference between 9 
groups at P < 0.05 and P < 0.01. Note that no differences between legs were found. 10 
 11 
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Objective: To investigate changes after a mountain ultramarathon (MUM) in the serum concentration of fast (FM) and slow (SM) 
myosin isoforms, which are fiber-type-specific sarcomere proteins. The changes were compared against creatine kinase (CK), 
a widely used fiber-sarcolemma-damage biomarker, and cardiac troponin I (cTnI), a widely used cardiac biomarker. Methods: 
Observational comparison of response in a single group of 8 endurance-trained amateur athletes. Time-related changes in serum 
levels of CK, cTnI, SM, and FM from competitors were analyzed before, 1 h after the MUM, and 24 and 48 h after the start 
of the MUM by 1-way ANOVA for repeated measures or Friedman and Wilcoxon tests. Pearson correlation coefficient was 
employed to examine associations between variables. Results: While SM was significantly (P = .009) increased in serum 24 h 
after the beginning of the MUM, FM and cTnI did not change significantly. Serum CK activity peak was observed 1 h after the 
MUM (P = .002). Moreover, serum peaks of CK and SM were highly correlated (r = .884, P = .004). Conclusions: Since there 
is evidence of muscle damage after prolonged mountain running, the increase in SM serum concentration after a MUM could 
be indirect evidence of slow- (type I) fiber-specific sarcomere disruptions.
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Mountain ultramarathons (MUM) are competitive events 
consisting of walking and running on mountain trails over a great 
cumulative elevation gain and over a longer distance than the ath-
letic marathon (>42.195 km). Distance and cumulative elevation 
gain are the main determinants of MUM difficulty. Long-distance 
trail competitions have risen in popularity over the last few years.1 
However, the acute physiological responses to extreme endurance 
events still remain unclear. It is known that MUM competitions are 
strenuous and generally include negative slopes, so long distances 
are run downhill. It has been stated that strenuous exercise can result 
in muscle damage,2 which is particularly exacerbated if eccentric 
contractions are performed (for a review see Proske and Allen3). 
Downhill running increases the eccentric component because the 
peak flexion angles are significantly greater, and it is a much stron-
ger stimulus for damage than level or uphill running.4 Therefore, 
it seems reasonable to relate most of the muscle damage to the 
negative-slope phases of the trail. MUM is a great opportunity for 
field-specific assessments of a physiologically stressful competitive 
event that induces muscle damage.5,6
Direct evaluation of muscle damage involves histological 
examination of muscle tissue by biopsy. However, in a sports con-
text, the analysis of exercise-induced muscle damage is essentially 
based on proxy markers such as measurements of enzyme activity 
in blood, especially the activity of creatine kinase (CK). Previous 
studies evaluated the muscle damage induced by MUMs5,6 and 
revealed large increases in total CK concentrations. However, CK 
is not a specific biomarker of skeletal muscle.7 Koller et al8 used 
slow (type I) myosin heavy-chain (MHC) fragments, and Melin 
et al9 used beta MHC as muscle-fiber-specific damage biomark-
ers. Those groups found increases in this protein in plasma after 
mountain-running events. Although slow (type I) MHC fragments 
and beta MHC are common to skeletal and cardiac muscle, the 
damage was mainly related to slow (type I) fibers of skeletal muscle. 
However, the results found by Koller et al8 and Melin et al9 were 
highly unspecific, since plasma levels of MHC fragments were not 
compared with any cardiac-specific biomarker. Since it has been 
stated that strenuous exercise could induce a significant release of 
cardiac proteins such as troponin into the bloodstream,10 it seems 
reasonable to assume that proteins found in cardiac and skeletal 
muscle, such as MHC fragments and beta MHC, could also be 
released from myocardium to blood.
Recently, myosin isoforms have been proposed as fiber-type-
specific biomarkers of muscle damage that would represent indi-
rect evidence of sarcomere disruptions.11 However, Carmona et 
al11 observed selective release of fast myosin isoforms (FM) after 
high-intensity knee-extensor exercise, but no changes in slow-
myosin-isoform (SM) serum concentration were reported. SM is 
found in both cardiac and skeletal muscle, and FM is characteristic 
of fast skeletal muscle. Limb skeletal muscles are composed of 
slow (type I) and fast (type II) fibers,12 but adult skeletal muscles 
shows plasticity and can undergo conversion between different fiber 
types in response to exercise.13 Endurance athletes tend to have a 
predominance of slow (type I) fibers.14,15 For these reasons, we 
hypothesized that serum increases in myosin isoforms, especially in 
SM, in endurance-trained participants after a MUM could indicate 
not only the extent but also the type of fiber affected. Furthermore, 
in the current study, the lack of specificity of SM was minimized by 
analyzing the changes in serum concentration of cardiac troponin 
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I (cTnI), a widely used myocardial-specific biomarker. It has been 
shown that cTnI is released after prolonged exercise. However, in 
contrast to myocardial infarction, in which cTnI is usually over 
0.6 ng/mL and remains stable in blood for at least 5 days, cTnI 
release after prolonged exercise does not achieve such high serum 
levels and returns to baseline within 24 to 48 hours.16 To the best of 
our knowledge, this is the first field study to use a combination of 
myosin isoforms and cTnI to assess indirectly the muscle damage 
induced by a MUM.
The aim of this study was to investigate changes in serum 
concentration of myosin isoforms after a MUM. SM and FM were 
compared with CK, a widely used biomarker of exercise-induced 
muscle damage. The lack of specificity of SM was countered with 
the measurement of serum cTnI concentration. Since there is evi-
dence of muscle damage after prolonged mountain running,5,6 we 
hypothesized that a specific increase in SM serum concentration 
after a MUM would be indirect evidence of slow (type I) -fiber 
sarcomere damage in endurance-trained mountain runners.
Methods
Participants
We initially recruited 17 endurance runners, 14 men and 3 women. 
However, due to bad weather conditions during the competition, 
only 8 subjects decided to complete the study: 7 men and 1 woman 
(mean ± SD; men, n = 7, 39.8 ± 3.3 y, 178.7 ± 5.2 cm, 76.9 ± 7.9 
kg; women, n = 1, 39.1 y, 173.0 cm, 67.0 kg). All of the participants 
were experienced white nonprofessional athletes (mean training 
regimen, 450.0 ± 210.31 min/wk of endurance training) who were 
specifically trained for MUM. All were healthy and had incurred 
no muscle injuries in the 6 months before the study. To avoid bias, 
no instructions were given about the type of training performed the 
week before the competition, but athletes were asked about it to 
better interpret the baseline serum levels of enzymes and contractile 
proteins. Physical activity after the race was limited and massages 
were prohibited. The study conformed to the Declaration of Hel-
sinki for medical research, participants provided written informed 
consent, and the research was approved by the ethics committee of 
the Catalan Sports Council (Government of Catalonia).
Design
The study design used observational comparison of response in a 
single group of endurance-trained amateur athletes.
Methodology
The participants ran in the “Cavalls del Vent” MUM in 2012, an 
official competition organized by Salomon Nature Trails. It was a 
circular route with an official length of 84.84 km (~85 km) and a 
total cumulative elevation gain of 12,180 m. The start of the race 
was at 755 m above sea level and the maximum summit achieved 
during the trail was 2520 m (Figure 1). Each runner’s average speed 
was calculated according to the total distance run divided by his 
or her official time.
Four blood samples were obtained: 1 day before the competition 
(pre), less than 1 hour after finishing the competition (post), and, 
because a significant degree of damage can occur during the race, 
24 and 48 hours after the beginning of the MUM. A 5-mL blood 
sample was drawn from an antecubital vein. Blood was allowed to 
clot for 30 minutes in a tube (SST II Advance, Becton Dickinson 
Vacutainer Systems, UK) before being centrifuged at 3000 g for 
10 minutes at 4°C. Three 200-μL aliquots of serum were stored at 
–80°C until analysis.
CK determinations were performed in an Advia 2400 auto-
matic device (Siemens Medical Solutions Diagnostics, Tarrytown, 
NY, USA), and cTnI determinations were made in a Dimension 
Clinical Chemistry System automatic device (Siemens Healthcare 
Diagnostics, Tarrytown, NY, USA) with an analytical measurement 
range of 0.017 to 40 ng/mL. To obtain muscle myosin-isoform 
concentrations in serum, we developed an enzyme-linked immuno-
sorbent assay (ELISA-sandwich), which is described elsewhere.11 
Briefly, a calibration curve was obtained by a serial dilution from 
0 to 250 ng of pure myosin from porcine muscle M0273, and the 
ELISA was completed by using monoclonal antimyosin (skeletal, 
fast) clone My-32, monoclonal antimyosin (skeletal, slow) clone 
NOQ7.5.4D, antimyosin polyclonal antibody M7523, and mouse 
anti-IGG linked to peroxidase A6154 (all Sigma Aldrich, Poole, 
UK). Intra-assay coefficients of variation were below 8% for FM 
and below 7.5% for SM. The linearity of the FM assay results was 
80%, and it was 90% for the SM assay.
Statistical Analyses
The normality of each variable was tested using the Shapiro-Wilk 
test. As SM and CK were asymmetrically distributed, these variables 
were log-transformed before analysis. One-way repeated-measures 
ANOVA was used to identify the effect of time on CK activity and 
SM and FM serum levels. When any significant main effects were 
found, pairwise t-test comparisons with a Bonferroni correction 
Figure 1 — Altitude profile of the entire mountain ultramarathon and the distance scale.
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were used. The time course of changes in cTnI serum concentration 
was evaluated with the use of Friedman and Wilcoxon nonparamet-
ric tests. Effect sizes (ES) (Cohen d) were calculated to determine 
the practical difference between baseline values and serum peaks 
of enzymes and proteins. ES values of above 0.8, 0.8 to 0.5, 0.5 to 
0.2, and lower than 0.2 were considered large, moderate, small, and 
trivial, respectively. Pearson correlation coefficient was employed 
to evaluate the association between the variables of interest. Data 
are presented as mean ± standard error of the mean unless otherwise 
stated. The level of significance was set at P < .01. All statistical 
analyses were conducted using SPSS version 20.0 statistical-anal-
ysis software (SPSS Statistics, IBM Corp, Armonk, NY).
Results
The week before the competition, participants reported the use of 
similar training strategies, based on a decrease in training volume 
(km/wk) and an increase in intensity (running average velocity). At 
the competition, only 1 participant finished the MUM (~85 km). 
The rest of the participants left the competition at different points 
along the trail due to bad weather conditions: temperature, range 
0.9°C to 13.1°C; rain, range 0 to 6.1 mm/h; humidity, range 90% to 
97%; and wind speed (east-southeast), range 1.1 to 5 m/s. The total 
distance (km) covered and official time (h:min:s) of each participant 
who decided to carry on with the study protocol were determined by 
the last official control point passed just before leaving the MUM. 
Individual average speed (km/h) was calculated according to these 
results (Table 1). With respect to biochemical markers, the average 
serum CK activity at baseline was in the clinically normal range 
(35–175 U/L) and rose significantly from 132 ± 22 U/L (pre) to a 
peak of 2052 ± 860 U/L (ES = 3.02) less than 1 hour after finish-
ing the MUM. Average CK serum activity remained significantly 
elevated 24 hours (1345 ± 651 U/L) (ES = 2.59) after the begin-
ning of the competition, but a clear decreasing trend was observed 
(Figure 2). The only woman who participated in the study until the 
end and also completed the whole long-distance trail (participant 
number 7) had the highest values of CK in serum in all samples 
(Table 1). Almost all participants were in the clinically normal range 
of cTnI (<0.017–0.050 ng/mL), or slightly above, in all analyzed 
samples (Table 1). No significant increase was seen in average cTnI 
serum concentrations 1 hour after the MUM (from 0.018 ± 0.001 
ng/mL to 0.067 ± 0.028 ng/mL), and values returned to baseline 
1 day after the trail (Figure 2). However, the average values of 
cTnI were highly biased, because participant number 7 showed an 
almost 10-fold increase in cTnI serum concentration 1 hour after 
the competition, which remained around 4-fold elevated 24 and 48 
hours after the start of the MUM (Table 1). A nonsignificant slight 
increase in average FM serum concentration was observed 1 hour 
after the competition (from 1508 ± 222 μg/L to 1731 ± 204 μg/L), 
which remained stable until 24 hours after the beginning of the 
competition (1744 ± 250 μg/L) and returned to baseline values at 
48 hours (1520 ± 318 μg/L) (Figure 1). Average FM serum values 
of all time points analyzed were in the previously established normal 
range (> 1000 μg/L).11 Finally, no changes in SM were found until 
24 hours after the start of the MUM, when SM serum concentra-
tion rose significantly from 1443 ± 390 μg/L to 3743 ± 1110 μg/L 
(ES = 1.34). SM serum activity remained nonsignificantly elevated 
48 hours after the initiation of the competition (2828 ± 762 μg/L). 
Average baseline SM serum levels were in the normal range (> 2000 
μg/L).11 (Figure 2). The SM serum peak at 24 hours after the start 
of the MUM was also highly correlated with the CK serum peak 
found 1 hour after the competition (r = .884; P = .004) (Figure 3). 
Finally, SM was not correlated with cTnI.
Discussion
To our knowledge, this is the first study to assess the utility of the 
myosin isoforms SM and FM as serum biochemical markers of 
fiber-specific muscle damage induced by a MUM in experienced 
endurance runners. SM and FM were compared against CK, a 
widely used biomarker of exercise-induced muscle damage, and 
cTnI, a specific biomarker of cardiac damage. The novel finding of 
the current study was that only SM serum levels were significantly 
raised, while FM serum levels remained almost unaltered after the 
MUM competition. Another remarkable finding was that CK and 
SM serum peaks were highly correlated.
In the absence of myocardial infarction, muscle injury, or 
disease, large and time-sustained increases in blood CK activity 
have been widely accepted as a biomarker of muscle damage.17 As 
expected, the MUM induced large increases in CK serum levels, up 
to an almost 16-fold rise 1 hour after the competition. Significant CK 
serum increases in healthy and well-trained participants have been 
previously documented after MUM competitions.5 Large variability 
in serum CK concentrations among participants is common and has 
been previously described in experienced ultramarathoners after 24 
hours of treadmill running18 and after a 166-km MUM.6 The reason 
for this variability still remains unclear, but it has been suggested 
that susceptibility is mainly related to genotype characteristics.19 
The CK serum peak 1 hour after the MUM and its recovery over 
the following 48 hours were also consistent with previous studies.6 
However, CK levels provide a gross indication of muscle-fiber 
damage, because they cannot identify the magnitude of damage20 
or the type of fibers affected.7
Although direct evidence of muscle damage is histological, 
force-generating capacity is considered a reliable and valid marker of 
muscle damage.21 It has moreover been demonstrated that running a 
MUM induces large decreases in the knee-extensor force-generating 
capacity (a 35% decrease after a 166-km MUM), which are related 
to fatigue and muscle damage.6 Furthermore, different studies have 
recently proposed sarcomere proteins such as troponin as proxy 
fiber-type-specific biomarkers of muscle damage.7,22 According to 
the observed time course, molecular mass, and fiber compartment in 
which these proteins are located, their elevation in serum suggests 
more severe damage, signifying sarcomere damage.22 As fiber-type-
specific sarcomere proteins, SM and FM could allow for indirect 
diagnosis of sarcomere damage and the type of fiber affected.11 
Because MUM running has been demonstrated to induce muscle 
damage,6 the significant increases in SM serum concentration seen 
24 hours after the start of the MUM suggested selective slow (type 
I) fiber damage, and due to its elevated molecular weight (493 kDa) 
and its fiber intrasarcomeric compartmentalization, increased serum 
SM could indicate sarcomere disruptions of those fibers. Moreover, 
since cTnI showed a nonsignificant serum increase 1 hour after the 
competition and returned to almost baseline values 24 hours after the 
beginning of the MUM, SM serum increases in healthy individuals 
can be mainly related to skeletal-muscle slow-fiber damage, rather 
than myocardial damage. Furthermore, there was no statistical 
relationship between SM and cTnI. However, further research is 
needed on cTnI and the distance of ultraendurance events, because 
the only participant who completed the whole MUM (participant 
number 7) showed the highest increases in cTnI in every sample 
analyzed after the competition.
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Due to its mainly sarcoplasmic location, CK is thought to 
indicate increased membrane permeability after membrane disrup-
tions at early time points24 and the peroxidation of membrane lipids 
caused by an increase in reactive oxygen species and the activation 
of ion (Na+ and Ca2+) channels for several days after exercise.25 The 
peak value for CK serum was found 1 hour after the MUM. This 
could be explained by the long duration of the competition, causing a 
significant degree of membrane damage during the run.26 It has been 
demonstrated that the resealing of artificially produced membrane 
disruptions occurs in less than a minute,27 but CK efflux may occur 
during the run due to a continuous process of membrane disruption 
followed by rapid resealing. The CK serum peak post-MUM and 
its recovery kinetics over the following 2 days were consistent with 
previous studies.6 Nevertheless, the average 1-hour post-MUM CK 
serum peak was lower than that found after longer distance races.28 
In this respect, and according to Waskiewicz et al,28 since the volume 
of exercise increases the metabolic demands for intracellular Ca2+,26 
and it is associated with muscle-damage indices, it seems reason-
able to assume that augmented membrane permeability is related to 
the distance covered, as can be seen in Table 1. While participants 
2 and 3, who completed 26 km, showed mild increases in serum 
CK activity post-MUM, participant 7, the only one who completed 
the whole MUM (~85 km), presented the greatest increases in CK 
serum activity after the competition. In contrast, exercise intensity, 
expressed as average speed (km/h) at which the participants ran 
the MUM, showed no trend, since participants left the competition 
at different points along the route (see Table 1). Further research 
with a larger sample is therefore needed in this area to clarify the 
relationship between biochemical markers of muscle damage and 
both distance (km) and average speed (km/h).
Myosin isoforms have a different serum time course than 
CK.11 Sarcomere-protein turnover is longer than that of sarcoplasm 
proteins,29 so the SM serum peak 1 day after the MUM can be 
explained by the increased activity of calpain 2 days after exercise.30 
Calpain is a Ca+2-dependent protease. The long duration of the 
Figure 3 — Association between serum creatine kinase (CK) (natural 
log) peak activity 1 hour after finishing the long-distance trail competition 
(post) and slow myosin (SM) (natural log) peak concentration 24 hours 
after the start of the mountain ultramarathon (n = 8). r, Pearson correla-
tion coefficient.
Figure 2 — Changes in (a) serum concentration of creatine kinase 
(CK) (n = 8), (b) slow myosin (SM) (n = 8), and (c) skeletal-muscle fast 
myosin (FM) (n = 7) 1 day before the competition (pre), less than 1 hour 
after finishing the competition (post), and 1 and 2 days after the mountain 
ultramarathon. Data are normalized (mean ± standard error of the mean) 
to pre-mountain-ultramarathon values (100%). **Significantly different 
from preexercise value at P < .01.
No changes in FM serum concentration were seen after the 
MUM, which indicates that the fast fibers suffered no damage or, at 
least, less damage than the slow fibers. Certainly, it has been proved 
by histology that fast fibers are most susceptible to eccentric contrac-
tions,23 and downhill running, which is a mainly eccentric activity, 
induces muscle damage.4 However, since endurance runners have 
greater levels of slow (type I) fibers,14,15 it is reasonable to assume 
that slow (type I) fibers are predominantly recruited and damaged 
during a MUM. However, the hypothesis that a MUM also induces 
fast (type II) -fiber damage cannot be completely ruled out because 
CK is non–fiber-type-specific. Moreover, baseline FM serum levels 
were over the previously described normal range,11 a phenomenon 
that can be attributed to the type of training (higher intensity and 
less volume) performed by the runners the week before the race, but 
this is only speculation. Future studies in this area should carefully 
analyze the training strategies used the week before the competition.
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MUM may have led to large increases in intracellular Ca+2 during 
the run, which would accelerate calpain degradation and lead to the 
significant increases in SM serum 1 day after the MUM. Calpain 
removes myosin from the filamentous structure of the sarcomere.31 
At this time, increased membrane permeability due to the activa-
tion of stretch-activated ion channels25 could lead to a release of 
large proteins into the interstitium. Once in the interstitial space, 
proteins are mainly transported via the lymphatic system into the 
bloodstream, because the capillary membranes in skeletal muscle 
are almost impermeable to proteins.7,32 The muscle-fiber compart-
ment in which SM is located and its complex degradation process 
could explain the delayed increases in serum of SM.
Finally, CK and SM serum peaks occurred with 1-day dif-
ference but were strongly correlated. Membrane damage could 
accompany sarcomere disruptions, due to the tight connection 
between myofibrils, cytoskeleton, and membranes.33 Therefore, it 
seems that membrane damage could be related to subsequent fiber 
sarcomere disruption of slow fibers.
Practical Implications
The current study shows that SM could provide indirect information 
about fiber-type-specific sarcomere damage 1 day after a MUM, 
and since the serum peak of myosin isoforms is not reached until 
1 day after a MUM, they could be used in diagnoses that are not 
made immediately after the competition. Although fiber specific-
ity cannot be determined by CK, its serum activity 1 hour after a 
MUM seems to be related to the subsequent SM serum response. 
MUM trainers and runners should be aware that the total distance 
covered could be related to muscle damage, and sharp SM serum 
increases suggest that a longer recovery may be needed. Further 
research regarding MUM distance covered, training and perfor-
mance variables, and damage degree inflicted to skeletal-muscle 
slow (type I) fibers is needed.
Conclusions
In summary, since there is evidence of muscle damage after pro-
longed mountain running, an increase in SM serum concentration 
after a MUM could be indirect evidence of selective slow (type I) 
-fiber-specific sarcomere disruptions.
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Abstract 1	
The aim of this study was to compare changes after a 35-km mountain trail 2	
race (MTR) and a 55-km mountain ultra-marathon (MUM) in serum activity or 3	
concentration of muscle damage biomarkers including creatine kinase (CK), 4	
creatine kinase MB isoform (CK-MB), aspartate aminotransferase (AST), 5	
alanine aminotransferase (ALT), cardiac troponin I (cTnI) and fast and slow 6	
myosin isoforms (SM and FM respectively).  7	
One group (n=10) of amateur trained men who ran a 35-km MTR and another 8	
group (n=6) of highly trained men who ran a 55-km MUM volunteered for the 9	
study. Changes in the serum levels of muscle damage biomarkers were 10	
assessed before, 1 hour after competitions, and 24 and 48 hours after the 11	
beginning of the races by repeated measures analysis of covariance 12	
(ANCOVA), including training hours per week as a covariate. 13	
The results showed that distance determines SM release, which signifies 14	
sarcomere damage of slow fibres following a 55-km MUM, even when the 15	
race was undertaken by highly trained athletes. The first changes in SM 16	
serum obtained at 24 hours were correlated with CK, CK-MB and AST 17	
activities or concentrations registered 1 hour after the competitions. These 18	
results indicate that mountain running distance is related to deeper slow (type 19	
I) muscle fibre damage, even in highly trained individuals.    20	
 21	
 22	
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Introduction 1	
Although physiological responses to mountain trail running competitions has 2	
become an important topic in sports science research in recent years, very 3	
little is known about the structural damage to the muscle fibres of athletes 4	
who participate in these strenuous events. While there is no consensus about 5	
the definition of these competitions (Millet, 2011), the term ‘mountain trail race’ 6	
(MTR) has been generically used to refer to competitive long-distance runs 7	
from 15 to > 90 km, which are performed in a mountain context and involve a 8	
great cumulative elevation gain (uphill and downhill) (Easthope et al., 2010), 9	
and the term ‘mountain ultra-marathon’ (MUM) has been specifically 10	
associated with MTR over a longer distance than the standard marathon (> 11	
42.195 km) (Carmona et al., 2015; Saugy et al., 2013).  12	
There is general agreement that mountain trail running leads to muscle 13	
damage because of strenuous competitive conditions, which cause fatigue, 14	
and the numerous eccentric contractions completed during the downhill 15	
phases (Millet et al., 2011). However, concerning muscle damage, an 16	
important question remains unanswered: is there a muscle damage threshold 17	
related to distance? During flat running, it has been well-established that the 18	
total running distance covered or the time spent running is related to the 19	
extent of muscle damage (Overgaard et al., 2004; Waskiewicz et al., 2012). 20	
Specifically, during ultra-endurance running, it has been stated that increased 21	
serum levels of muscle enzymes indicate that active muscle suffers a 22	
significant degree of sarcolemmal damage with increased running distance 23	
(Overgaard, Lindstrom, Ingemann-Hansen, & Clausen, 2002).  24	
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Biochemical assessment of muscle damage has also been used in mountain 1	
trail competitions, but the relationship between distance and muscle enzyme 2	
efflux is less clear (Saugy et al., 2013). This could be because of the high 3	
complexity of mountain trail competition characteristics (total elevation gain), 4	
environmental factors (weather and surface conditions), and the pacing 5	
strategy used by runners, especially during downhill running when the 6	
eccentric component is exacerbated (Eston, Mickleborough, & Baltzopoulos, 7	
1995). Besides, muscle enzymes are not fibre-type-specific (Friden & Lieber, 8	
2001) and, due to their mainly sarcoplasmic location, their appearance in 9	
blood can only suggest a loss of sarcolemma integrity (Noakes, 1987). To 10	
overcome these limitations, the use of serum levels of fast and slow (FM and 11	
SM respectively) myosin isoforms as indirect biomarkers of fibre-type-specific 12	
sarcomere damage, have been used previously (Guerrero et al., 2008; 13	
Carmona et al., 2014). Concretely, significant increases in SM, suggesting 14	
sarcomere disruptions of slow (type I) fibres, were found in MUM participants 15	
who completed different total distances of the whole trail (Carmona et al., 16	
2015).          17	
The aim of the present study was to investigate the influence of mountain 18	
running distance on structural muscle damage by comparing the time course 19	
response of muscle enzymes and sarcomere fibre-type-specific proteins in 20	
two groups of mountain runners performing a 35-km MTR or a 55-km MUM.  21	
 22	
 23	
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Methods 1	
Participants 2	
Ten men who ran a 35-km MTR [mean ± standard deviation] (age 37.7 ± 7.4 3	
years, weight 73.9 ± 9.4 kg, height 177.6 ± 3.4 cm), and six men who ran a 4	
55-km MUM (age 34.0 ± 5.2 years, weight 71.3 ± 8.8 kg, height 176.2 ± 7.3 5	
cm) volunteered for the study. The group that ran the 35-km MTR was 6	
composed of amateur, trained runners (7.0 ± 1.1 hours per week) with at least 7	
3 years of mountain training experience. The other group, which ran the 55-8	
km MUM, was composed of amateur and/or sponsored highly trained runners 9	
(12.6 ± 3.0 hours per week), with at least 5 years of mountain training 10	
experience. All participants were healthy and had not suffered any muscle 11	
and/or tendon injury 6 months before the study. Physical activity after the 12	
competitions was limited, and massages were prohibited. All participants were 13	
asked about the type of training performed the week before the race to better 14	
understand the baseline values of serum enzymes and fibre-type-specific 15	
proteins. The study conformed to the Declaration of Helsinki for medical 16	
research and participants provided written informed consent. The study was 17	
previously approved by the Ethics Committee of the Catalan Sports Council 18	
(0099S/690/2013).  19	
Mountain trail race and mountain ultra-marathon 20	
Both competitions, 35-km MTR and 55-km MUM, were included in the Volta a 21	
la Cerdanya Ultrafons® mountain endurance competitions in 2013, and had 22	
similar total elevation gains of 2089 and 2259 m respectively. Average 23	
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negative slopes were 8.9% for the 35-km MTR and 8.0% for the 55-km MUM 1	
(see the mountain trail profiles in Figure 1). Environmental conditions for the 2	
35-km MTR were 8.9ºC and 92% relative humidity (RH) at the start (9:00) of 3	
the race and 13.9ºC and 59% RH at the end of the race (between 13:00 and 4	
15:00). Environmental conditions for the 55-km MUM were 10.4ºC and 79% 5	
RH at the start of the race, and 10.8ºC and 83% RH at the end of the race 6	
(between 15:00 and 17:00). 7	
****Figure 1 near here**** 8	
Blood sampling 9	
Blood samples of 5 mL were drawn from an antecubital vein by standard 10	
venipuncture before the competition (pre), 1 hour after (post), and 24 and 48 11	
hours after the beginning of the race(s). Samples were allowed to clot for 30 12	
min and then centrifuged at 3000 x g for 10 min. Three aliquots of serum were 13	
obtained and stored at -80ºC until they were analysed for enzymatic activity or 14	
concentration, cardiac troponin I concentration, and myosin isoform 15	
concentration.  16	
Biochemical assays 17	
Automatized analyses of creatine kinase (CK), aspartate aminotransferase 18	
(AST) and alanine aminotransferase (ALT) were performed in an Advia 2400 19	
(Siemens Medical Solutions Diagnostics, Tarrytown, NY, USA). Creatine 20	
kinase MB isoform (CK-MB) and cardiac troponin I (cTnI) analyses were 21	
performed using a Dimension Clinical Chemistry System (Siemens Healthcare 22	
Diagnostics, Tarrytown, NY, USA), with an analytical measurement range of 23	
Mountain trail distance and sarcomere damage 
	
	 8	
0.5–300 ng·mL-1, and 0.017–40 ng·mL-1, respectively. The concentration of 1	
myosin isoforms, FM and SM, was measured using the enzyme-linked 2	
immunosorbent assay (ELISA sandwich). Briefly, two plates (Corning 96-well 3	
EIA/RIA, Sigma Aldrich, Poole, UK) were coated overnight at 4ºC with capture 4	
monoclonal antibodies (all Sigma Aldrich, Poole, UK), anti-myosin (skeletal, 5	
fast) clone My-32 and anti-myosin (skeletal, slow) clone NOQ7.5.4D, for FM 6	
and SM assessment respectively. The plates were then washed 3 times 7	
(phosphate buffered saline, pH 7.4, 10 mM) and blocked with block buffer 8	
(Super Blocking Buffer, Thermo Fisher Scientific Inc., Rockford, Illinois, USA) 9	
before being incubated (60 min at 37ºC). After a wash step, samples (10 µL) 10	
were added by triplicate, and a calibration curve of 6-point serial dilution, from 11	
0 to 250 ng, of commercial pure myosin of porcine muscle M0273 was 12	
obtained. To complete the ELISA, anti-myosin polyclonal antibody M7523 was 13	
used as the primary antibody, and mouse ant-IGG linked to peroxidase A6154 14	
as the secondary antibody. Finally, myosin concentrations (µg·L-1) were 15	
obtained by the interpolation of the calibration curve (r2 > 0.95). Intra-assay 16	
coefficients of variation were 10.0% and 5.5% for FM and SM respectively. 17	
The linearity of the FM assay was 80% and 90% for SM.  18	
Statistical analysis 19	
Data were tested for approximation to a normal distribution using the Shapiro-20	
Wilk test. Not normally distributed data, such as CK, CK-MB, AST and cTnI, 21	
were log- or sqrt-transformed before analysis. Repeated measures analysis of 22	
covariance (ANCOVA), with distance groups (35-km MTR and 55-km MUM) 23	
as an independent variable, was used to identify the effect of time (pre, post, 24	
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24 and 48 hours following the competition) on serum biomarkers of muscle 1	
damage (CK, CK-MB, AST, ALT, cTnI, FM and SM). Training hours per week 2	
was included as a covariate, because the training status of the runners could 3	
have a pronounced effect on time-related serum changes of muscle 4	
biochemical markers. When significant effects were found, a post-hoc test 5	
was performed by applying a paired t test with a Bonferroni correction for the 6	
time per distance effect. Spearman’s rank order correlation analysis was used 7	
to assess relationships between variables of interest. The differences 8	
between groups were analysed by using the unpaired t test or Mann-Whitney 9	
test (depending on the variable distribution). Data are presented as mean ± 10	
standard error of the mean (SEM), unless otherwise stated. The level of 11	
significance was set at P < 0.05. The statistical analysis was conducted using 12	
SPSS version 20.0 (SPSS Statistics, IBM corp., Armonk, NY, USA) statistical 13	
analysis software. 14	
 15	
 16	
 17	
 18	
 19	
 20	
 21	
 22	
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Results 1	
Training and performance 2	
The training status (training hours per week) of the 55-km MUM group was 3	
significantly 80% (P = 0.04) higher than in the 35-km MTR group. No 4	
differences were seen in the years of mountain running training experience. 5	
As expected, the official running time was significantly (P = 0.04) higher for 6	
the group who ran the 55-km MUM, but no differences were found in the 7	
average running velocity (km·h-1) (Table 1).  8	
****Table 1 near here**** 9	
Serum muscle enzymes activity 10	
Serum CK activity of the 35-km MTR group showed significant increases at 11	
every time point analysed after the trail, until a peak of 832 ± 267 U·L-1 (P = 12	
0.003) 48 hours after the beginning of the MTR. However, although eight of 13	
the 35-km MTR participants’ peak CK activity was obtained at 24 hours, 14	
participants 1 and 6 showed high peak values at 48 hours (Table 2). Serum 15	
CK activity of the 55-km MUM group increased significantly and peaked (1238 16	
± 201 U·L-1; P < 0.001) at 24 hours, returning to non-significantly different 17	
values from the baseline 48 hours after the beginning of the MUM. The 18	
comparison between groups showed that CK activity was significantly 164% 19	
(P < 0.001) higher 1 hour after finishing the competition for the group who ran 20	
55-km MUM. No other differences were found between the groups (Figure 2). 21	
There were no differences between groups in pooled CK peak activity, 22	
independently of the time to peak (Table 2). 23	
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Serum concentration of CK-MB was significantly elevated in both groups 1	
following the race until its peak at 24 hours (6.15 ± 1.2 ng·mL-1; P < 0.001, 2	
and 15.2 ± 2.1 ng·mL-1; P < 0.001, for the 35-km MTR and 55-km MUM 3	
groups respectively) and returning to non-significantly different values from 4	
the baseline 48 hours after the beginning of the competitions. The comparison 5	
between groups showed that CK-MB concentration was significantly 251% (P 6	
< 0.001) and 147% (P = 0.003) higher 1 hour after and 24 hours after the 7	
beginning of the competition for the group who ran 55-km (P = 0.003) (Figure 8	
2). Moreover, the magnitude of the CK-MB peak concentration, independently 9	
of its time course, was significantly different between groups (P < 0.001) 10	
(Table 2).   11	
Serum AST levels were significantly increased in both groups at every time 12	
point analysed following the competition. Serum peaks were at 24 hours (49 ± 13	
4 U·L-1, P < 0.001 and 63 ± 7 U·L-1, P < 0.001 for the 35-km MTR and 55-km 14	
MUM groups respectively) and no differences between groups were detected. 15	
No significant time-related changes and no differences between groups were 16	
seen in ALT serum activity (Figure 2; Table 2). 17	
****Figure 2 near here**** 18	
Serum muscle myosin isoforms concentration 19	
While the serum SM concentration of the 35-km MTR group showed no 20	
changes from baseline values, the SM serum concentration of the 55-km 21	
MUM group was significantly increased at every time point analysed following 22	
the competition, peaking at 48 hours (4766 ± 916 µg·L-1; P < 0.001). 23	
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Accordingly, the comparison between groups showed significant higher time-1	
related and time-independent peak values of serum SM for the group that ran 2	
the 55-km MUM (Figure 3; Table 2). Furthermore, in both groups, the first 3	
significant increases in enzyme activity (CK and AST), registered 1 hour after 4	
the competition, were significantly correlated with the first SM serum 5	
significant increase obtained at 24 hours after the beginning of the trail (Figure 6	
5). Time-independent serum peaks of SM and CK-MB were also correlated (r 7	
= 0.76; P < 0.001). No significant changes from baseline values were seen in 8	
average FM serum concentration over time in any of the groups. However, 9	
participants 2 and 3 from the 35-km MTR, and 14 and 16 from the 55-km 10	
MUM, showed high relative serum peaks at different time points (Table 2). 11	
Finally, the 55-km MUM group had significantly higher FM serum 12	
concentrations throughout the experimental period, even at the baseline 13	
(Figure 3).  14	
****Figure 3 near here**** 15	
Serum cardiac troponin I 16	
While no significant changes were seen in the cTnI serum concentration for 17	
the 35-km MTR group at any time point analysed, individual peak values of 18	
cTnI showed increases over the clinical normality range (0.050 ng·mL-1) for 19	
seven of the 35-km MTR group (Table 2). A significant cTnI peak of 0.143 ± 20	
0.07 ng·mL-1 (P = 0.03) was found in the group that ran the 55-km MUM 1 21	
hour after finishing the race, returning to baseline values at 24 hours after the 22	
beginning of the MUM. A comparison between the groups showed no 23	
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significant time-related or time-independent peak differences between the 1	
cTnI serum concentrations (Figure 4; Table 2).  2	
****Figure 4 near here**** 3	
****Figure 5 near here**** 4	
****Table 2 near here**** 5	
 6	
 7	
 8	
 9	
 10	
 11	
 12	
 13	
 14	
 15	
 16	
 17	
 18	
 19	
Mountain trail distance and sarcomere damage 
	
	 14	
Discussion 1	
To the best of our knowledge, this is the first study that analyses the effect of 2	
mountain running distance on structural muscle damage by comparing the 3	
muscle biochemical response to two mountain running events of different 4	
lengths (35-km MTR versus 55-km MUM). Furthermore, because different 5	
training levels were found between the groups of competitors, the influence of 6	
training status on biochemical indices of muscle damage was also analysed. 7	
The main finding of the present study was that (I) distance was the main 8	
determiner of SM release, signifying sarcomere damage of slow fibres 9	
following a MUM, even when the race was undertaken by highly trained 10	
athletes. Other relevant findings were that (II) excepting CK-MB, only minor 11	
differences in enzymatic activities after the competitions were found between 12	
groups, (III) the first changes in SM serum obtained at 24 hours were 13	
correlated with CK, CK-MB and AST activities or concentrations registered 1 14	
hour after the competitions, and (IV) cTnI was only significantly elevated in 15	
serum following the 55-km MUM. 16	
The release of sarcomere proteins, such as myosin, from muscle fibre to the 17	
bloodstream has been reported previously as indirect evidence of sarcomere 18	
damage (Guerrero et al., 2008; Carmona et al., 2014). In the present study, 19	
the 55-km MUM induced elevations of SM in serum that suggest the presence 20	
of slow (type I) fibre sarcomere damage. In contrast, the fibre damage inflicted 21	
by the 35-km MTR was mainly located at membrane level, because only 22	
muscle enzyme efflux to the bloodstream was observed, which indicates 23	
increased sarcolemmal permeability (for a review see (Hyldahl & Hubal, 2013). 24	
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No significant increases in sarcomere fibre-type-specific proteins were found 1	
in the 35-km MTR group. Notably, although significant differences were found 2	
in the training status between groups (significantly, training was 80% higher in 3	
the group that ran the 55-km MTR), in this case, no muscle fibre sarcomere 4	
protective effect seems to be provided by training status. It has been proved 5	
in humans during flat running that endurance training status only has a minor 6	
influence on muscle damage indices and, especially, on Ca2+ accumulation in 7	
the human vastus lateralis after running 20 km (Overgaard et al., 2004). 8	
Progressive intercellular Ca2+ accumulation is important in mediating two 9	
forms of muscle damage: increased sarcolemmal permeability (Mikkelsen, 10	
Fredsted, Gissel, & Clausen, 2004), and degradation of sarcomere proteins 11	
due to the activation of calcium-dependent proteases (Goll, Thompson, Li, 12	
Wei, & Cong, 2003). Therefore, as accumulation of Ca2+ is dependent on the 13	
time of exposure to exercise (Overgaard et al., 2004; Overgaard et al., 2002), 14	
it seems reasonable to assume that the greater the distance, and 15	
consequently duration, of a mountain trail competition, the greater the muscle 16	
damage. Moreover, both competitions, 35-km MTR and 55-km MUM, had 17	
similar average negative slopes and no significant differences were seen 18	
between the years of training experience, and, especially, between the 19	
average velocities in which both groups ran the mountain races. Therefore, it 20	
can be concluded that although other factors that were not measured during 21	
the races, such as pacing strategy, may substantially influence the degree of 22	
muscle damage, in the present study the distance, and consequently the 23	
duration of the exercise (86% higher for the 55-km MUM group) were the 24	
main factors inducing slow (type I) fibre sarcomere damage.  25	
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Regarding enzymatic serum activities obtained after the competitions, 1	
significant increases were found and similar time courses were observed in 2	
both groups. With the exception of CK-MB, which will be discussed later, only 3	
minor significant time-related differences in CK and AST serum activities were 4	
found between groups 1 hour after finishing the races. Moreover, no 5	
differences between groups were found in serum CK and AST activities 6	
obtained from 24 to 48 hours after the beginning of the races, because the 7	
activities of enzymes from the 55-km MUM group tended to stabilize in blood 8	
at 48 hours. It has been stated that enzyme clearance time depends, among 9	
other factors, on athlete’s training status (Brancaccio, Lippi, & Maffulli, 2010) 10	
and since the 55-km MUM participants were highly trained, it cannot be ruled 11	
out that they presented enhanced clearance rates.  12	
Another remarkable finding is that CK, CK-MB and AST serum activities from 13	
all participants 1 hour after both the 35-km MTR and the 55-km MUM were 14	
correlated to the serum concentration of SM registered 24 hours after the 15	
beginning of the competitions. Although fast (type II) and slow (type I) fibres 16	
present similar CK activity (Apple & Tesch, 1989), competitive distance 17	
runners tend to have greater levels of slow fibres (Harber & Trappe, 2008; 18	
Secher, Mizuno, & Saltin, 1984), and it is reasonable to assume that slow 19	
fibres are predominantly recruited and damaged during a mountain race. 20	
Therefore, CK serum activity could be related to slow fibres contractile activity. 21	
The correlation between SM and both CK-MB and AST could be explained by 22	
the fact that slow (type I) fibres have higher activity of those enzymes 23	
(Schantz & Henriksson, 1987; Yamashita & Yoshioka, 1991). Time-24	
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independent serum peaks of CK-MB and SM were also correlated, which 1	
indicates a close relationship between the magnitudes of appearance of these 2	
biochemical markers. This could be related to the fact that muscle-type 3	
creatine kinase subunit (M-CK) interacts with sarcomere structure 4	
(Hornemann et al., 2003). Moreover, CK-MB was the only enzyme whose 5	
concentration was significantly higher for the group that ran the 55-km MUM 6	
until 24 hours after the beginning of the race. When it is not possible to 7	
analyse the presence of fibre-type-specific sarcomere proteins in serum, and 8	
myocardial damage is ruled out, sharp increases in CK-MB serum 9	
concentration could be more precisely related to slow-fibre damage.  10	
Prolonged endurance exercise has been related to cTnI release in healthy 11	
individuals (Mingels et al., 2009). In the present study, only the group that ran 12	
the 55-km MUM showed significant increases in cTnI, which suggests that run 13	
length, and consequently exercise duration, could be closely related to cTnI 14	
release. However, average values of the 55-km MUM group are largely 15	
biased, since participant 14 presented 0.505 ng·mL-1 following the race (see 16	
Table 2) and there were no differences in cTnI peaks between groups. The 17	
mechanisms of prolonged exercise-induced cardiac troponin release are not 18	
yet fully understood, but some hypotheses have been developed (Clarke, 19	
Caldwell, Chiao, Miyake, & McNeil, 1995; Koller & Schobersberger, 2009). 20	
However, it seems likely that prolonged exercise-induced cardiac troponin 21	
release is a benign process (Shave et al., 2010), especially when its serum 22	
levels return to baseline within 24–48 h	 (Mehta et al., 2012), as in the case of 23	
the present study.  24	
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Finally, although fast (type II) fibre damage cannot be ruled out, especially 1	
because some individuals (participants 2 and 3 from the 35-km MTR, and 14 2	
and 16 from the 55-km MUM) showed large FM increases following the 3	
competitions, no significant time-related changes were seen in average serum 4	
FM concentration. It is also remarkable that the group that ran the 55-km 5	
MUM showed higher FM values than the 35-km MTR group at every time-6	
point analysed, even at baseline. The training strategies used several days 7	
before the competition by the 55-km MUM participants, based on a drastic 8	
reduction of running km per week and allowing for an increase in running 9	
intensity (i.e. fast running series), could induce damage to fast fibres. As 10	
previously found, when muscle force-generating capacity is fully recovered, 11	
persistent high serum levels of FM could indicate sarcomere remodelling 12	
rather than damage (Carmona et al., 2014). This is in accordance with 13	
previous findings indicating that myofibrillar disruptions that appear shortly 14	
after exercise signify damage, and the changes in myofibrillar structures 15	
observed some days into recovery may represent remodelling (Yu, Carlsson, 16	
& Thornell, 2004). Therefore, the high FM baseline values of the 55-km 17	
participants may represent a remodelling process induced by a previous 18	
increase in training intensity several days before the competition.  19	
Conclusions 20	
In summary, although the reproducibility of this kind of field studies is low 21	
because of the complex characteristics of mountain trail competitions (i.e. 22	
total elevation gain), and important performance variables (e.g. pacing 23	
strategy) were not analysed, to the best of our knowledge, this is the first 24	
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study to indicate that mountain running distance is related to biochemical 1	
indices of muscle damage. Physicians, trainers and runners should be 2	
conscious that competing in mountain running events longer than the 3	
standard marathon distance (> 42.195 km) is related to deeper slow (type I) 4	
muscle fibre damage, even in highly trained individuals.    5	
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TABLES 1	
Table 1 2	
 Distance group 
Variables 35-km MTR 55-km MUM 
Training   
   Years of mountain running training 6.1 ± 1.3  8.1 ± 1.2 
   Training hours (h·wk-1) 7.0 ± 1.1 12.6 ± 3.0* 
Performance   
   Official running time (h:min:sec) 3:50:50 ± 0:08:38 6:52:38 ± 0:34:22* 
   Average running velocity (km·h-1) 9.22 ± 0.33 8.29 ± 0.69 
 3	
Training and performance characteristics of participants by distance group. 4	
Values are means ± SEM. * Significantly different from the 35-km MTR group 5	
value at P < 0.05. 6	
	7	
	8	
	9	
	10	
	11	
	12	
	13	
	14	
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Table 2 1	
 Participant 
Peak CK 
Activity 
(IU·L-1) 
[time of 
peak]a 
Peak  
CK-MB 
Concentration  
(ng·mL-1) 
[time of peak]a 
Peak AST 
Activity 
(IU·L-1) 
[time of 
peak]a 
 
Peak cTnI 
Concentration 
(ng·mL-1) [time of 
peak]b 
Peak SM 
Concentration (% 
Change from 
Baseline) 
[time of peak]c 
Peak FM 
Concentration (% 
Change from 
Baseline) 
[time of peak]c 
35-km  
MTR 1 2755[48 h] 5.3[24 h] 90[48 h] 0.037[Post] 0 7[Post] 
 2 411[24 h] 3.9[Post] 35[24 h] 0.192[Post] 15[Post] 47[24 h] 
 3 588[24 h] 2.8[24 h] 40[24 h] 0.070[Post] 17[Post] 73[Post] 
 4 588[24 h] 6.4[24 h] 48[24 h] 0.067[Post] 6[48 h] 16[24 h] 
 5 900[24 h] 11.4[24 h] 66[24 h] 0.107[Post] 4[48 h] 19[Post] 
 6 1855[48 h] 9.1[24 h] 64[48 h] 0.096[Post] 20[24 h] 0 
 7 702[24 h] 9.3[24 h] 50[24 h] 0.089[Post] 30[48 h] 9[24 h] 
 8 1599[24 h] 5.9[24 h] 64[24 h] 0.028[Post] 31[48 h] 0 
 9 322[24 h] 5.3[24 h] 43[Post] 0.037[Post] 1[48 h] 11[Post] 
 10 388[24 h] 3.3[Post] 40[Post] 0.117[Post] 0 0 
55-km  
MUM 11 1425[24 h] 13.2[24 h] 86[24 h] 0.113[Post] 28[24 h] 36[48 h] 
 12 687[24 h] 21.3[24 h] 54[24 h] 0.038[Post] 80[48 h] 8[Post] 
 13 1612[24 h] 17.2[24 h] 83[24 h] 0.098[Post] 109[24 h] 36[Post] 
 14 1119[24 h] 18.9[24 h] 51[24 h] 0.505[Post] 156[24 h] 69[48 h] 
 15 1889[24 h] 19.4[Post] 62[24 h] 0.089[Post] 130[48 h] 34[Post] 
 16 940[48 h] 10.9[Post] 41[Post] 0.017 75[24 h] 100[48 h] 
 
35-km   
MTR  
(mean 
value)  1011 6.3 54 0.084 12 18 
 
55-km  
MUM  
(mean 
value)  1279 16.8* 63 0.143 96* 47 
 2	
Individual peak values [time of peak] for main variables. Time-independent 3	
mean values of each group are shown. Creatine kinase (CK), creatine kinase-4	
myocardial band (CK-MB), aspartate aminotransferase (AST), cardiac 5	
troponin I (cTnI), slow myosin (SM), fast myosin (FM).   6	
a See Figure 2 7	
b See Figure 4 8	
c See Figure 3 9	
*, Significant difference between groups at P < 0.001 10	
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Figure captions 1	
Figure 1. Altitude profile and the distance scale in km of the 35-km mountain 2	
trail race (35-km MTR) (a) and the 55-km mountain ultra-marathon (55-km 3	
MUM) (b). 4	
 5	
Figure 2. Changes in enzyme activities of creatine kinase (CK) (a), creatine 6	
kinase MB isoform (CK-MB) (b), aspartate aminotransferase (AST) (c), and 7	
alanine aminotransferase (ALT) (d). Values are means ± SEM. ** and *** 8	
Significantly different from baseline at P < 0.01, and P < 0.001, respectively. #, 9	
## and ###, Significant differences between groups at P < 0.05, P < 0.01, and P 10	
< 0.001, respectively. 11	
 12	
Figure 3. Changes in serum concentration of slow myosin (SM) (a) and fast 13	
myosin (FM) (b). Values are means ± SEM. *** Significantly different from 14	
baseline at P < 0.001. #, ## and ###, Significant differences between groups at 15	
P < 0.05, P < 0.01, and P < 0.001, respectively. 16	
 17	
Figure 4. Changes in serum cardiac troponin I (cTnI) concentration. Clinical 18	
normality range (< 0.050 ng·mL-1). Values are means ± SEM. *, Significantly 19	
different from baseline at P < 0.05.  20	
 21	
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Figure 5. Spearman rank correlation coefficients (rs) between serum mean 1	
values of SM, slow myosin; CK, creatine kinase (a); CK-MB, creatine kinase 2	
MB isoform (b); and AST, aspartate aminotransferase (c). Note that serum 3	
values of CK, CK-MB and AST are from 1 hour after the trail and SM serum 4	
values are from 24 hours after the beginning of the competitions.  5	
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5. RESULTATS i DISCUSSIÓ  
5.1 Cap a un model molecular indirecte de dany 
muscular induït per l’exercici (EIMD) 
A partir dels resultats obtinguts als diversos estudis exposats en aquesta tesi (I, II, III, 
IV i V), es proposa establir un model molecular indirecte d‘EIMD. El perfil temporal i 
la magnitud d’aparició en sèrum dels diversos enzims i proteïnes del múscul 
esquelètic després de l’execució d’un exercici que indueixi dany muscular sembla 
dependre no només de la tipologia (volum i intensitat) de l’exercici, sinó també del 
seu pes molecular i de la seva compartimentació estructural a la fibra muscular. A 
més, l’ús de les isoformes de la miosina permet no només ubicar el dany estructural 
(afectació del sarcòmer), sinó també discernir quina tipologia de fibra (ràpida [tipus 
II] o lenta [tipus I]) muscular s’ha vist afectada principalment per l’exercici (Figura 
14).  
5.1.1 Enzims 
Tal com s’ha indicat al llarg d’aquesta tesi, està àmpliament acceptat per la 
comunitat científica que l’augment de l’activitat o de la concentració enzimàtica en 
sèrum després de l’exercici excèntric és un indicador de l’increment de la 
permeabilitat de la membrana de la fibra muscular (106, 160), ja sigui per disrupció 
(134) o per l’activació dels canals iònics (Ca2+) amb increment dels nivells de les 
espècies reactives de l’oxigen (ROS) i el desencadenament consegüent dels 
processos de peroxidació lipídica del sarcolemma (4). No obstant això, fenòmens 
com ara grans pics d’activitat sèrica de creatina quinasa (CK) (> 10.000 IU·L-1) més 
enllà de les 48 hores posteriors a l’exercici (estudi III), increments per damunt del 
llindar de la normalitat clínica de la concentració en sèrum de l’isoenzim MB de la CK 
(CK-MB) (estudis IV i V) o augments significatius de la CK mitocondrial sarcomèrica 
(sMtCK) (estudis III, IV i V) mereixen una atenció especial, ja que són fets que poden 
ser indicatius d’un procés de dany muscular que vagi més enllà de l’increment de la 
permeabilitat de la membrana. Per tant, el perfil temporal i la magnitud d’aparició en 
sèrum dels diversos enzims analitzats permeten determinar el grau d’afectació 
muscular del tren inferior en funció de la tipologia d’exercici realitzat.   
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Creatina quinasa: de l’increment de la permeabilitat de la 
membrana a la necrosi de la fibra muscular 
En dos dels estudis de laboratori basats en protocols d’HIE (estudis I i II), es van 
trobar increments —significatius en el cas de l’estudi I— de l’activitat sèrica de la CK 
al cap de 24 hores, la qual va tornar a valors de normalitat 48 hores després de 
l’exercici. L'única excepció va ser el subjecte control de l’estudi II, en el qual es va 
registrar el pic sèric d’activitat de la CK 48 hores després de l’exercici (Figura 4). 
D’altra banda, en els estudis de camp basats en protocols d’LDE (estudis IV i V), es 
van descriure increments significatius a partir d’una hora després de la finalització de 
l’exercici, els quals es van mantenir al cap de 24 hores. 48 hores després de l’inici 
de l’exercici, es va observar una clara tendència a la baixa en l’activitat en sèrum de 
la CK, amb l’excepció del grup de corredors moderadament entrenats que va córrer 
l’MTR de 35 km (estudi V) (Figura 4).  
 
Figura 4. Mitjana ± error estàndard de la mitjana (SEM) de l’activitat de la creatina quinasa 
(CK) obtinguda en dos dels estudis de laboratori basats en protocols d’exercici d’alta 
intensitat (HIE) (estudis I i II) i dels estudis de camp basats en exercicis de llarga durada 
(LDE) (estudis III i IV). *, ** Significativament diferent respecte als valors basals a escala P < 
0,01, i P < 0,001, respectivament.  
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Contràriament al que s’ha exposat fins ara, —increments moderats de l’activitat 
sèrica de la CK amb una marcada tendència a la baixa a partir de les 48 hores 
posteriors a l’exercici—, en l’estudi III, els subjectes classificats com a high 
responders van mostrar pics d’increment de l’activitat sèrica de la CK molt superiors 
als que es poden observar a la Figura 4, tant pel que fa a la seva magnitud (45.455 
± 11.721 IU·L-1) com al curs temporal fins al pic (72 hores després de l’exercici) 
(Figura 5). 
 
Figura 5. Mitjana ± error estàndard de la mitjana (SEM) de l’activitat de la creatina quinasa 
(CK) obtinguda en dos grups de subjectes (high and moderate responders) (estudi III). L’eix y 
es mostra en escala logarítmica. La línia discontínua marca la frontera entre la resposta 
fisiològica i el dany muscular lleu (mild muscle damage). *, ** Significativament diferent 
respecte als valors basals a escala P < 0,05, P < 0,01, i P < 0,001, respectivament. #, ## 
Diferències significatives entre grups a escala P < 0,05 i P < 0,01, respectivament. Adaptat 
de (32, 47, 57, 163). 
Mentre que els pics sèrics de CK observats durant les primeres 24 hores després de 
l’exercici indiquen un increment de la permeabilitat de la membrana, és més 
probable que els pics produïts més enllà dels 4-5 dies posteriors a l’exercici es trobin 
relacionats amb un procés de necrosi en alguns segments de les fibres musculars (7, 
162). Així, doncs, els nivells de CK observats a partir de les 48 hores i fins als set 
dies posteriors a l’exercici en la població de subjectes categoritzada com a high 
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responders a l’estudi III indiquen molt possiblement la necrosi d’alguns segments de 
les fibres musculars afectades per l’exercici excèntric. La CK, en certa mesura, 
reflecteix la quantitat de dany, especialment quan l’EIMD esdevé greu (120).  
 
Figura 6. Coeficients de correlació de Spearman (rs) entre els valors de força isomètrica 
voluntària màxima (MVC) de la cama que va patir el nivell de pèrdua de capacitat de 
generació de força (FGC) més accentuat i la creatina quinasa (CK) obtinguts 48 hores i set 
dies després de l’exercici de rull de cames excèntric (estudi III, n = 13). L’eix x es mostra en 
escala logarítmica. 
Finalment, les correlacions obtingudes entre els increments de CK i les davallades 
marcades de la capacitat de generació de força (FGC) observades també en l’estudi 
III reforcen la noció segons la qual els nivells sèrics de CK reflecteixen la quantitat 
de dany, especialment quan l’EIMD esdevé greu i és probable la necrosi d’alguns 
segments de les fibres musculars afectades per l’exercici (Figura 6).  
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Isoenzim MB de la creatina quinasa i disrupció del sarcòmer 
de les fibres lentes (tipus I)? 
Les diverses correlacions trobades entre l’activitat o concentració de diversos 
enzims amb la concentració en sèrum de la isoforma lenta (tipus I o ß) de la miosina 
(SM) suggereixen que elevacions significatives de CK-MB podrien estar 
relacionades amb el dany estructural del sarcòmer de les fibres lentes (tipus I). 
Concretament, a l’estudi V es reporta una correlació elevada entre el pic sèric de 
CK-MB registrat una hora després de l’exercici i la concentració sèrica pic d’SM 
observada 24 hores després de l’inici de l’LDE (r = 0.725, P = 0.001). A més, el pool 
total de valors de CK-MB obtinguts una hora després de l’exercici dels estudis de 
camp basats en protocols d’LDE (estudis IV i V) també presenta una correlació 
elevada amb els nivells d’SM registrats 24 hores després de l’exercici (Figura 7).  
El CK-MB està format per les subunitats M i B (30). La subunitat M de la CK es troba 
a la regió M (també anomenada banda M) del sarcòmer (103). La regió M és el 
centre de múltiples processos metabòlics, mecanosensitius i de proteòlisi 
intracel·lular (proteasoma) (2, 96). Tots aquests processos sostenen l’homeòstasi de 
la fibra i l’activitat contràctil mitjançant el manteniment de la integritat sarcomèrica 
per donar resposta a les demandes energètiques durant la contracció i adaptar-se a 
diversos estímuls bioquímics i biomecànics (103). D’aquesta manera, increments en 
sèrum de CK-MB per sobre del llindar de normalitat clínica (4 ng·mL-1) podrien estar 
relacionats amb l’afectació de la integritat d’aquesta estructura sarcomèrica. D’altra 
banda, atès que s’ha provat que les fibres lentes (tipus I) presenten nivells de CK-
MB més elevats que no pas les fibres ràpides (tipus II) (211), un increment 
significatiu de la concentració en sèrum de CK-MB es podria associar al dany de les 
fibres lentes (tipus I).  
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Figura 7. Coeficient de correlació de Spearman (rs) entre els pools totals (n = 24) (estudis IV i 
V) de l’isoenzim MB de la creatina quinasa (CK-MB) registrats una hora després de l’exercici 
i els nivells de miosina lenta (tipus I o ß) (SM) obtinguts 24 hores després de l’inici de 
l’exercici. Els valors del subjecte 7 de l’estudi IV (CK-MB: 245 ng·mL-1; SM: 6999 µg·L-1) 
s’han exclòs de la representació gràfica.   
Les diverses característiques del CK-MB, com ara la ubicació de la subunitat M al 
sarcòmer (96, 103) o la seva presència superior a les fibres lentes (tipus I) (211) 
unides amb les correlacions elevades trobades amb l’SM, suggereixen que 
increments significatius d’aquest isoenzim, per sobre del llindar de normalitat clínica 
(4 ng·mL-1), podrien indicar no només un increment de la permeabilitat de la 
membrana, sinó també un dany més profund relacionat amb l’aparell contràctil (regió 
M del sarcòmer) de les fibres lentes (tipus I).  
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Creatina quinasa mitocondrial sarcomèrica: de l’efecte 
protector de l’entrenament a l’apoptosi de la fibra muscular 
En els estudis de camp basats en protocols d’LDE (estudis IV i V) s’observen 
increments significatius d’sMtCK a partir d’una hora després de la finalització de 
l’exercici, els quals es van mantenir 24 hores després de l’exercici. L’única excepció 
va ser el grup de corredors que presentaven nivells d’entrenament més elevats 
(highly trained) en l’estudi V (Figura 8). Tal com s’ha demostrat amb rates (Sprague-
Dawley), l’exercici de llarga durada indueix a dany mitocondrial, però el nivell 
d’entrenament exerceix un efecte protector sobre els mitocondris (49) a partir d’una 
reducció específica de la captació de Ca2+ (27) i un increment de la capacitat 
antioxidant (198). Aquest fet, encara que només s’hagi provat en un model animal, 
podria explicar les concentracions menors d’sMtCK observades en l’estudi V en els 
corredors que presentaven nivells d’entrenament més elevats (highly trained).  
 
Figura 8. Mitjana ± error estàndard de la mitjana (SEM) de la concentració de creatina 
quinasa mitocondrial del sarcòmer (sMtCK) obtinguda en els estudis de camp basats en 
exercicis de llarga durada (estudis IV i V). * Significativament diferent respecte als valors 
basals a escala P < 0,05. 
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D’altra banda, en l’estudi III es van trobar valors de concentració sèrica d’sMtCK molt 
superiors als obtinguts en els estudis de camp basats en protocols d’LDE (estudis IV 
i V). A més, també es van trobar notables diferències significatives entre els grups 
de subjectes (high versus moderate responders) (Figura 9).  
 
Figura 9. Mitjana ± error estàndard de la mitjana (SEM) de la concentració de creatina 
quinasa mitocondrial del sarcòmer (sMtCK) obtinguda en l’estudi III. * Significativament 
diferent respecte als valors basals a escala P < 0,05. # Diferència significativa entre grups a 
escala P < 0,05.  
Recentment, els mitocondris han estat reconeguts com a agents clau en els 
sistemes de regulació cel·lular, com la gestió del Ca2+ i els processos d’apoptosi 
(147). Concretament, sembla que l’sMtCK desenvolupa el paper de sensor de l’estat 
energètic de la fibra muscular i que, en funció d’aquest, desencadena el procés 
d’apoptosi (180). Així, és probable que grans increments d’sMtCK, com en el cas de 
l’estudi III, siguin indicatius d’inflamació i disrupció mitocondrial, amb la reducció 
consegüent de la capacitat respiratòria de la fibra muscular i, en última instància, 
l’apoptosi de segments de la fibra muscular (49). A més, s’ha descrit una correlació 
elevada entre els decrements d’FGC i la disrupció miofibril·lar (163, 174). En 
conseqüència, s’ha assumit que la magnitud de pèrdua d’FGC reflecteix el nombre 
de fibres afectades (120). Ateses les diverses correlacions mostrades en l’estudi III 
entre els valors d’sMtCK i la força isomètrica voluntària màxima (MVC) (decrements 
d’FGC) al cap de 48 hores i, especialment, set dies després de l’exercici, sembla 
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raonable pensar que les pèrdues sensibles d’FGC són un reflex d’un cert nombre de 
miofibril·les que han mort per apoptosi (112, 169) (Figura 10).  
 
Figura 10. Coeficients de correlació de Spearman (rs) entre els valors de força isomètrica 
voluntària màxima (MVC) de la cama que va patir el nivell de pèrdua de capacitat de 
generació de força (FGC) més accentuat i la creatina quinasa (CK) obtinguts 48 hores i set 
dies després de l’exercici de rull de cames excèntric (estudi III, n = 13). 
5.1.2 Isoformes de la miosina 
En dos dels estudis de laboratori basats en protocols d’HIE (estudis I i II), es van 
trobar increments (significatius en el cas de l’estudi I) de la concentració sèrica de la 
miosina ràpida (tipus II) (FM) al cap de 48 hores. L'única excepció va ser el subjecte 
control de l’estudi II, en el qual no es van observar canvis en els nivells d’FM en cap 
dels punts temporals analitzats. D’altra banda, en els estudis de camp basats en 
LDE (estudis IV i V), es van descriure increments significatius de la miosina lenta 
(tipus I o ß) (SM) a partir de les 24 hores posteriors a l’inici de l’exercici. Així, doncs, 
en termes generals, es pot concloure que, mentre que els LDE indueixen 
majoritàriament a increments d’SM, els HIE provoquen augments d’FM (Figura 11).  
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Figura 11. Mitjana ± error estàndard de la mitjana (SEM) de la concentració de miosina 
ràpida (tipus II) i lenta (tipus I o ß) obtinguda en dos dels estudis de laboratori basats en 
protocols d’exercici d’alta intensitat (HIE) (estudis I i II) i dels estudis de camp basats en 
exercicis de llarga durada (LDE) (estudis III i IV). *, **, *** Significativament diferent respecte 
als valors basals a escala P < 0,05, P < 0,01, i P < 0,001, respectivament.  
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Així, doncs, en els estudis I, II, IV i V, mentre que augments sèrics d’enzims com la 
CK indiquen un increment de la permeabilitat de la membrana (sarcolemma) (106), 
increments significatius de miosina suggereixen un dany més greu relacionat no 
només amb el sarcolemma, sinó també amb la disrupció del sarcòmer (40, 41). 
Aquesta afirmació té el suport de diversos estudis anteriors sobre el fenomen de 
l’EIMD en els quals també es va utilitzar com a biomarcador la concentració sèrica 
de diverses proteïnes del sarcòmer, com ara la α-actina (131) o la troponina I (187), i 
també les seves respectives isoformes ràpida (fsTnI) i lenta (ssTnI) (46, 61), o els 
fragments de la cadena pesada de la miosina (MHC) lenta (tipus I o ß) (129, 187, 
188). A més, les isoformes de la miosina ja s’havien mostrat com a biomarcadors 
vàlids de lesions musculars diagnosticades per ressonància magnètica (MRI) i 
ecografia. De la mateixa manera, les isoformes de la miosina no només es 
presentaven com una eina de diagnòstic del grau de lesió muscular (graus I, II i III), 
sinó que també permetien diferenciar quina tipologia de fibra s’havia vist afectada 
principalment (86). En aquest sentit, els resultats obtinguts als diversos estudis 
d’aquesta tesi suggereixen que la miosina també pot ser un biomarcador vàlid i 
fiable de dany muscular (fins i tot quan aquest és de caràcter lleu) induït per diverses 
tipologies d’exercici. A més, les isoformes de la miosina són biomarcadors específics 
de fibra que permeten identificar quina tipologia de fibra (ràpida [tipus II] o lenta 
[tipus I]) s’ha vist afectada principalment per l’exercici (40, 41). 
Curs temporal d’aparició en sèrum 
En els diversos estudis realitzats, el pic sèric d’isoformes de la miosina es va trobar 
entre les 24 i les 48 hores posteriors a l’exercici (Figura 11). Aquests resultats són 
coincidents amb els exposats prèviament per Guerrero et al. (86). A més, en l’estudi 
I, en el qual es van arribar a mesurar les concentracions sèriques de miosina fins a 
144 hores després de l’exercici, es va observar que l’FM es mantenia elevada de 
manera significativa fins gairebé una setmana després de l’exercici (40). L’FM i l’SM, 
per tant, presenten un curs temporal en sèrum diferent del dels enzims. S’ha 
suggerit que després de l’exercici excèntric s’inicia un procés de proteòlisi en què la 
proteasa calpaïna allibera les proteïnes contràctils de l’estructura filamentosa del 
sarcòmer (84). Llavors, el procés de degradació de les proteïnes de l’aparell 
contràctil com la miosina es completa amb el sistema ubiquitina-proteasoma (65). 
Una raó que podria explicar els increments sèrics de la concentració de miosina més 
enllà de les 24 hores posteriors a l’exercici és que el procés de recanvi de les 
proteïnes sarcomèriques requereix més temps que no pas el de les proteïnes no 
 183 
contràctils del sarcoplasma (143). A més, l’activitat màxima de la calpaïna augmenta  
unes 48 hores després de l’exercici excèntric i arriba a nivells fins a tres vegades 
més elevats al cap de 144 hores (110), fet que podria explicar l’obtenció de valors 
significativament elevats de miosina fins gairebé una setmana després de l’exercici 
(vegeu l’estudi I). La cascada de reaccions que tenen com a resultat la degradació 
de proteïnes de l’aparell contràctil del múscul esquelètic és un procés complex que 
sembla que determina el curs temporal d’aparició de les isoformes de la miosina en 
sèrum.  
Atès que la miosina presenta un pes molecular de 493 kDa (95) i el teixit muscular 
presenta una permeabilitat capil·lar baixa, sembla raonable pensar que la seva 
entrada al corrent sanguini es produeix per via limfàtica (22, 126, 127). Aquest fet 
també contribuiria a la seva aparició tardana en el sèrum després de l’exercici 
excèntric. 
Finalment, atesa l’estabilitat elevada en sang de la miosina (86), fins a 144 hores 
després de l’exercici en el cas de l’FM (40), en estudis futurs caldrà clarificar el curs 
temporal dels mecanismes de depuració responsables del retorn dels valors sèrics 
de les isoformes de la miosina als nivells registrats de manera prèvia a l’exercici.   
Disrupció i remodelació 
Mentre que els increments significatius d’isoformes de la miosina observats fins a 48 
hores després de l’exercici excèntric suggereixen una disrupció del sarcòmer (40) 
(41), els valors elevats de manera persistent fins gairebé una setmana després de 
l’exercici indicarien un procés de remodelació, especialment quan els valors d’FGC 
han recuperat els nivells basals (Figura 12). Això està en línia amb estudis anteriors 
en què, mitjançant l’observació a través de microscopi immunoelectrònic de mostres 
de teixit muscular, s’afirma que les disrupcions miofibril·lars observades poc després 
de l’exercici indiquen dany de l’aparell contràctil, mentre que els canvis en les 
estructures miofibril·lars observats després de diversos dies de recuperació podrien 
representar un procés de remodelació (214). 
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Figura 12. Mitjana ± error estàndard de la mitjana (SEM) de la concentració de miosina i 
potències inercials màximes (resultats estudi I). CON, concèntric. ECC, excèntric. FM, 
miosina ràpida (tipus II). * Significativament diferent respecte als valors basals a escala P < 
0,01. 
5.1.3 Limitacions del model. La problemàtica de les 
fibres híbrides 
Mitjançant models animals (mamífers), Hämäläinen i Pette (88) van descriure les 
fibres «híbrides» en músculs esquelètics «normals» (no sotmesos a canvis en els 
patrons d’estimulació neural mitjançant electrostimulació). Aquest tipus de fibres del 
múscul esquelètic expressen més d’una isoforma de l’MHC, mentre que les fibres 
«pures» n’expressen només un tipus (179). S’ha demostrat en humans que les fibres 
híbrides coexpressen diversos tipus d’MHC: MHC ß/slow i 2A, i MHC 2A i 2X (25) 
(115). Aquestes expressen un fenotip de fibres en transformació (5) com les 
descrites en condicions d’immobilització induïda per lesió (87) o com a resposta a 
l’entrenament (100). D’aquesta manera, l’aparició en sèrum d’FM o SM podria 
indicar no només la disrupció sarcomèrica de fibres pures (ràpides o lentes), sinó 
també de fibres híbrides que expressen diferents tipus d’MHC. Per a aquest model 
molecular d’EIMD, mentre que les fibres híbrides MHC 2A i 2X no representen cap 
tipus de problema, ja que l’anticòs monoclonal utilitzat les reconeix de manera 
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genèrica com a fibres ràpides (tipus II), el dany potencial provocat sobre les fibres 
híbrides MHC 1 ß/slow i 2A podria induir a interpretacions errònies. Cal destacar, 
però, que en el vast lateral de subjectes sedentaris joves (23-31 anys), només s’ha 
trobat un 8 % de fibres híbrides que coexpressen MHC 1 ß/slow i 2A (115), i en 
subjectes moderadament actius no s’han trobat indicis d’aquesta tipologia de fibres 
híbrides (114). D’aquesta manera, el biaix al qual podria induir un dany potencial de 
les fibres híbrides MHC 1 ß/slow i 2A es veuria pal·liat de manera notable en els 
estudis basats en exercicis del tren inferior a intensitats elevades, ja que durant la 
seva realització, la mostra emprada incloïa, principalment, participants joves i 
moderadament actius. Per contra, hi ha discordança entre estudis amb humans 
sobre el percentatge de fibres híbrides MHC 1 ß/slow i 2A en subjectes entrenats en 
resistència. Mentre que Klitgaard et al. (114) van reportar que un 36 % de les fibres 
analitzades del vast lateral de subjectes entrenats en resistència coexpressaven 
MHC ß/slow i MHC 2A, Putman et al. (173) no van trobar indicis d’aquesta tipologia 
de fibres (o percentatges extremament baixos [<1 %]) també al vast lateral de 
subjectes entrenats en resistència. Pel que fa al gastrocnemi lateral, s’ha descrit un 
~6-7 % de fibres híbrides MHC 1 ß/slow i 2A en atletes de mig fons i fons (rang: 800-
10.000 m) (90) i de cros atlètic (89). Per tant, i malgrat la manca de consens entre 
estudis, atès que en subjectes entrenats en disciplines de resistència la presència de 
fibres híbrides MHC 1 ß/slow i 2A podria arribar a ser relativament elevada, els 
increments sèrics d’SM indicarien no només dany de fibres lentes (tipus I), sinó 
també de fibres híbrides MHC 1 ß/slow i 2A.    
5.1.4 Resum 
En els estudis de laboratori I i II, basats en protocols d’HIE en què s’han emprat 
exercicis globals del tren inferior amb gran participació dels extensors del genoll (mig 
esquat), s’han obtingut increments lleus de l’activitat o concentració enzimàtica en 
sèrum (p. ex., CK ≤ 1000 IU·L-1) 24 hores després de l’exercici. En els estudis de 
camp IV i V, basats en protocols d’LDE en què s’han utilitzat curses competitives de 
muntanya, s’han obtingut increments moderats de l’activitat o concentració 
enzimàtica en sèrum (p. ex., CK 1000 - 2000 IU·L-1) entre una i 24 hores després de 
l’exercici. En ambdós casos (HIE i LDE), el curs temporal i la magnitud dels 
augments són coherents amb un procés d’increment de la permeabilitat de la 
membrana (106, 160). Els resultats indiquen que els extensors del genoll presenten 
una resistència elevada al dany muscular induït per HIE (106), especialment quan 
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els exercicis són de caràcter global i multiarticular. L’exposició a contraccions 
excèntriques de la cadena extensora del tren inferior durant les activitats diàries (48, 
107) i la seva arquitectura (18, 209) sembla que són els factors determinants del seu 
nivell baix de susceptibilitat. 
Els increments posteriors a l’exercici de la concentració sèrica del CK-MB, per sobre 
del llindar de normalitat clínica, observats en els estudis de camp IV i V i basats en 
protocols LDE podrien suggerir un dany de l’aparell contràctil (afectació de la regió M 
del sarcòmer) de les fibres lentes (tipus I).  
D’altra banda, en l’estudi de laboratori III, basat en un protocol d’HIE en què s’ha 
emprat un exercici analític (monoarticular, amb aïllament elevat del múscul 
semitendinós) d’alta intensitat (120 % de la repetició màxima [1-RM] concèntrica) de 
la musculatura flexora del genoll (isquiotibials), és probable que grans pics sèrics 
d’activitat/concentració enzimàtica (p. ex., CK > 10.000 IU·L-1; > sMtCK 500 ng·mL-1) 
registrats més enllà de les 72 hores posteriors a l’exercici i encara significativament 
elevats als set dies es trobin relacionats amb processos de necrosi (7, 162) i 
apoptosi (112, 169) d’alguns segments de les fibres musculars. Els isquiotibials 
(flexors del genoll) són més susceptibles a l’EIMD excèntric que no pas els 
extensors del genoll (48).  
Pel que fa a les isoformes de la miosina, en els estudis de laboratori I i II, basats en 
protocols d’HIE en els quals s’han emprat exercicis globals del tren inferior amb gran 
participació dels extensors del genoll (mig esquat), s’han obtingut increments 
(significatius en el cas de l’estudi I) de la concentració d’FM en sèrum 48 hores 
després de l’exercici. En els estudis de camp IV i V, basats en protocols d’LDE en 
els quals s’han utilitzat curses competitives de muntanya, s’han obtingut increments 
significatius de la concentració sèrica d’SM entre les 24 i 48 hores posteriors a 
l’exercici. En cap dels estudis no s’han trobat increments (significatius) concurrents 
d’FM i SM. En ambdós casos (HIE i LDE), els augments d’FM o SM són coherents 
amb un procés de disrupció del sarcòmer de les fibres ràpides (tipus II) (40) o lentes 
(tipus I) (41), respectivament. És interessant destacar que l’anàlisi estadística del 
pool total de concentracions en sèrum d’isoformes de la miosina dels estudis basats 
en protocols d’HIE (estudis I i II) i els estudis basats en LDE (estudis IV i V) confirma 
aquesta tendència de dany selectiu (Figura 13). 
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Figura 13. Mitjana ± error estàndard de la mitjana (SEM) del pool total de concentracions de 
miosina ràpida (tipus II) i lenta (tipus I o ß) obtingut dels estudis basats en exercicis d’alta 
intensitat (HIE) (n = 12) (estudis I i II) i de llarga durada (LDE) (n = 24) (estudis III i IV). Les 
dades estan normalitzades respecte als valors basals (100 %). *, ** Significativament diferent 
respecte als valors basals a escala P < 0,01, i P < 0,001, respectivament . 
Valors d’isoformes de la miosina elevats de manera persistent, fins gairebé una 
setmana després de la realització de l’exercici excèntric, poden ser indicatius d’un 
procés de remodelació sarcomèrica més que no pas de disrupció (214), 
especialment quan els valors d’FGC ja s’han recuperat (40). 
 
Finalment, a la Figura 14 es resumeix el model molecular d’EIMD. Fonamentat 
inicialment en les propostes de diversos autors (3, 4, 13, 19, 30, 61, 65, 83, 84, 106, 
127, 129, 134, 160, 180, 189), s’ha desenvolupat en base als resultats de l’estudi I 
(40) i, a partir d’aleshores, s’ha enriquit mitjançant els resultats de la resta d’estudis 
(II, III, IV i V) que composen la present tesi. El model es basa en el pes molecular i la 
compartimentació estructural en la fibra muscular dels diversos enzims i isoformes 
de la miosina, i també en el seu perfil temporal i la seva magnitud d’aparició en 
sèrum. En la Figura 14 es mostren els mecanismes hipotètics que podrien estar 
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involucrats en l’aparició d’aquests enzims i proteïnes en el sèrum a partir d’un 
estímul primari com són les contraccions excèntriques desenvolupades en els 
exercicis d’alta intensitat (estudis I, II i III) o llarga durada (estudis IV i V).  
A la Figura 14 es mostra com mentre els increments sèrics moderats de CK 
indiquen un augment de la permeabilitat de la membrana (106, 160), per disrupció 
(134) o per l’activació dels canal iònics (Ca2+) (4), augments de FM o SM són 
coherents amb un procés de dany més profund, relacionat amb la disrupció del 
sarcòmer de les fibres ràpides (tipus II) (40) o lentes (tipus I) (41), respectivament. 
Finalment, a la Figura 14 també es reflecteix com increments sèrics de sMtCK 
poden ésser indicatius d’un dany miofibril·lar profund basat en la inflamació i 
disrupció mitocondrial i, en última instància, l’apoptosi de segments de la fibra 
muscular (49). 
Així doncs, a partir d’aquest model es pot caracteritzar el dany muscular en funció 
del tipus d’exercici excèntric (alta intensitat o llarga durada). No obstant, cal tenir en 
compte que el grau de dany muscular que pot induir un exercici està altament 
determinat per factors individuals de tipus genètic (54, 104, 150, 213), pel nivell 
d’activitat (entrenament) (69, 81, 162) o per l’efecte protector del repeated bout effect 
(RBE) (133), de forma que no es pot realitzar una universalització d’aquests resultats 
en poblacions amb característiques diferents a les dels subjectes que han composat 
les mostres dels diversos estudis.  
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Figura 14. Model 
molecular indirecte de 
dany muscular induït per 
l’exercici (EIMD) que 
indica els mecanismes 
hipotètics que hi podrien 
estar involucrats. Ca2+, 
calci (ions). CK, creatina 
quinasa. sMtCK, creatina 
quinasa mitocondrial 
sarcomèrica. ROS, 
espècies reactives de 
l’oxigen, RNS, espècies 
reactives del nitrogen. 
Basat en (3, 4, 13, 19, 30, 
40, 61, 65, 83, 84, 106, 
127, 129, 134, 160, 180, 
189) 
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6. CONCLUSIONS 
6.1 Indirect molecular model of exercise-
induced muscle damage  
• FM and SM serum increases revealed sarcomere disruption as well as 
increased membrane permeability of fast (type II) and slow (type I) fibers 
respectively. Consequently, myosin isoforms can be adopted as fiber type-
specific biomarkers of muscle damage. 
• An indirect model of EIMD can be constructed based on the serum evolution 
of muscle enzymes and muscle FM and SM according to their molecular 
weight, the fiber compartment in which they are located and, in the case of 
myosin isoforms, the fiber type in which they are expressed. 
6.2 Application of the indirect molecular model 
of exercise-induced muscle damage for 
exercise characterization 
6.2.1 High intensity exercise 
• An increase in FM serum concentration following inertial exercise suggests 
selective fast (type II) fiber damage. 
• The exercise output of the pole vault athlete revealed an explosive (power-
oriented) profile leading to selective mild damage of fast (type II) fibers. In 
contrast, the exercise output of the physical education student showed a 
fatigue-resistant profile, which led to a higher extent of slow (type I) fiber 
damage. 
• Although large differences between subjects (high and moderate responders) 
can be expected according to the sporting activity and the activity level 
(training status), intensive eccentric unilateral leg curl exercise induces 
severe EIMD. 
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• Changes in the serum enzyme activities or concentrations after exercise were 
in accordance with the differences between-subjects (high and moderate 
responders) in terms of the extent of EIMD reflected by FGC reductions. 
• sMtCK is a promising novel EIMD biomarker of myofibrillar apoptosis which is 
able to identify high responders. 
6.2.2 Long duration exercise 
• An increase in SM serum concentration following MUM (42.195 km) indicates 
selective slow (type I) fiber damage. 
• Although the reproducibility of field studies is low because of the complex 
characteristics of mountain running competitions, distance may be related to 
biochemical indices of muscle damage. 
• When competing in a MUM, training status does not seem to have any effect 
on serum changes in EIMD biomarkers. 
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Skeletal muscle fast myosin increases in serum after maximal concentric-
eccentric inertial exercise 
Carmona, G.1, Guerrero, M.2, Cussó, R.2, Padullés, JM.1, Moras, G.1, Lloret, M.1, Bedini, 
JL.3, Cadefau, JA.1-2 
1: INEFC (Spain, Barcelona), 2: UB (Spain, Barcelona), 3: Hospital Clínic (Spain, Barcelona) 
Introduction 
We hypothesized that a model of muscle damage could be made by measuring the time 
course of the serum concentration of muscle enzymes and proteins following inertial exercise, 
according to their molecular weight and their fibre compartmentalization. Moreover, by 
measuring fibre-type specific sarcomere proteins, fast myosin (FM) and slow myosin (SM), 
the type of fibres that are affected could be assessed (1). 
Methods 
Ten recreationally active men were required to perform 7 sets of 10 maximum intensity 
concentric-eccentric (C-E) repetitions of a half-squat exercise in a flywheel inertial resistance 
device (Portable VersaPulleyTM, Heart Rate Inc., Costa Mesa, CA). The exercise dynamic 
muscle work was characterized using the time course of force, displacement and velocity 
data, sampled at a frequency of 100 Hz from the force sensor and linear encoder of 
MuscleLab 4020e (MuscleLab, Ergotest Technology, Langesund, Norway) (2). The muscle 
damage effect of this exercise was assessed through the evolution of serum muscle enzymes 
and fibre-type specific myosin isoforms. Serum profiles of creatine kinase (CK), creatine 
kinase MB isoenzyme (CK-MB), aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), and myosin isoforms (FM and SM), were measured before and 24, 48 and 144 h post-
exercise. 
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Results 
Muscle enzymes, CK, CK-MB and, to a lesser extent, AST, were early increased in serum (24 
h), and returned to baseline values at 48 h post-exercise. FM was late increased in serum (48 
h) and remained elevated until 144 h post-exercise. SM serum concentration showed no 
significant changes. 
Discussion 
The maximal C-E inertial exercise of the knee extensors, involving a highly specific 
movement similar to several sports actions, induces a different level of damage in fast and 
slow fibres. Interestingly, while an increase in muscle damage biomarkers like CK, CK-MB, 
and to a lesser extent AST, indicated increased membrane permeability, FM serum increases 
revealed sarcomere disruption as well as increased membrane permeability of fast fibres. 
Consequently, FM could be adapted as a fast-fibre biomarker of muscle damage. The results 
support a model of muscle damage based on the serum time course of muscle proteins 
according to their molecular weight and their fibre compartmentalization, depending on 
exercise and fibre-type. 
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